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The present study set out to investigate whether melatonin 
interacts with the serotonergic system. Established rodent 
behavioural models for specific 5-hydroxytrypfamine (5-HT) mediated 
behaviour were used to test this hypothesis. The generation of 
headtwitches by the non-specific 5-HT agonists 5-Methoxy-N,N- 
dimethyltryptamine (5MeODMT) and 5-hydroxy-L-tryptophan (L-5HTP) was 
used as a model for the activition of 5-HT2 receptors; hyperphagia 
and hypothermia induced by 8-hydroxy-2-(di-n-propylamino)tetralin 
(8-OHDPAT) were used as models for 5-HTia receptor activation; and 
hyperactivity induced by 5-methoxy-3-(1,2,3,6-tetrahydropyrindin-
4-yl)-1H-indole (RU24969) was used as a putative model for 5-HTib 
receptor activation. It was recognized that sensitivity to melatonin 
might vary over 24 h and therefore experiments were conducted at 
four time points where conditions permitted. Melatonin had no effect 
on any of the behavioural models at any of the time points 
investigated.
The discriminative stimulus produced by L-5HTP was used as 
a further example of 5-HT receptor activation. Melatonin was found 
to have no effect on the cue generated by L-5HTP using the T-maze 
(shock escape) drug discrimination paradigm. Furthermore, melatonin 
itself failed to produce a discriminative stimulus that could be 
distinguished from saline using both the T-maze and Skinner box 
(food reward) drug discrimination paradigms at doses upto 50mg/kg 
ip. Moreover, melatonin was found to be without effect on both the 
visual and temporal components of a combined light-dark:time-of-day 
discriminative cue.
A second series of experiments examined the effects of
melatonin on the circadian rhythm of locomotor activity in rats. 
Melatonin failed to affect the rate and direction of re-entrainment 
following a phase inversion of the LD cycle. However, the ability of 
appropriately-timed injections of melatonin to entrain free-running 
circadian locomotor activity rhythms was confirmed. Since melatonin 
does not act as a discriminative stimulus at similar doses it is 
concluded that this ability is not dependent upon the periodic 





It is the intention of this introduction to give an 
overview of the three main subjects covered in this thesis, namely 
melatonin, circadian rhythms and 5-hydroxytryptamine (5-HT). 
Melatonin is considered first; its site of manufacture, its 
synthesis, its physiological and pharmacological properties and the 
identification of specific melatonin receptors. There follows a 
section describing the properties and regulation of circadian 
rhythms. The final part of this chapter is devoted to the 
biochemistry and physiology of 5-HT. It also discusses the recent 
proliferation in 5-HT receptor subtypes and their biochemical and 
behavioural correlates. Specific 5-HT mediated behaviours are 
examined in greater detail in chapters 3 and 4.
1.1. Melatonin
1.1.1. Morphology and Vascularization of the Mammalian Pineal 
Gland
The mammalian pineal gland is the major manufacturer of 
the indoleamine, melatonin. The organ is located in the midline of 
the brain at the junction of the cerebellum and the cerebral 
hemispheres. Although it is generally thought of as lying outside 
the blood brain barrier (Reiter, 1988; Moller et al., 1978) it is 
connected to the brain via a stalk that descends downwards and 
attaches to the choroid plexus. Goldman and Wurtman (1964) reported 
that the gland supports a very generous blood supply, second only to 
the kidney per gram of tissue. Arterial supply is derived from the 
posterior choroidal vessels which in turn arise from the posterior 
cerebral arteries as they travel around the dorsolateral aspect of
2the mesencephalon (Reiter, 1981). The pineal parenchyma consists of 
several cell types commonly found elsewhere e.g. glial cells and 
mast cells. The pinealocyte, however, is specific to the gland and 
constitutes the melatonin production factory. It is thought to be 
derived phylogenically from retinal photoreceptors since lower 
vertebrates possess modified photoreceptors that bear a strong 
functional and structural resemblence to their retinal counterparts 
(Falcon and Collin, 1989). These early pinealocytes are able to 
detect the presence or absence of light directly unlike those 
present in mammals that respond to a retinally-derived neural signal 
only. Structurally, mammalian pinealocytes resemble neurons in that 
many long cytoplasmic processes spread out from the cell body in 
various directions. These processes have been shown to terminate 
near perivascular spaces, blood vessels, calcicular concretions, 
between connective tissue and between pinealocytes (Vollrath, 1984). 
One of the most interesting infrastructural features of pinealocytes 
is the synaptic ribbons and synaptic spherules described by Vollrath 
(1984). It has been shown that these display an inverse day/night 
rhythmicity relationship in the guinea pig (Vollrath et al., 1983). 
Their numbers are low during the daytime, but high at night. It has 
been suggested by King and Dougherty (1982a, 1982b) that the 
synaptic ribbons may be involved in the regulation of 
beta-adrenoceptors located on the pinealocyte membrane.
It is generally accepted now that mammalian pinealocytes 
are secretory cells that release melatonin into the capillary 
vessels that vascularize the gland via the capillary spaces and the 
fenestrated capillary endothelial wall and that this constitutes the 
major route of secretion (Hedlund et al. 1977; Rollag et al., 1978; 
Reiter, 1986). From these vessels the product is ultimately able to
3drain into the large intracranial veins (Kappers et al., 1973). It 
has also been suggested by many authors that pinealocytes present in 
the pineal recess (the stalk extension of the pineal gland that 
attaches to the third ventricle of the brain at the choroid plexus) 
secrete melatonin directly into the cerebro-spinal fluid (CSF) 
(Anton-Tay and Wurtman, 1969; Collu et al., 1971). The pineal recess 
is described by Hewing (1978) as having an interruption in the 
ependymal lining which allows pinealocytes to come into direct 
contact with the CSF. Circumstantial evidence supporting this 
concept is provided by Hedlund et al. (1977) who identified a higher 
concentration of melatonin in the CSF of sheep than in the plasma. 
Conversely, Brown et al. (1979) have shown that human blood titres 
of melatonin are greater than those measured in the CSF.
A curious feature of the pineal gland is the calcicular 
concretions which provide a useful radiological landmark for 
identifying the midsagittal plane of the brain (Vollrath, 1984) but 
have so far escaped a proven physiological role. It has been shown 
that calcification increases with age (Kitay and Altschule, 1954; 
Reiter et al., 1976) and may well reflect the secretory activity of 
the gland (Vollrath, 1984). This speculation arises from Reiter et 
al. (1976) who observed a decrease in concretion formation after 
sympathetic denervation which suppresses melatonin production.
1.1.2. Innervation of the Mammalian Pineal Gland
The ability of light to regulate the synthesis of 
melatonin was first reported by Wurtman et al. in 1963. This was 
followed up in 1964 by the same research group who identified the 
central role played by the sympathetic nervous system in mediating 
this effect of light (Wurtman et al., 1964a). Since then extensive
4studies by Moore and Lenn (1972) and Moore (1973) have established 
the presence of the retino-hypothalamic tract (RHT), a monosynaptic 
neural pathway from retina to the suprachiasmatic nucleus (SCN), in 
addition to the subsequent route to the pineal gland itself. The
ganglion cell layer of the retina conveys neurally coded photic
information bilaterally to the optic chiasm and, following
decussation, to the region of the hypothalamus known as the SCN.
From the SCN photic signals are transmitted to the paraventricular 
nucleus (PVN), also of the hypothalamus, over the medial forebrain 
bundle to the upper thoracic interiomediolateral cell column of the 
spinal cord (Klein et al., 1983). Synaptic connections are made at 
this point with preganglionic cell bodies which innervate the 
superior cervical ganglia (SC6) whose postganglionic fibres project 
back to the brain and enter the pineal gland via the conarian nerve. 
In the rat, at least, it appears that these sympathetic fibres in 
the pineal gland do not form distinguishable synapses with the 
pinealocytes, but instead release transmitter into the perivascular 
space (Moore, 1978). In addition to this peripheral sympathetic 
innervation, certain species also possess a central innervation from 
the habenular nuclei that penetrates the pineal organ via the 
stalk, though its function remains obscure (Korf and Moller, 1984; 
Dafny, 1980). It is thought that there may be two types of 
transmission for photic stimuli; a fast one using the central 
habenulo-pineal route and a slow one via the SCG (Kappers, 1983).
Parasympathetic innervation of the pineal gland has also 
been reported (Kenny, 1961; Romijn, 1973) along with the 
identification of a low density of postsynaptic muscarinic binding 
sites (Taylor et al., 1980). Schrier and Klein (1974) reported an 
absence of choline acetyltransferase in the gland and Romijn (1975,
51976) observed only minor changes in the infrastructure of 
pinealocytes after parasympathectomy and administration of 
parasympatholytic drugs. However, the recent work of Laitinen et al. 
(1989) suggests that muscarinic Mi receptors might be involved in 
phosphoinositide turnover in the rat pineal.
1.1.3. Sources of Melatonin
A number of studies have been published now that counter 
the early belief that the manufacture of melatonin was the sole 
prerogative of the pineal organ. The retina (Quay, 1965; Cardinali 
and Rosner, 1971; Leino and Airaksinen, 1985; Weichmann, 1986), 
Harderian gland (Bubenik et al., 1974, 1978; Reiter et al., 1981; 
Hoffmann et al., 1985), the gastrointestinal tract (Raikhlin et al., 
1975; Quay and Ma, 1976), the central nervous system (Bubenik et 
al., 1974), red blood cells (Rosengarten et al., 1972) and blood 
platelets (Launay et al., 1983) have all been claimed to produce 
melatonin. As with the pineal organ, production of melatonin in the 
Harderian gland and the retina exhibits a circadian rhythm (Binkley 
et al., 1979; Hamm and Menaker, 1980; Pang et al., 1980; Reiter et 
al., 1983). However, the purpose of this production in these 
structures has yet to be identified since their contribution to 
circulating melatonin is minimal. It is important, though, to 
realize that pinealectomy does not render an animal "melatonin-free” 
(Reiter et al., 1983).
1.1.4. Biosynthesis of Melatonin
If one ignores the legendary role assigned by philosophers 
and early anatomists to the pineal gland, McCord and Allen in 1917 
were the first to observe a specific action attributable to the
6pineal. They demonstrated that an extract of bovine pineal gland 
caused blanching of the skin of a tadpole. Lerner et al. (1958, 
1959) finally identified the active principle as being 5-methoxy-N- 
acetyltryptamine, which is now known as melatonin. Once discovered 
the biosynthetic pathways leading up to melatonin production and its 
subsequent degradation were quickly elucidated (see Fig. 1). 
Tryptophan is the starting material and this is metabolized to the 
intermediate compound in the synthetic sequence, 5-HT. 5-HT is then 
converted into ultimately four products: melatonin, 5-methoxy-
tryptamine, 5-methoxyindoleacetic acid or 5-methoxytryptophol. 
Metabolic elimination of melatonin itself involves hydroxylation to 
6-hydroxymelatonin and then conjugation with glucuronic acid in the 
liver. In the brain melatonin may also be metabolized by cleavage of 
its indole nucleus into N-gamma-acetyl-N-2-formyl-5-methoxy- 
kynurenamine and N-gamma-acetyl-5-methoxykynurenamine (Hirata et 
al., 1974) (See Fig. 1). It has even been suggested that the 
indoleamines melatonin, serotonin and 5-methoxytryptamine may 
undergo cyclohydrogenation into psychoactive beta-carboline 
derivatives (Binkley, 1988).
From its precursor there are four enzymes involved in the 
synthetic pathway to melatonin production. The first, tryptophan 5- 
hydroxylase (EC 1.14.16.4, L-tryptophan, tetrahydropteridine:oxygen 
oxido-reductase (5-hydroxylating)) is found only in serotonin- 
synthesizing cells and catalizes the formation of 5-hydroxy-L- 
tryptophan (L-5HTP). The ubiquitously distributed L-aromatic acid 
decarboxylase (EC 4.1.1.28), located in the pinealocyte cytoplasm, 
is a pyridoxal-dependent enzyme that rapidly acts upon L-5HTP to 
produce the optically inactive serotonin. The third enzyme in the 
sequence is one of two N-acetyltransferases that exist in the pineal
7(Voisin et al., 1984). Serotonin arylalkylamine N-acetyl-transferase 
is the one commonly abbreviated to SNAT and, using acetyl co-enzyme 
A, preferentially acetylates indoleamines (e.g. tryptamine, 5-HT and 
5-methoxytryptamine) rather than phenylethylamines. The second, 
pineal arylamine N-acetyltransferase, is thought to bear greater 
homology to extrapineal N-acetyltransferases located in the the 
blood, liver, thyroid, spleen and a host of other sites (Binkley,
1988) and is not involved in the synthesis of melatonin. The 
activity of SNAT, believed to reside in a 10kDa portion of the 
protein (Sugden, 1989), converts serotonin into N-acetylserotonin. 
Then, using S-adenosyl methionine (SAM) as the donor of the methyl 
group, hydroxyindole-O-methyltransferase (HIOMT; S-adenosyl-L- 
methionine: N-acetylserotonin-O-methyltransferase, E.C.2.1.1.4)
changes the hydroxyl group on the 5-position of the indole ring to a 
methoxy group thereby creating 5-methoxy-N-acetyltryptamine 
(melatonin). This final enzyme shares with SNAT the property of a 
restricted distribution, being found almost exclusively in the 
pineal gland. The retina has been shown to possess a much smaller 
concentration (Axelrod and Weissbach, 1960; Axelrod and Weissbach, 
1961), and the Harderian gland is thought to possess an enzyme 
unrelated to pineal HIOMT (Cardinali and Wurtman, 1972). Kuwano and 
Takahashi (1980) purified pineal HIOMT and proposed that it 
consisted of two identical subunits of 38kDa.
Fig. 1. Synthesis and main metabolic routes of melatonin.
(Adapted from Ebadi, 1984 and Hi rata et al, 1974)
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91.1.5. Biosynthetic Factors Influencing Melatonin Production.
The concentration of the essential amino acid tryptophan 
in the rat pineal gland is high (Mefford et al., 1983; Young and
Anderson, 1982) and is thought to enter via an analogous mechanism
to that used by the brain for extracting tryptophan from the plasma. 
Interestingly though the diurnal rhythm expressed by plasma
tryptophan, which displays its zenith during the dark phase and is 
caused by the diurnal rhythm in feeding, is not shared by pineal 
tryptophan which peaks near the end of the light phase (Sugden,
1979). There is, however, some disagreement over the presence of a
pineal tryptophan rhythm since Mefford and Barchas (1980) and Young 
and Anderson (1982) have reported otherwise. Tryptophan loading in 
the rat induces a large increase in pineal 5-HT (Deguchi and 
Barchas, 1972; Young and Anderson, 1982) suggesting that the enzyme 
tryptophan hydroxylase is not fully saturated with this substrate. 
This effect appears to be species dependent since tryptophan loading 
has little influence on ovine pineal 5-HT levels (Sugden et al., 
1985a). Sheep tryptophan hydroxylase is therefore saturated with 
respect to its substrate. Since these two mammals possess similar 
tryptophan concentrations and tryptophan hydroxylase activity, the 
implication is that either the two enzymes are structurally 
different, or the immediate environment in which they work is 
different to cause a lower Km for the sheep enzyme. The activity of 
this enzyme is regulated by a betai-adrenergic receptor mechanism 
which utilizes the second messenger cyclic adenosine monophosphate 
(cAMP) (Shein and Wurtman, 1971). In the rat it has been reported to 
express a diurnal rhythm (Shibuya et al., 1978; Sitaram and Lees, 
1978), attaining a two fold increase in night-time activity although 
this conflicts with Deguchi (1977) who reported an absence of
10
circadian change in the same animal. Conversely, Steinlechner et al.
(1983) have demonstrated that peak activity for this enzyme in the 
Syrian hamster is reached during the daytime. The study by Chan and 
Ebadi (1980) emphasizes species variability since they could detect 
no circadian variation in tryptophan hydroxylase activity in the 
bovine pineal gland.
The activity of pineal 5-HTP decarboxylase is high as 
suggested by the low concentrations of pineal 5-HTP and by the 
administration of exogenous 5-HTP which increases pineal melatonin 
concentrations in rats (Wurzburger et al., 1976) and plasma 
melatonin levels in sheep (Namboodiri et al., 1983). King et al.
(1984) have demonstrated a diurnal rhythm for endogenous rat pineal 
5-HTP levels while Steinlechner et al. (1983) documented no 
circadian change in Syrian hamsters.
The pineal gland contains the highest concentration of 
5-HT in the body (Saavedra et al., 1973) and it was thought to
constitute an additional functional hormone of the gland since 
Garrick et al. (1983) described a pineal dependent circadian rhythm 
of CSF 5-HT levels. However, the indoleamine concerned has since
been shown to be N-acetylserotonin (Taylor et al., 1985). Although a
definitive function other than a precurser for melatonin synthesis 
has yet to be properly ascribed to 5-HT, a role in modulating 
adrenergic responses on pinealocytes via 5-HT receptors has been 
proposed (Sugden, 1989). Stimulation of pineal glands in vitro by 
noradrenaline (NA) has been shown to release tritiated 5-HT into the 
incubation medium (Aloyo and Walker, 1987; Aloyo and Walker, 1988). 
This efflux also occurs in denervated glands indicating that the
5-HT originates from pinealocytes, (rather than as a co-transmitter 
from presynaptic adrenergic nerve terminals), is dose-dependent and
11
inhibited by prazosin, an alphai-adrenergic antagonist (Aloyo and 
Walker, 1988). In addition, radioligand binding sites for 5-HT have 
been identified in the bovine pineal gland (Ebadi and Govitrapong, 
1986) but have yet to be characterized. Using this evidence Sugden 
(1989) suggests that 5-HT may be involved in regulating the 
alphai-adrenergic potentiation of betai-adrenergic stimulation of 
cAMP and therefore melatonin synthesis. Alpha2-adrenergic receptors 
are also thought to be involved, being located presynaptically to 
modify the release of NA (Lewy et al., 1986; Palazidou et al.,
1989).
Light acts via the RHT to suppress NA release from the 
SCG-derived postganglionic terminals in the pineal. Darkness removes 
this inhibitory effect allowing NA to be released to stimulate 
betai-adrenergic receptors (Parfitt et al., 1976; Zatz et al., 1976) 
located on the pinealocyte membrane (Auerbach et al., 1981; Foldes 
et al., 1983; Craft et al., 1985). Stimulation of this receptor 
activates adenylate cyclase via a stimulatory guanine nucleotide 
binding regulatory protein, Gs, leading to the synthesis of cAMP 
and, in turn, the stimulation of SNAT (Klein and Berg, 1970). Rapid 
accumulation of cAMP, attaining maximum levels within 10 minutes 
following NA administration to cultured pinealocytes (Vanecek et 
al., 1985), mediates the induction of SNAT by activating a 
cAMP-dependent protein kinase. Progressive desensitization of the 
beta-adrenoceptor soon after the onset of darkness probably accounts 
for the gradual decline in cAMP levels after 10 minutes of NA 
stimulation (Vanecek et al. 1985). Desensitization is brought about 
by two mechanisms: the first is a circadian variation in the density 
of beta-adrenergic receptors located on the pinealocyte membrane 
which expresses a peak at the end of the light phase when
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stimulation of the receptor has been minimal for some hours; the 
second is caused by a reduction in affinity of the beta-receptor for 
its endogenous ligand due to the activation of a beta-adrenergic 
protein kinase which phosphorylates the occupied adrenoceptor 
(Lefkowitz et al., 1986). An additional mechanism which would reduce 
the prolongation of the initial surge in pineal cAMP levels is an 
increase in cAMP phosphodiesterase activity induced as a result of a 
lag-period (Minneman and Iversen, 1976) which is in turn regulated 
by an interactive alpha- and beta-adrenergic mechanism (Vacas et 
al., 1985).
Beta-adrenergic stimulation of cAMP and SNAT is markedly 
enhanced by simultaneous activation of an alpha-adrenoceptor also 
located on the pinealocyte membrane (Klein et al., 1983b; Vanecek et 
al. 1985). Subsequent radioligand binding studies have characterized 
the receptors as being of the alphai-adrenergic subtype (Sugden and 
Klein, 1984; Sugden et al., 1985b). The increase of 
phosphatidylinositol (PI) turnover as a result of alpha-adrenergic 
receptor activation appears to involve protein kinase C (PKC), a 
Ca2+-activated, phospholipid-dependent protein kinase as suggested 
by Sugden et al. (1985b) and Zatz (1985a). These workers measured 
cAMP levels and SNAT activity respectively and demonstrated that 
both could be increased by the administration of phorbol esters and 
the beta-adrenergic agonist isoprenaline. Phorbol esters in the 
absence of a beta-adrenergic agonist had no effect on cAMP and SNAT 
levels. Earlier in 1978, Zatz and Romero demonstrated that chelation 
of extracellular calcium inhibited the isoprenaline-induced or 
cAMP-induced induction of SNAT, indicating that an influx of calcium 
into the cytoplasm was required. This was later supported by studies 
on pineal explants and cultured pinealocytes indicate that inositol
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monophosphate is the major product of PI hydrolysis. The negligible 
quantities of inositol biphosphate and triphosphate found by Ho et 
al. (1987a) and Zatz (1985b) suggest that an alternative means of 
mobilizing intracellular Ca2+ is utilized. An increase in 
intracellular Ca2 + induced by alpha-adrenergic receptor activation 
has been observed by Sugden et al. (1987). This increase, it has 
been proposed, is brought about by the opening of a ligand-dependent 
channel rather than a voltage-dependent channel since inhibition by 
nifedipine is not observed (Sugden et al., 1987). Activation of this 
channel probably involves Pi-induced production of the endogenous 
activator of PKC, diacylglycerol, which encourages PKC to be 
redistributed from the cytoplasm to its "active'’ site - the cell 
membrane - and subsequently becomes responsible for amplifying the 
beta-adrenergic signal (Sugden et al., 1985c). Indirect evidence in 
support of this is given by Sugden and Klein (1988), who have shown 
that the amplified beta-adrenergic response induced by alpha- 
adrenergic agonists (e.g. phenylephrine) or phorbol esters is 
unaltered in pinealocytes pretreated with phosphodiesterase 
inhibitors which eliminates inhibition of cAMP metabolism by 
inhibited phosphodiesterase as a mechanism of potentiation. They 
suggest that phosphorylation of Gs or adenylate cyclase by the 
activated PKC as the most plausible explanation.
In addition to the above mentioned negative feedback 
mechanism of beta-adrenergic receptors, Sugden et al. (1988) have 
identified evidence indicating an equivalent action involving the 
desensitization of alpha-adrenergic receptors. This is probably 
brought about by the phosphorylation of the receptor by activated 
PKC (Leeb-Lundberg et al., 1986). The physiological implications of 
this were spelled out by Sugden (1989). The onset of night, allowing
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the release of NA, leads to a massive surge of cAMP levels which may 
well be required to support the transcription of mRNA. Elevated mRNA 
levels accompanying the increase in SNAT activity are thought to be 
required for manufacturing either more SNAT molecules or an 
activator protein for the enzyme (Morrissey and Lovenberg, 1978a; 
Morrissey and Lovenberg, 1978b; Romero et al., 1975).
The role of cyclic guanine monophosphate (cGMP) in 
pinealocytes has yet to be elucidated. Its mention is warranted on 
the basis of a similarity with cAMP in the mechansims by which cGMP 
is regulated. As with cAMP, NA greatly elevates cGMP levels (O’Dea 
and Zatz, 1976; Vanecek et al., 1985) by an alpha- and beta- 
adrenergic receptor interaction (Vanecek et al., 1985; Vanecek et 
al., 1986). Alone, beta-adrenergic stimulation approximately doubles 
cGMP levels, unlike alpha-adrenergic stimulation alone which has no 
effect. However, if activated together, cGMP levels are elevated
100-fold (Vanecek et al., 1985). There appears to be an inverse
relationship between the two second messenger cascade components 
that has been dubbed "see-saw signal processing” by Klein et al. 
(1981). This group discovered that inducing sympathetic denervation, 
either by constant light (LL) conditions or by superior cervical 
ganglionectomy elicited opposing effects for the pinealocyte cAMP 
and cGMP systems - the cAMP response becomes super-senstitive, 
whereas the cGMP response is diminished.
Unlike the well-defined diurnal variation in activity 
displayed by SNAT, a circadian rhythm in HIOMT activity as first
reported by Axelrod et al. in 1965, is still in dispute (Ebadi,
1984). Its activity appears to be regulated by an adrenergic 
mechanism since Sugden et al. (1983a, 1983b, 1983c) have illustrated 
that LL or pineal sympathectomy-induced reduction in HIOMT activity
15
is reversed by beta-adrenergic agonists, e.g. isoprenaline or NA. 
The regular nocturnal stimulation of the pineal gland by NA is 
thought to be necessary to maintain HIOMT levels. In constant dark 
(DD) the opposite occurs, HIOMT levels become and remain elevated in 
contrast to SNAT levels which express a freerunning circadian 
rhythm. Changes in HIOMT activity have been identified but are 
expressed slowly over a period of days (Moore and Rapport, 1971; 
Klein and Moore, 1979). This fact, together with the results of 
Eichler and Moore (1971) which show a correlation between high HIOMT 
levels and testicular weight in hamsters, has prompted Binkley 
(1988) to suggest that HIOMT could regulate the amplitude of the 
melatonin produced on a seasonal basis, while SNAT is responsible 
for the production of the daily cycle.
The picture of melatonin synthesis is further complicated 
by the role of other components in pineal biochemistry, for example, 
vasoactive intestinal peptide (VIP) and prostaglandins. Direct 
evidence for the involvement of VIP in the physiological regulation 
of melatonin is presently lacking but since its first identification 
in the pineal by Uddman et al. (1980) VIP receptors have been 
characterized on the pinealocyte (Kaku et al., 1983). Furthermore, 
VIP has been shown to induce SNAT activity (Kaneko et al., 1980; 
Yuwiler, 1983a, 1983b) and increase the levels of both cAMP (Kaneko 
et al., 1980) and cGMP (Ho et al., 1987b). Recently, Chik et al. 
(1988a, 1988b) have demonstrated the involvement of alphai-
adrenergic receptors in potentiating the VIP-induced stimulation of 
cAMP and cGMP through the probable use of PKC. The involvement of 
prostaglandins in modulating melatonin synthesis may well be a side 
effect of alphai-adrenergic stimulation which activates 
phospholipase A2 . This has been shown to cause an efflux of
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arachidonic acid from the pinealocyte (Ho and Klein, 1987) which may 
be the source of PGE2 Cardinali et al. (1982), using pineal 
explants, demonstrated as inducing an increase in the melatonin 
content of the medium.
1.1.6. Physiology of Melatonin
There are many factors involved in the control of pineal 
melatonin synthesis at both the extracellular and intracellular 
level. Environmental lighting plays a pivotal role in the external 
control of melatonin production (Wurtman et al., 1963). Melatonin is 
a nocturnal hormone, the mechanism by which it is synthesized being 
shut-off during the hours of day-light. In all species of animal so 
far investigated which produce melatonin, whether diurnally or 
nocturnally active its peak production occurs during the first half 
of the scotoperiod (dark period). The actual plasma levels of 
melatonin present an approximately symmetrical picture during the 
dark phase (Wilkinson et al., 1977; Waldhauser al., 1984). However, 
the duration of melatonin synthesis varies according to the length 
of the photoperiod. This has since been implicated as an important 
regulatory factor in photoperiodism - the ability to exploit the 
number of light hours in a day to modulate a seasonal activity, the 
best example being seasonal breeding animals.
Early studies identified a factor in the pineal gland that 
prevented gonadal maturation in rodents (Kitay and Altschule, 1954). 
Prepubertal pinealectomy increased ovarian and testes weight 
(Simonnet et al., 1951; Wurtman et al., 1959), an effect
subsequently shown to be reversed by the administration of bovine 
pineal extract (Wurtman et al., 1959). However, identifying the 
active principle(s) involved proved slow due to the inconsistent
17
responses produced by melatonin in rodents (Chu et al., 1964). 
Additionally, contradictory results were obtained when various 
workers tested the reproductive responses to constant release 
melatonin capsules in certain rodent species (Reiter et al., 1974; 
Turek et al., 1976; Lynch et al., 1978;). It has since been shown to 
be a physiological action mediated by light (see Stetson and 
Watson-Whitmyre, 1984, and references cited therein). Plasma 
melatonin levels are higher during the short days of winter than in 
the summer which would appear to be due to the lengthening 
scotoperiod - as the duration of the dark period increases, so does 
the duration of melatonin production. This has a far-reaching effect 
in terms of reproduction. The golden hamster, for example, is a 
"long-day breeder"; a day-length greater than the "critical 
photoperiod" of 12.5 hours is required to maintain gonadal activity, 
whereas shorter day-lengths promote gonadal regression (Gaston and 
Menaker, 1967; Elliott et al., 1972; Elliott, 1976). Pinealectomy 
prevents these inhibitory responses to a short day-length whereas 
exogenous melatonin duplicates the effect of gonadal regression if 
administered during the "late afternoon" of the photoperiod or at 
the time approximating to "lights on". This, it was noted, 
artificially extends the duration of melatonin in the blood 
(Tamarkin et al., 1976). Melatonin administered at other times 
proved ineffective suggesting the existence of a diurnal rhythm in 
gonad sensitivity. Subcutaneous implants that produce a continuous 
release of melatonin were found to induce testicular regression in 
Syrian hamsters maintained under a long-daylength schedule (Turek et 
al. 1975). Interestingly, pinealectomized hamsters that receive a 
single injection dose of melatonin do not experience gonadal 
regression. For melatonin to be effective it must be given as an
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infusion or as several bolus injections over an appropriate period 
that can be in the light or the dark phase (Carter and Goldman, 
1983a; Bittman, 1984). This antigonadotropic action of melatonin is 
well established. Equally established, but somewhat contradictory, 
is the ability of melatonin to inhibit gonadal regression in certain 
circumstances - a property termed by Reiter (1980) as being 
"counterantigonadotropic". He found that subcutaneous melatonin 
implants prevented the gonadal regression in male Syrian hamsters 
transferred from long to short day-length conditions (Reiter et al., 
1974). In addition melatonin implants inhibit testicular regression 
induced by normally effective evening injections of melatonin 
(Reiter et al., 1977). Carter and Goldman (1983b) provided evidence 
for a more active "progonadal" effect of melatonin with with the 
report that precisely timed daily infusions of this hormone elicited 
gonadal development in pinealectomized juvenile male Djungarian 
hamsters which was partially the result of melatonin exhibiting a 
stimulatory action on the secretion of follicle-stimulating hormone 
(FSH) and prolactin (PRL). The explanation considered most likely 
for the properties of melatonin is that it mediates its effects via 
an interaction with a specific receptor that undergoes a circadian 
rhythm in sensitivity.
1.1.7. Melatonin Receptors
Early studies using standard ligand binding techniques 
utilized [3H]-melatonin and located various potential sites on both 
peripheral and central structures (Cohen et al., 1978; Niles et al., 
1979). These reports were inconsistent mainly due to the specific 
activity of [3H]-melatonin. The advent of in vitro autoradiography 
and the development of the radioligand 2-[125I]-iodomelatonin has
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considerably improved the prospects for future melatonin receptor 
research and already provided significant insights into its loci of 
action. Early studies demonstrated that many structures of the brain 
were capable of concentrating [3H]-melatonin (e.g. Anton-Tay and 
Wurtman, 1969) which were taken as potential sites of action for 
endogenous melatonin. Evidence gradually accumulated to implicate 
the hypothalamus as the most likely candidate. It readily took up 
[3H]-melatonin (Anton-Tay and Wurtman, 1969) and constant release 
melatonin implants located in the SCN region of the hypothalamus 
inhibited the reproductive activity of white-footed mice (Glass and 
Lynch, 1981). Melatonin had been shown to exert a significant 
effect on the protein microtubule content of the hypothalamus 
(Cardinali and Friere, 1975; Cardinali et al., 1975). Demaine (1979) 
demonstrated that melatonin modified the rate of discharge of 
spontaneously active hypothalamic neurones. Interestingly, Demaine 
(1979) also reported the ability of melatonin to reduce or abolish
the inhibition of activity caused by dopamine. In addition, the
presence of both membrane and cytosolic binding sites had been
reported in the hypothalamus (Cardinali et al., 1979; Niles et al.,
1979). It was realized though that the hypothalamus was not likely 
to be the only site of action. Cohen et al. (1978) had reported 
peripheral cytoplasmic binding sites for [3H]-melatonin most
concentrated in the ovary and uterus. Recently high affinity
melatonin binding sites have been located on membranes prepared from 
the pars tuberalis of the adenohypophysis (Vanecek et al, 1987; 
Williams and Morgan, 1988; Morgan et al., 1989) of both rat and 
sheep using 2-[125I]-iodomelatonin as the radioligand. This binding 
site was subsequently linked to a G-protein due to the ability of 
guanine triphosphate (GTP) to regulate its affinity with melatonin
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(Morgan et al., 1989). The linking of a binding site to a
"classical” second messenger system gives more credence to its claim 
as a receptor. In addition, a receptor at this site is consistent 
with the effects of melatonin on reproduction and its mediation via 
the hypothalamic-pituitary axis (Glass and Lynch, 1981). The work of 
Dubocovich has identified the retina as a further site of action 
for melatonin in addition to providing more information on the
interaction between melatonin and dopamine. Picomolar concentrations 
of melatonin inhibit the calcium dependent release of [3H]-dopamine 
from the rabbit retina (Dubocovich, 1983). It was subsequently shown 
that the efficacy of melatonin analogues in eliciting this effect 
depended upon the identity of the chemical group located on 
position 5 of the indole nucleus, but affinity (and therefore 
antagonist potential) was determined by the moiety substituted on 
position 3 (Dubocovich et al., 1985). It has since been established 
that this functional property of melatonin is associated with a 
binding site, determined using 2-[125I]-iodomelatonin (Dubocovich 
and Takahashi, 1987).
Zisapel et al. (1988), having identified melatonin binding 
sites in the striatum and the hypothalamus reported a circadian
rhythm of binding site density (but not affinity) only in the
hypothalamus. Interestingly, the zenith of this rhythm would appear 
to be towards the end of the photophase. This does not concur with 
the report by the same group that the circadian rhythm of the 
inhibition of dopamine release from the hypothalamus by melatonin is 
approximately minimal at this time (Zisapel et al., 1985). Moreover, 
autoradiography has been used to provide evidence for a circadian 
rhythm in density of melatonin binding sites in the SCN region of
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the rat hypothalamus (Laitinen et al., 1989) which also has its 
nadir at approximately the end of the dark phase. Autoradiography 
has revealed that potentially only a few central regions of the rat 
possess specific melatonin binding properties: the SCN, the median
eminence; the choroid plexus and the anterior pituitary (Vanecek, 
1988). It would appear that the distribution of these binding sites 
is much more widespread in the hamster (Weaver et al., 1987, 1988, 
1988b; Vanecek and Jansky, 1989 from Morgan and Williams, 1989). 
Differing orders of potency and dissimilar Ki values between binding 
sites in the chicken retina and the hamster brain have led 
Dubocovich (1988) to propose the existence of two melatonin 
receptors. ML1 possesses high affinity for melatonin and is found in 
the chicken retina and brain, ML2 is a low affinity site located in 
the hamster brain (Dubocovich, 1988; Morgan and Williams, 1989).
Inherent in the term "melatonin receptor" is the concept 
of structural analogues that might act as antagonists at these 
sites. Early studies identified N-acetyltryptamine as being capable 
of inhibiting the blanching effect of melatonin on frog skin and was 
without activity itself (Heward and Hadley, 1975). 2-benzyl-N- 
acetyltryptamine (luzindole) was developed from N-acetyltryptamine 
and has a similar antagonistic profile (Dubocovich, 1985) though 
whereas N-acetyltryptamine appears to be a partial agonist with 
respect to the inhibitory effect of melatonin on dopamine release in 
the rabbit retina, luzindole elicits full competitive antagonism in 
both the chicken and the rabbit retina (Dubocovich, 1988). Despite 
the absence of an N-acetyl group (considered important for binding) 
N-(2,4-dinitrophenyl)-5-methoxytryptamine (ML23) has been reported 
to possess antagonistic activity (Laudon et al., 1988; Zisapel, 
1988). In the rat it blocks both delayed maturation and inhibition
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of ovulation induced by melatonin in addition to the inhibitory 
effect of melatonin on dopamine release in the hypothalamus (Laudon 
et al., 1988; Zisapel and Laudon, 1987; Zisapel, 1988). However, 
this ability is not reproduced in the rabbit retina and ML23 also 
fails to inhibit the reproductive effects of melatonin in the Soay 
ram (Dubocovich, 1988; Lincoln and Kelly, 1988).
1.1.8. Pharmacology of Melatonin
The first pharmacological (and physiological) action 
attributed to melatonin was a blanching effect it exerted on 
tadpoles (McCord and Allen, 1917; Lerner et al., 1958). Its potency 
was great enough for the technique to be adopted as a bioassay for 
many years until the more quantitative radioimmunoassay test was 
developed. Melatonin is essentially inert in numerous 
pharmacological tests except sleep where it has been shown to extend 
barbiturate-induced sleeping time (Barchas et al., 1967; Holmes and 
Sugden, 1982). Several studies have confirmed a hypnotic action 
though the underlying mechanism is not understood. It is 
conceivable that inhibited metabolism of the barbiturate accounts 
for the prolonged barbiturate-induced sleeping time since they share 
the same metabolic enzymes in the liver (Wurtman et al., 1968; Datta 
and King, 1980). However, intranasal, intravenous or oral 
administration of melatonin have been reported as effective at 
inducing sleep or reducing the time to sleep-onset in humans 
(Vollrath et al., 1981; Cramer et al., 1974; Anton-Tay et al., 1971) 
and hypothalamic implants of crystalline melatonin in cats also 
induce sleep (Marzcynski et al., 1964). Conversely, it should be 
mentioned that Mendelson et al. (1980) claimed that melatonin 
induced arousal in the rat at much lower doses than those required
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to elicit hypnosis, while Chamblin (1973) failed to find a 
significant effect on any stage in sleep in cats. More recent 
studies of melatonin and sleep have implicated the serotonergic 
system, specifically the 5-HT2 receptor, as a target for a 
melatonin-mediated modulating effect (Dugovic et al., 1988; 1989a;
1989b). Additionally, Waldhauser et al. (1990) proposed that the 
sleep-inducing properties of melatonin are the result of 
accelerating the initiation of sleep and improving its maintenance.
Sugden (1980) endeavoured to establish the toxicology of 
melatonin and demonstrated that large doses (i.e. >100mg/kg) were
required to impair performance in a variety of tests (e.g. righting 
reflex, rotor-rod test). Animals recovered with no apparent 
ill-effects. Regardless of the route of administration melatonin 
was shown to possess negligible toxicity (LDso >1000mg/kg using 
i.p., s.c. and oral routes of administration). Melatonin has also 
been shown to affect mood and performance in humans (Leiberman and 
Lea, 1988, and references cited therein). An early study by Kovacs 
et al. (1974) investigated low doses of melatonin on certain 
conditioned behaviours and found that a daily dose of 50ug/rat 
facilitated the extinction of active avoidance reflex and decreased 
the intertrial activity during extinction. It was also noted that 
melatonin facilitated passive avoidance behaviour using the 
electrified drinking spout in water-deprived rats paradigm. In a 
review by Datta and King (1980) it is suggested that melatonin might 
elicit these effects by influencing the ’'memory fixation process” 
but there is little hard evidence to support this proposal.
The action of melatonin on locomotor activity has been 
subject to a number of studies with conflicting results (Kovacs et 
al., 1974; Wong and Whiteside, 1968; Kastin et al., 1973; Sugden,
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1980). The work described in chapter 3 also examined the 
relationship between melatonin and locomotor activity though only in 
the context of 5-HT-induced abnormal activity. Its action on the 
circadian rhythm of locomotor activity has received more favourable 
attention and is reviewed in greater detail in chapter 5. Briefly, 
Redman et al. (1983) demonstrated that a free-running locomotor 
activity rhythm in rats could be entrained by appropriately timed 
s.c. injections of melatonin. Further work by the same group has 
established a "dose-response curve” and the importance of an intact 
SCN for the action to be observed (Cassone et al., 1986a; Cassone et 
al., 1986b). Cassone et al. (1986a) were able to show that as little 
as 50ug/kg of melatonin produced entrainment. Together with the work 
of Kovacs et al. (1974) mentioned above and the early bioassay 
technique, this demonstrates the potency of melatonin in eliciting a 
pharmacological effect in an appropriate model.
1.2. Circadian Rhythms
1.2.1. Background
Until comparatively recently in the history of science 
rhythmic fluctuations in the day to day management of the life of an 
organism was taken for granted by the scientific community. It was 
assumed that the environmental light signal of dawn induced activity 
or rest according to the ecological niche occupied by the organism. 
The first doubts on this passive acceptance began in 1729 when the 
Frenchman de Mairan observed that the daily leaf movements exhibited 
by the Mimosa plant persisted in constant darkness (DD). De Marian 
concluded, wrongly, that an environmental factor other than light or 
dark was involved in the regulation of rhythms. Systematic 
investigation of this phenomenon was eventually begun this century
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with Richter’s report on rodent activity in constant conditions 
(Richter, 1922). This was followed by the work of Johnson (1926) 
who, as a result of investigating wild mice (Peromyscus leucopus), 
first postulated the existence of a ’’self-winding and self- 
regulatory clock” (Johnson, 1939). The concept of an endogenous 
clock did not gain wide acceptance, however, until the 1950's 
(Pittendrigh, 1954).
Biological rhythms are now recognised in almost every 
eukaryotic organism and range from a few milliseconds in period 
length (e.g. electrical activity of the brain) to several years. The 
origin of geophysical rhythms is thought to have derived from early 
life forms that had to cope with extreme variations in for example, 
damaging UV light exposure as the earth rotated on its axis 
approximately every 24 h. It became an advantage to be able to
predict the onset of light and dark in order for the organism to
restrict its UV sensitive activities to the dark phase. The term 
circadian (circa=”about”, diem=”day”) was introduced by Halberg 
(1959) to describe those rhythmic fluctuations that, when subjected 
to a constant environment would free-run with a period approximating 
to 24 h. The prefix ’’circa” has since been added to tidal, lunar and 
annual to describe other geophysically-derived rhythms which express 
periods of approximately 12 h, 28 days and 365 days respectively. 
The terms infradian and ultradian have been introduced to
distinguish between those rhythms that are greater or shorter than
24 h respectively. This section will concentrate on the physiology 
and mechanisms of circadian rhythms.
The fundamental characteristic of a proposed circadian 
process, which can be physiological, behavioural or biochemical in 
nature, is that it free-runs, i.e. in a constant environment it
expresses a period approximating to but not exactly equal to 24 h 
and can be synchronized (or entrained) by the appropriate time-cue 
(or "zeitgeber" - literally "time-giver"). In the entrained state, 
therefore, there is a constant phase angle difference between the 
rhythm and the zeitgeber (Aschoff et al., 1982). It is apparent that 
the circadian clock controlling the rhythm of locomotor activity 
expressed by, for example, a nocturnal rodent, must be continually 
reset by the environmental light/dark cycle - the most important 
natural zeitgeber. This is achieved by a daily phase-shift in the 
onset of locomotor activity. Thus a mechanism must exist which 
allows the organism to "read" the appropriate incoming 
environmental signals and adjust its behaviour accordingly. Initial 
investigations examined the role of the visual system in the 
entrainment mechanism since blinding elicited free-running rhythms 
in the absence of zeitgebers other than the standard light-dark (LD) 
cycle (Richter, 1965). However, earlier work by Altman (1962) had 
shown that lesioning the visual cortex or superior colliculus, 
failed to disrupt the diurnal rhythm of locomotor activity. In 
addition, Chase et al. (1969), Moore and Eichler (1972) and Stephan 
and Zucker (1972) demonstrated that lesioning of the primary and 
accessory optic tracts also failed to abolish entrainment. Reason 
dictated that there were two components to the light information 
transmitted from the retina that only became distinguishable after 
the optic chiasm. Earlier work by Richter (1967) established the 
importance of the hypothalamus in regulating circadian rhythms by 
demonstrating that lesions of the ventral median region of the 
hypothalamus disrupted circadian locomotor activity. As a result the 
retino-hypothalamic tract (RHT) itself was finally identified in 
mammals by two independent autoradiography studies of the visual
27
system (Hendrikson et al., 1972; Moore and Lenn, 1972). As briefly 
described above in the section on melatonin, this tract, originating 
from the retina, terminates in the SCN of the hypothalamus (Moore, 
1973). Unlike blinded rats which express free-running rhythms as if 
in DD, the destruction of this area was found to induce 
arrhythmicity in the circadian rhythms of adrenal corticosterone 
content (Moore and Eichler, 1972), locomotor activity and drinking 
behaviour (Stephan and Zucker, 1972).
1.2.2. Neural Regulation of Circadian Rhythms
Visual stimuli from ganglion cells are transmitted to the 
optic chiasm bilaterally along the optic nerves. The largest of the 
four projections leaving the chiasm, the primary optic tract (POT), 
has components that terminate in the superior colliculus, pretectal 
nuclei and lateral geniculate nucleus (cited from Rusak and Zucker, 
1979). The superior and inferior accessory optic tracts (SAOT and 
IAOT, respectively) originating from the chiasm terminate in the 
midbrain tegmentum. Lesions of these pathways have been shown to 
elicit abnormal free-running rhythms, for example Rusak (1977) 
reports elongated periods or an extension in the active phase or a 
reduced rate of re-entrainment to a 12 h phase shift in the 
light-dark cycle. It should be mentioned that such lesions are 
difficult to restrict to the tracts themselves and Rusak admits 
damage to adjacent structures that offer input to the SCN. Thus the 
involvement of the primary and accessory optic tracts in the 
mechanism of entrainment remains tentative and unproven. The fourth 
tract, the RHT, carries photic information directly to the SCN, 
preferentially terminating in the ventral and caudal regions of the 
nuclei and forming both Gray-type I and Gray-type II synapses
28
suggesting both excitatory and inhibitory components (Rusak and 
Zucker, 1979). The SCN is a bilateral structure that resides 
immediately superior to the optic chiasm and ventrolateral to the 
third ventricle. It projects to and receives input from: the
anterior hypothalamic area, the paraventricular nucleus, the
retrochiasmatic area, several nuclei of the tuberal hypothalamus, 
the paraventricular thalamic nucleus, the midbrain periaqueductal 
gray, and the contralateral SCN. It receives input only from 
ascending serotonergic fibres of the midbrain raphe nuclei, and the 
ventral lateral geniculate nucleus in addition to the retina. 
Structures that receive output only from the SCN are the lateral 
hypothalamic area and the lateral septal nucleus (Rusak and Zucker, 
1979; Moore, 1983). There are no long ascending or descending 
projections from the SCN suggesting that processing of its output is 
performed at the hypothalamic level.
The SCN is now regarded as a major pacemaker for circadian 
rhythms in the body, but not necessarily the only one. As mentioned 
above SCN ablation results in arrthymicity in a number of rhythms 
provided at least 75% of the SCN has been destroyed (Moore, 1982). 
Circadian function is also eliminated by lesions in the rat neonate 
SCN and fails to recover during maturation to adulthood (Mosko and 
Moore, 1977). Schwartz et al. (1977, 1980) measured glucose
consumption of the SCN using (14C)-deoxyglucose and demonstrated 
that, unlike other brain structures, it expressed a circadian 
rhythm. This measure of metabolic activity was found to be high 
during the light phase and low during the dark phase - a result 
consistent with the electrophysiological studies of Inouye and 
Kawamura (1979). They detected high multiunit activity in the SCN 
during the day which became low at night, an effect resistant to
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surgical isolation of the SCN. In addition, Rusak and Groos (1982) 
found that electrical stimulation of the nuclei affected both the 
tonic and phasic expression of free-running circadian rhythms in the 
rat and hamster. These results reflect the importance of the SCN as 
an oscillator for the circadian system but further evidence supports 
the existence of other oscillatory centres coupled together under 
entrained conditions. Stephan (1984) has been able to show that 
activity rhythms of SCN lesioned rats in DD entrained to a 
restricted food availability. Food available ad libitum induced 
arrythmia. The animals even displayed food anticipatory behaviour 
with an increase of activity prior to the provision of food, 
implying a memory pacemaker for feeding times. Clarke and Coleman 
(1986) have found that wheel-runnning and drinking rhythms persist 
in SCN-lesioned rats if food availability is alternated between 
schedules of restriction and ad libitum. It has been suggested that 
this reflects internal desynchronization of circadian rhythms after 
SCN lesioning rather than arrhythmicity (Mitchell, 1989). The 
locations of secondary oscillators are likely to reside in the near 
vicinity of the SCN due to its lack of long projections although a 
humoral input using perhaps melatonin has not yet been eliminated. 
Moore (1982, 1983) has suggested the most likely candidates are the 
lateral geniculate nuclei (LGN) retrochiasmatic area (RCN), the 
lateral hypothalamus (LH) and the ventral median hypothalamus (VMH).
Lesions of certain hypothalamic structures surrounding the 
SCN have yielded information concerning the regulation and 
generation of circadian rhythms though currently their value is 
limited. Damage to the VMH can reverse the normal pattern of feeding 
where a rat fed ad libitum ingests mainly during darkness 
(Kakolewski et al., 1971; Zucker, 1971). Alternatively such damage
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may equalize the quantities of food ingested in the light and dark 
phases (Bernadis, 1973). The nocturnal drinking rhythm in rats is 
also attenuated by VMH lesions. In contrast, Rowland (1976) 
demonstrated that lesions to the LH increased the dark-phase 
appropriate behaviours of feeding and drinking. It is interesting to 
note that the LH has been shown to receive retinal input (Riley et 
al., 1980). These results are less surprising when one considers the 
importance of this region to the regulation of food intake. They may 
well be explained more by the hyperinsulinaemia and peripheral 
metabolic changes induced by VMH damage than by circadian rhythms 
(LeMagnen et al., 1973; Friedman and Strieker, 1976; Rusak and 
Zucker, 1979).
The influence of the ventral lateral geniculate nucleus 
(vLGN) has recently aroused more intense investigation. This 
receives a direct photic input from the retina via the retinolateral 
hypothalamic tract (RLHT). It therefore provides an indirect photic 
pathway from the retina to the SCN via the geniculo-hypothalamic 
tract (GHT) which originates from the region known as the 
intergeniculate leaflet (IGL, Swanson et al., 1974; Pickard, 1982, 
1985; Card and Moore, 1982) and terminates in the ventral portion of 
the SCN (Rusak and Zucker, 1979). Harrington and Rusak (1986) have 
been able to show that IGL lesioned hamsters show reduced 
phase-advances in running wheel activity rhythms if subjected to an 
appropriately timed light pulse. No effect on phase-delays was 
observed. In agreement with this result Pickard et al. (1987) have 
also demonstrated that lesions of the IGL modify the amplitude of 
light pulse induced phase-shifts on free-running locomotor activity 
rhythms, though phase-delays were increased. In addition this study 
reported that such lesions lengthened the free-running period in DD
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in comparison to non-lesioned control animals and reduced the normal 
lengthening of the period of animals maintained in constant light 
(LL) - a property that was dependent on the intensity of the 
incident light. From this Pickard et al. (1987) reasoned that the 
LGN partially mediates the tonic action of environmental lighting 
(i.e. determination of period length). The ability of an animal to 
remain entrained, with respect to wheel running activity rhythms, to 
a given LD cycle is not impaired following lesions to the IGL (Dark 
and Asdourian, 1975; Pickard et al. 1987) which suggests that it 
transmits information on photic signals regarding the intensity of 
environmental lighting as opposed to absolute illumination. However, 
following a 12 h phase shift in the LD cycle the activity rhythms of 
LGN-lesioned hamsters reentrain significantly more slowly than 
neurologically intact animals (Dark and Asdourian, 1975; Rusak; 
1977). Recently Rusak et al. (1988) reported that in hamsters 
housed under LL or DD conditions electrical stimulation of the GHT
induces mostly phase advances of wheel-running activity rhythms if
given during the late subjective day or small phase delays if given 
during the late subjective night or early subjective day. It appears 
that GHT stimulation mimicks the effects of dark pulses (Rusak et 
al., 1988) in LL. The GHT is characterized in part by immuno- 
reactivity to neuropeptide Y (NPY) in its cells of origins and 
constitutes the major source of this peptide found in the SCN (Card 
and Moore, 1982; Harrington et al., 1985). It is thought that 
electrical stimulation of the LGN leads to the release of this 
peptide since its application directly into the SCN results in
time-dependent phase-shifts in the free-running activity rhythms of
hamsters (Albers and Ferris, 1984) which also mimic dark pulses in 
LL.
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The precise role of the raphe nuclei (RN) in the 
regulation of circadian rhythms is still a matter of debate. 
Ascending serotonergic projections from the median and dorsal RN 
innervate the ventral region of the SCN (Rusak and Zucker, 1979) and 
the LGN (Azmitia and Segal, 1978; Moore et al., 1978). There is also 
evidence that the nuclei provide another indirect photic pathway to 
the SCN, since Foote et al. (1978) identified a retinal projection 
to the RN. Studies using both lesions of the SCN and serotonin 
depleting drugs have shown that the integrity of the RN is not 
required for entrainment of the locomotor activity rhythm to a LD 
schedule (Kam and Moberg, 1977; Honma et al., 1979; Levine et al.,
1986). However, a lesioned animal subjected to a constant 
environment either DD or LL displays severe perturbation of the 
rhythm (Levine et al., 1986) while animals treated with 
para-chlorophenylalanine (pCPA) become arrhythmic for several days 
(Honma et al., 1979). Presumably this reflects the duration of 5-HT 
deprivation induced by the drug, although neither drugs nor 
lesioning removes all 5-HT. Electrical stimulation of the raphe 
reduces SCN activity (Bloom et al., 1972) as does direct application 
of 5-HT into the SCN (Meijer and Groos, 1988). The lack of 
responsiveness of SCN visual cells (i.e. those that respond to 
visual stimulation of the retina) to iontophoretic application of 
5-HT agrees with the concensus that the median and dorsal RN exert 
a modulatory role on circadian rhythm expression rather than an 
absolute one. Interestingly, two recent reports have presented 
evidence that suggest serotonergic innervation of the SCN may be 
necessary for the ontogenic development of certain circadian rhythms 




The majority of 5-HT, also known as serotonin, found in 
the body is located in the enterochromaffin cells of the gut and 
blood platelets. Only in the CNS which holds approximately 1-2% does 
it act as a neurotransmitter (Kruk and Pycock, 1983). Its isolation 
from the blood and the subsequent deduction of its structure was 
reported by Rapport (Rapport et al., 1948; Rapport, 1949). The 
peripheral pharmacology of 5-HT has, however, assumed a secondary 
importance with respect to scientific investigation since it was 
first identified in the brain (Twarog and Page, 1953). Central 5-HT 
pathways were originally mapped in 1964 by Dahlstrom and Fuxe using 
the Falck histofluorescence technique. It was found that 5-HT 
neurons stretched to practically every region of the brain but the 
cell bodies were located primarily in well defined clusters of the 
raphe nuclei which lie in the mid-portion of the pons and upper 
brain stem (Dahlstrom and Fuxe, 1964; Fuxe, 1965; Anden et al., 
1966). Dahlstrom and Fuxe devised an alphanumeric-based nomenclature 
for the ascending and descending 5-HT pathways originating from this 
region. The more caudal 5-HT cells (B1 to B3) descend to the 
medulla, pons and spinal cord while the rostral ones (B5, B7 to B9) 
project to the diencephalon and forebrain. There are three ascending 
pathways projecting dorsally to the neostriatum, medially primarily 
to the substantia nigra and ventrally to innervate the diencephalon, 
limbic system and cortex. This wide distribution is consistent with 
a wide sphere of influence in central physiology for 5-HT. As a 
central neurotransmitter it has been implicated in playing a 
modulatory role in: sleep, thermoregulation, appetite, pain
perception, control of pituitary secretions, sexual behaviour,
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pituitary secretions, sexual behaviour, circadian rhythms, in the 
pathophysiology of migraine, depressive illness, anxiety, psychosis, 
and in the action of hallucinogenic drugs (Barchas and Usdin, 1973; 
Iversen, 1984; Roberts, 1984).
1.3.2. Synthesis and Metabolism
The essential steps of 5-HT synthesis have been outlined 
in section 1.1.4. and can be seen in Fig 1. It should be mentioned 
that central 5-HT is derived exclusively from the brain as the 
molecule is too polar to traverse the blood brain-barrier (BBB). 
Thus to increase endogenous brain levels of 5-HT, the immediate 
presursor in its biosynthesis, L-5HTP, is administered in
combination with a decarboxylase inhibitor, e.g. carbidopa to 
prevent peripheral metabolism to 5-HT. Carbidopa fails to penetrate 
the brain which L-5HTP can enter freely and so be converted to 5-HT. 
Central 5-HT is thought to be derived from 5-HT neurons although
recent evidence suggests that cerebrovascular endothelial cells
might be capable of 5-HT synthesis (Maruki et al., 1984). The rate 
limiting step in neuronal 5-HT synthesis is the conversion of 
L-tryptophan to L-5HTP by tryptophan hydroxylase (Ashcroft et al., 
1965). The location of this enzyme is restricted to only those 
cells capable of producing 5-HT. Despite this it would appear that 
tryptophan hydroxylase works in vivo at only 10-25% its capacity in 
comparison to ideal conditions in vitro (Carlsson, 1974; Gal and 
Whitacre, 1981). This would suggest along with data produced by 
Knowles and Pogson (1984) that in vivo the enzyme is not fully 
saturated hence the ability of the amino acid precursor of 5-HT, 
L-tryptophan, to exert a strong influence on 5-HT synthesis. Entry 
of tryptophan into the brain depends on the ratio of tryptophan
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concentration in plasma to the concentration of other large neutral 
amino acids that compete with tryptophan for same brain uptake 
mechanism (Fernstrom, 1981). This ratio can be altered by drugs or 
carbohydrate metabolism that lead to insulin secretion which 
increases brain uptake of tryptophan thereby increasing brain 5-HT 
levels.
Central 5-HT is deactivated pre- and postsynaptically by­
conversion to 5-hydroxyindoleacetaldehyde by monoamine oxidase (MAO) 
(EC 1.4.3.4, amine: oxygen oxidoreductase (deaminating)(flavin-
containing)) which is then rapidly oxidized to 5-hydroxyindoleacetic 
acid (5-HIAA). 5-HT in the pineal gland and certain other central 
and peripheral sites undergoes an alternative metabolic pathway as 
explained above to manufacture melatonin. Small amounts of 
5-hydroxytryptophol, reduced from the aldehyde, have been detected 
in the brain though this is not considered an important elimination 
route for 5-HT (Cheiftefz and Warsh, 1980). MAO is a flavoprotein 
that exists in two forms, A and B, as first reported by Johnston 
(1968) and resides on the outer surface of mitochondria (Youdim and 
Findberg, 1983). Their distinction depends on their susceptibility 
to inhibition by either clorgyline which preferentially inhibits MAO 
type A, or deprenyl which prefers type B. Immnunological 
localization studies have identified MAO-B in 5-HT cells and glial 
cells while MAO-A is located in high concentrations in catecholamine 
neurons. Both types of enzyme can metabolize 5-HT, although MAO-A 
favours 5-HT and the catecholamines as substrates while MAO-B 
favours phenylethylamine, benzylamine and tryptamine (Neff et al., 
1974; Cooper et al., 1986; Fowler and Tipton, 1982; Youdim and
Findberg, 1983). An early concept that both types of MAO were the 
same enzyme but with two active sites according to the substrate
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(White and Wut 1975; Boullin, 1978) can be discounted since Cawthon 
et al. (1981) isolated the different forms and determined their 
respective molecular weights (63000 for type A and 60000 for type B) 
and peptide pattern.
1.3.3. Multiple 5-HT Receptors
Gaddum and Picarelli (1957) were the first to demonstrate 
the existence of two pharmacologically distinct receptors for 5-HT. 
They were labelled ’D * and fM ! according to the mechanism behind the 
ability of 5-HT to contract smooth muscle in the guinea pig ileum. 
The *D f receptor elicited contraction directly and could be blocked 
by phenoxybenzamine (dibenzylamine, hence the label *D ') or the 
hallucinogen D-lysergic acid diethylamide (D-LSD). The 'Mf receptor 
effected contraction indirectly through the release of acetylcholine 
which could be inhibited by morphine or cocaine. This system 
received much criticism for many years and has never been 
particularly applicable to the CNS, but recently attempts have been 
made to incorporate it into the current classification of 5-HT 
receptor subtypes. Early functional studies using
microiontophoresis identified the main effect of 5-HT on the 
activity of neurons to be a reduction in excitability but in a few 
brain regions 5-HT evoked a facilitatory action (Roberts and 
Straughan, 1967; Bloom et al., 1972). To satisfy this dichotomous 
action it was proposed that there were at least two central 5-HT 
receptors, one of which was responsible for excitatory effects and 
subject to inhibition by the classic 5-HT antagonists (methysergide, 
cyproheptadine, metergoline and cinanserin); and one which effected 
inhibitory actions of 5-HT and was resistant to drug-induced 
antagonism. A modulatory effect has also been ascribed to 5-HT by
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Aghajanian (1981), who reported that the current of 
iontophoretically applied glutamate required to produce the 
activation of facial motoneurons is significantly reduced in the 
presence of 5-HT. Based on electrophysiological evidence Aghajanian 
(1981) proposed the existence of three 5-HT receptors. Si, located 
postsynaptically, exerts a modulatory influence on excitatory amino 
acid neurons and is readily blocked by the classic 5-HT antagonists. 
The second type of receptor, S2 , at which LSD acts as an agonist, 
is an autoreceptor, and inhibits the activity of cell bodies in the 
raphe nuclei. The third type of 5-HT receptor, S3 , is postsynaptic 
and suppresses neuronal activity. The standard antagonists are 
ineffective and LSD acts only as a weak partial agonist.
1.3.4. Radioligand Binding Studies
Radioligand binding has had the most significant impact 
on 5-HT receptor nomenclature in recent years. Early studies 
utilized [3H]-5-HT and [3H]-LSD as ligands to characterize high 
affinity 5-HT binding sites in the brain. Marchbanks (1967) 
demonstrated the existence of a high affinity binding site in rat 
synaptosomes but the non-hallucinogenic L-LSD was found to displace 
5-HT as effectively as D-LSD and nonindolic psychotomimetics did not 
affect 5-HT binding. Later, however, Farrow and Van Vunakis (1973) 
identified a specific high affinity site in the cerebral cortex of 
the rat using [3H]-LSD, which could be displaced by high 
concentrations of other hallucinogens (e.g. psilocin and mescaline) 
but not by their congeners (e.g. L-LSD). Subsequent work by Bennett 
and Aghajanian (1974), with an improved technique and using rat 
brain homogenates, demonstrated that there was a high and a low 
affinity component to the binding of D-LSD. L-LSD competed with the
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binding of D-LSD at the low affinity site indicating that only the 
high affinity site was stereospecific. This latter site was subject 
to regional variations, being found in cerebral cortex, striatum and 
the midbrain. Destruction of the cell bodies at the raphe nuclei had 
minimal effect on [3H]~LSD binding suggesting that a postsynaptic 
location of the binding sites. Bennett and Snyder (1975) extended 
this work to show that the non-hallucinogen 2-bromo-LSD was as
potent as LSD in displacing [3H]-LSD from brain membrane binding 
sites. This, together with the finding by Lovell and Freedman (1976) 
that hallucinogenic compounds chemically distinct from LSD failed to 
inhibit [3H]-LSD binding, disproved the original concept that there 
was a single population of receptors responsible for the
hallucinogenic effects of certain drugs. Bennett and Snyder (1976) 
continued their investigation of putative 5-HT binding sites by 
comparing the specific binding of [3H]-5-HT and [3H]-LSD to rat 
brain membranes. They showed that D-LSD was equally effective in 
displacing both [3H]-5-HT and [3H]-LSD from their respective binding 
sites, but 5-HT displayed a much greater affinity for the site
labelled with [3H]-5-HT. Several analogues of 5-HT also shared this
property. A number of known 5-HT antagonists (e.g. cyproheptadine, 
methiothepin) though expressed a preference for the [3H]-LSD 
labelled site. This led Bennett and Snyder to propose a two-state 
model for the 5-HT receptor where [3H]-5-HT binds to the agonist 
state. Due to its equal affinity for both sites it was thought that 
[3H]-LSD labelled both the agonist and antagonist states.
The discovery by Leysen (1978) that spiperone, previously 
considered to be a pure dopaminergic ligand, labelled the antagonist 
serotonergic sites in the rat frontal cortex, a region known to be 
sparsely populated with respect to dopamine receptors (Leysen and
Laduron, 1977), proved a significant turning point in 5-HT receptor 
research. It was followed in 1979 by the work of Peroutka and Snyder 
that has essentially established the foundation for modern 5-HT 
receptor nomenclature. On the basis of the differing binding 
characteristics of [3H]-5-HT and [3H]-spiperone Peroutka and Snyder 
suggested that 5-HT receptors be referred to as 5-HTi and 5-HT2. 
[3H]-5-HT expresses high affinity (nM range) for the 5-HTi site but 
only micromolar affinity for the 5-HT2 site. [3H]-spiperone exhibits 
nanomolar affinity for the '5-HT2 site but possesses a much lower 
affinity for the 5-HTi site. Radiolabelled D-LSD has equal affinity 
for both sites (the Bmax obtained with [3H]-LSD was found to 
correspond to the sum of Bmax for [ 3H]-spiperone and Bmax for 
[3H]-5-HT binding). Consistent with [3H]-LSD binding sites, 
structurally related compounds, e.g. methysergide and metergoline, 
were found to displace both [3H]-5-HT and [3H]-spiperone from 5-HTi 
and 5-HT2 binding sites to the same extent. 5-HTi binding sites have 
since been found in the highest concentrations in the prefrontal 
cortex, hippocampus, tuberculum olfactorium, striatum, thalamus and 
raphe nuclei. 5-HT2 binding sites densely populate the prefrontal 
cortex, tuberculum olfactorium, nucleus accumbens and striatum 
(Leysen, 1985). It has been noted that the distribution of 5-HTi and 
5-HT2 binding sites corresponds neither to the regional brain 
distribution of specific 5-HT uptake nor to the distribution of 5-HT 
content in brain areas (Leysen and Tollenaere, 1982; Leysen et al., 
1983). This inconsistency between 5-HT innervation and 5-HT binding 
sites has been used as an argument against the physiological 
significance of a binding site (Barbaccia et al., 1983).
The 5-HTi site as labelled by [3H]-5-HT was soon shown to 
be heterogenous by Pedigo et al. (1981). Displacement of [3H]-5-HT
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binding by spiperone revealed two sites, one exhibiting high 
affinity (Kd in the nM range) for spiperone and the other low 
affinity (Kd in the micromolar range) which were designated 5-HT1a 
and 5 -H T i b  respectively. However, further investigations by 
Schnellmann et al. (1984) into tissue and species differences 
revealed this to be a too simplistic explanation of 5-HTi receptor 
heterogeneity. Realization of the existence of 5-HT receptor 
subtypes and the implications for behavioural pathophysiology 
inherent in their characterization encouraged the synthesis of novel 
compounds aimed at achieving selective agonist or antagonist action 
at a particular site. This had the effect of accelerating 5-HT 
research. Of particular importance was the synthesis of 
8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT) by Arvidsonn et 
al. in 1981 which proved to be a highly selective ligand for 5 -H T i a  
receptors. The consequence of this was twofold: first was the
synthesis of a family of piperazine derivatives all expressing 
nanomolar affinity for 5 -H T i a  receptor sites (e.g. ipsapirone, 
buspirone, gepirone); and second was the ability to redefine 5-HTi 
receptors as those that express a high affinity for 8-OHDPAT 
( 5 - H T i a )  and those that express low affinity for 8-OHDPAT ( 5 - H T i b ) .  
1981 also saw the introduction of ketanserin, an agent reported to 
block responses mediated by 5-HT2 receptor activation. Subsequent 
ligand-binding studies confirmed that it possessed high affinity 
for 5-HT2 binding sites and negligible affinity for 5-HTi sites 
(Leysen et al., 1982). This was a major breakthrough since existing 
"classical" 5-HT antagonists had been plagued by lack of 
specificity, e.g. spiperone also expressed high affinity for 
dopamine-2 and 5 -H T i a  receptor sites (Leysen et al., 1978). Use of 
[3H]-mianserin had been troubled by its affinity for histaminergic-1
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(H1) receptors. Although [3H]-ketanserin possessed moderate affinity 
for H1 and alphai adrenergic receptor sites provided low nanomolar 
concentrations were used these were not labelled (Leysen et al., 
1981; Leysen et al., 1982).
Autoradiography provided the evidence for another 5-HTi 
receptor subtype identified in high concentrations in the choroid 
plexus of the rat and porcine brain, which was designated 5-HTic 
(Cortes et al., 1984; Pazos et al., 1984). The 5-HTic receptor 
possessed high affinity for 5-HT, as demanded by the criteria for a 
5-HTi receptor (Peroutka and Snyder, 1981) and could be labelled by 
[3H]-mesulergine and [3H]-LSD, but putative selective ligands for 
5 -H T i a , 5 -H T i b  and 5-HT2 receptors displayed low affinity. Although 
initially greeted with scepticism by 5-HT investigators, doubt has 
since been replaced by recognition that multiple 5-HT receptor 
subtypes are likely to prove the norm. This proved prophetic upon 
the identification of a fourth 5-HTi receptor subtype now known as 
5 -H T i d . It was first reported by Heuring and Peroutka (1987) in 
bovine brain membranes and has since also been identified in pig and 
most importantly in man (Hoyer et al., 1988; Waeber et al., 1988). 
5 -H T i d  receptors are characterized by displaying nanomolar affinity 
for [3H]-5-HT and micromolar affinity for 5 -H T i a  selective ligands 
such as 8-OHDPAT, ipsapirone and buspirone. Agents that label 5 -H T i b  
sites in rat brain (e.g. RU24969 and (-)-pindolol) are approximately 
two orders of magnitude less potent at 5 -H T i d  sites and the 
affinities of 5-HT2 and 5-HT3 selective ligands are negligible. To 
identify further 5-HT receptor subtypes research groups are now 
required to use cocktail-style incubation mediums containing the 
appropriate selective ligands in sufficiently high concentrations to 
inhibit the binding of the crucial ligand to non-target binding
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sites. Using this procedure Sumner and Humphrey (1989) have reported 
that two subpopulations of 5-HTid binding sites can be discerned in 
porcine brain, one of which shares the binding characteristics of 
the novel 5-HTi receptor subtype, 5-HTi e, identified and named by 
Leonhardt et al. (1989). It remains to be seen as to whether these 
sites can withstand peer scrutiny and be allocated a function.
Having had a quiet decade as the best functionally 
characterized 5-HT receptor, the 5-HT2 receptor is now receiving its 
share of controversy. Previously thought of as a single entity, 
differing opinions on the precise heterogeneity of this receptor are 
being voiced. The classification of 5-HT receptors has always been 
hindered by the lack of suitably selective antagonist molecules for 
5-HTi receptor/receptor subtypes and selective agonist molecules for 
the 5-HT2 site. The hallucinogenic amphetamine derivative, 
2,5-dimethoxy-4-methylamphetamine (DOM) and its halogen homologues 
1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane (DOB) and 1 — (2,5-di­
me thoxy-4-iodophenyl)-2-aminopropane (DOI), had long been suspected 
of acting through the serotonergic system but it was not until the 
manufacture of the equivalent radioligands that their 5-HT2 receptor 
binding properties was fully appreciated (e.g. Lyon et al., 1986). 
Titler and colleagues argue that these compounds label a high 
affinity "agonist'1 state of the 5-HT2 receptor (Titler et al., 1987; 
Leonardt and Titler, 1989), while [3H]-ketanserin displays equal 
affinity for this high affinity state and a low affinity 
"antagonist" state of the receptor (reminiscent of Bennett and 
Snyder's two state 5-HT receptor model of 1976). Conversely, 
Peroutka and colleagues interpret the evidence as indicating the 
existence of 5-HT2A and 5-HT2B (Wang et al., 1988; Pierce and 
Peroutka, 1989). The matter has yet to be resolved (see Strange,
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1990 and Peroutka, 1990) despite the recent cloning of the 5-HT2 
receptor (Pritchett et al., 1988).
The presence of 5-HT3 receptors in the CNS was not 
revealed until quite recently (Kilpatrick et al., 1987). Previously 
they had been characterized pharmacologically in the periphery by 
criteria described by Bradley et al. (1986). They categorized a 
response as being mediated by 5-HT3 receptors if:
(a) It could be inhibited by the recognized selective 5-HT3 
antagonists (-)cOcaine, MDL 72222 (3,5-dichlorobenzoyltropine ester) 
or ICS 205-930 (3a-tropanyl)-1H-indole-3-carboxylic acid ester).
(b) 5-HTi and 5-HT2 antagonists were ineffective.
(c) The response was mimicked by 2-methyl-5-HT, a selective 5-HT3 
agonist of approximate equal potency to 5-HT.
The synthesis of selective ligands enabled central 5-HT3 
binding sites to be identified, which in turn revealed the affinity 
expressed by the endogenous ligand for the receptor which is
variously reported as having a Ki of between 40 and 190nM (McKernan
et al., 1990; Kilpatrick et al., 1987; Peroutka and Hamik, 1988) 
depending on the conditions used in the assay procedure. 5-HT3 
receptors are located in the highest concentrations in the cortex, 
hippocampus, amygdala, nucleus accumbens and tuberculum olfactorium 
(Kilpatrick et al., 1987; Milburn and Peroutka, 1989). Anomalies in 
the binding characterization of 5-HT3 receptors between different 
species using the recognized agonists and antagonists have revealed 
potentially three subtypes, though attempts to designate them as
5-HT3A, 5-HT3B and 5-HT3C have so far been resisted. A further
example of the diverging and converging history of 5-HT receptor 
terminology is the attempt to revive the early 5-HT receptor 
classification described by Gaddum and Picarelli (1957). Bradley et
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al. (1986) have proposed that the 5-HT3 receptor is the modern-day 
equivalent of the *M ' receptor and the 5-HT2 receptor corresponds to 
the ’D' receptor. This latter designation is generally accepted 
amongst the 5-HT research community but the suitability of the 
5-HT3/*M’ linkage has been questioned (Fozard, 1987).
Soon after the recognition of 5-HT3 receptors in the CNS 
(Kilpatrick et al., 1987) a further brief report was published also 
claiming the identification of a binding site in cultured mouse 
embryo colliculi neurons unsuited to 5-HTi or 5-HT2 classification 
(Dumius et al., 1988) and positively coupled to adenylate cyclase. 
It was found that the 5-HT3 ligand ICS 205-930 acted as a antagonist 
at this new site, albeit with much lower affinity, and proposed that 
it could be an embryonic form of the 5-HT3 receptor. Subsequent 
analysis has revealed that this site was originally identified in 
guinea pig hippocampal membranes by Shenker et al. (1987). It bears 
little resemblence to any existing 5-HT receptor classes with regard 
to its biochemical pharmacology and has therefore been designated 
5-HT4 (Dumius et al., 1988).
1.3.5. Functional Correlates of 5-HT Receptors
Sceptics demanded evidence of functional relevance before 
assigning receptor status to binding sites (e.g. Leysen, 1984). The 
response was the publication of more detailed reports that 
correlated binding sites with behavioural data and/or biochemical 
data such that the site was linked with a second messenger system. 
The biochemical correlates will be considered first.
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1.3.5.1. Biochemical Correlates
Peroutka and Snyder backed their original 5-HT receptor 
classification by the simultaneous publication that suggested a 
functional role for the 5-HTi receptor site (Peroutka and Snyder, 
1979; Peroutka et al., 1979). They advanced that this receptor was 
regulated by guanidine nucleotides indicating a receptor-adenylate 
cyclase coupled system (Peroutka et al., 1979b). However, data 
reported by Nelson et al. (1980) showed that 5-HT stimulated 
adenylate cyclase and 5-HTi binding sites have differing regional 
and subcellular distributions. In addition, inhibition of 
radioligand binding by the presence of GTP or GDP is no longer
considered synonomous with an adenylate cyclase effector system
(Blackmore et al. 1985). There has since been published conflicting 
reports as to whether the 5 -H T i a  receptor is positively or 
negatively coupled to adenylate cyclase (Conn and Sanders-Bush, 
1987; Barbaccia et al., 1983b; Shenker et al., 1985; Weiss et al., 
1986; Markstein et al., 1986). De Vivo and Maayani (1985, 1986) have 
used forskolin, a pharmacological agent that bypasses the guanine 
nucleotide subunits to stimulate adenylate cyclase directly, to add 
to the evidence that activation of 5-HTia receptors in rat and
guinea pig hippocampal membranes inhibit cAMP production. Recently, 
the 5 -H T i d  receptor in the calf substantia nigra has been shown to 
be negatively-linked to adenylate cyclase using forskolin (Hoyer and 
Schoeffter, 1988). Inhibition of forskolin to elevate cAMP levels by 
the activation of a receptor is taken as evidence of a
negatively-coupled arrangement. Interestingly the 5-HTi d  receptor 
has not been identified in rodents and conversely the presence of 
5 -H T i b  receptors has not been demonstrated in porcine, bovine or 
human brain tissue. It has been suggested that their similar
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functional pharmacology (differing essentially in their respective 
sensitivities to certain beta-adrenoceptor antagonists) and their 
similar distribution in the brain (high concentrations are found in 
the basal ganglia and substantia nigra) reflects a biological 
equivalence (Waeber et al., 1988). Thus it would appear that the 
5 -H T i b  subtype, also mediates inhibition of forskolin-stimulated 
adenylate cyclase activity in the rat substantia nigra (Bouhelal et 
al., 1988; Schoeffter and Hoyer, 1989). The opposite action on 
adenylate cyclase activity has been afforded to the putative 5-HT4 
receptor - evidence being currently in favour of a positive coupling 
arrangement (Dumuis et al., 1988).
Data obtained from in vitro release experiments (e.g. 
Middlemiss, 1985) supports the presence of a 5-HT autoreceptor 
situated presynaptically on 5-HT terminals which inhibits the 
stimulated release of 5-HT, its identity corresponding to the 5 -H T i b  
receptor subtype (Engel et al., 1983). From the 
electrophysiological work of Aghajanian and colleagues as noted 
above there appears to be an autoreceptor located 
somatodendritically in the raphe nuclei. Autoradiographic 
localization of 5 -H T i a  receptors demonstrate a high concentration in 
the raphe nuclei, providing circumstantial evidence that identifies 
this subtype as the 5-HT cell body autoreceptor (Palacios et al.,
1987). Behavioural evidence shows that where 5-HT is thought to have 
an inhibitory role, 8-OHDPAT has a stimulatory action, e.g. sexual 
activity (Ahlenius et al., 1981), feeding behaviour (Dourish et al., 
1985; Bendotti and Samanin, 1986), body temperature control (Goodwin 
et al., 1985a) all of which support the 5 -H T i a  receptor as the cell 
body receptor in the raphe nuclei. However, the lack of specific 
antagonists of the functional effects of 8-OHDPAT combined with the
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evidence from Middlemiss (1984) would suggest prudence before 
confirming an identity.
Unlike other 5-HTi receptor subtypes, the 5-HTic receptor 
appears to be coupled to phosphoinositol system (PI) (Conn et al., 
1986). Chemical denervation of serotonergic neurons leads to a 
supersensitive phosphoinositide hydrolysis response to 5-HTic 
receptor activation in the choroid plexus which would indicate a 
serotonergic input to the area (Conn et al., 1987) and it has been 
suggested that it may regulate CSF production (Sanders-Bush, 1987). 
Its considered role in CSF production is based on the observation 
that, the receptor appears to be located on the secretory epithelium 
of the choroid plexus (Yagaloff and Hartig, 1986), PI hydrolysis is 
involved in the regulation of other secretory and transport
processes and that systemic administration of 5-HT depresses CSF
formation (Maeda, 1983). On the basis of coupling to second
messenger systems 5-HTic displays more similarity to the 5-HT2
receptor than to other members of the 5-HTi receptor family. In 1984 
Conn and Sanders-Bush demonstrated the ability of specific 5-HT2 
antagonists (ketanserin and pizotifen) to inhibit the 5-HT-induced 
increase in PI formation in the rat cerebral cortex. Regulation of 
phosphoinositol turnover by 5-HT2 receptor activation is thought to 
involve guanine nucleotides (Lyon et al., 1986). Further similarity 
between these two receptors is evident on consideration of their 
respective naomolar affinities for 5-HT antagonists, in addition to 
the finding that radioligands used to label 5-HT2 sites can also be 
used to label 5-HTic sites (Sanders-Bush and Breeding, 1988).
So far the receptors considered mediate their 
intracellular activities through a metabotropic mechanism, 
exploiting GTP-binding proteins, leading to changes in postsynaptic
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cell excitability that are slow in onset and last at least for 
several hundreds of milliseconds. The 5-HT3 receptor is the first 
5-HT receptor to be assigned an ionotropic function (Derkach et al. , 
1989). The ability of 5-HT to operate a cationic-channel indicates 
that it is capable of initiating immediate changes in membrane 
conductance.
The last word in biochemical receptor nomenclature will
probably rest with molecular biology and the results of the latest
receptor cloning experiments. So far the 5 -H T i a , 5 -H T i c  and 5-HT2 
receptors have been cloned and their amino acid sequence elucidated 
(Fargin et al., 1988; Lubbert et al., 1987; Julius et al., 1988; 
Pritchett et al., 1988). The structural homology displayed between 
the 5-HT2 and 5-HTic receptors lends further support to the argument 
that they should be reclassified as 5-HT2A and 5-HT2B respectively 
(Hartig, 1989). It remains to be seen whether this technique can 
resolve the high affinity/low affinity states of 5-HT2 receptors 
proposed by Titler and colleagues and incorporate the remaining 
uncloned 5-HT receptors into a workable nomenclature.
1.3.5.2. Behavioural Correlates
Despite the undisputed importance of the 
radioligand-binding technique in identifying binding sites, it
lacks the ability to determine the function of a binding site and
therefore should not be used to define a receptor. Its usefulness 
is also limited in that it is incapable of distinguishing between 
agonist and antagonist molecules. With the rapidly multiplying 
number of 5-HT receptor subtypes it becomes increasingly necessary 
to identify functional binding sites in order to understand the 
physiological and pathophysiological implications of this
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neurotransmitter. Analysis of behavioural measures specific to 5-HT 
receptor activation or blockade would allow a relatively easy means 
of characterizing receptors. The serotonergic system is fortunate 
in that there are several distinct behavioural effects induced by 
the activation of certain 5-HT receptors. Initial doubts concerning
the confidence by which one might assign the 5-HTi binding site
receptor status have been dispelled as a result of several functions 
being attributed to the activation of 5-HTi-iike receptors. The 
grouping together of 5-HTi receptor subtypes under the title
M5-HTi-iike” resulted from Bradley et al. (1986) who attempted to 
resolve the increasing controversy in the classification of 5-HT 
receptors. The principle of the exercise was to ensure that
functional receptors were recognized as such and distinguished from 
binding sites. The study also realized the heterogeneity of 5-HTi
binding sites and that functional correlates might well be
attributed to them eventually. However, it was considered that the 
anomalies present at the time amongst these sites were insufficient 
to warrant granting a separate identity (i.e. 5 -H T i a , 5 -H T i b , 5 -H T i c  
etc.), hence the use of the term "5-HTi-iike". The classification of 
5-HT receptors as 5-HTi-iike, 5-HT2 and 5-HT3, although still used, 
did not catch on universally and was not able to decrease "progress" 
on the identification of further 5-HT binding sites and their
incorporation into the original Peroutka and Snyder classification 
system as A,B,C,D,E subtypes of the 5-HTi receptor.
Individual behaviours attributable to the activation of 
certain components of the serotonergic system are dealt with in
greater detail in chapters 3 and 4. Briefly, the 5-HT syndrome first 
used by Corne et al. (1963) as a behavioural index of serotonergic 
activity, comprises several discrete symptoms thought to result from
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postsynaptic 5 -H T i a  receptor activation (Hjorth et al., 1982;
Tricklebank et al., 1985). These include reciprocal forepaw
treading, hindlimb abduction, lateral headweaving, flat body 
posture, tremor, Straub tail, hyperreactivity and hyperactivity. An 
additional component, headtwitches (described as head-shakes or 
"wet-dog shakes” in the rat), arise from stimulation of the 5-HT2 
receptor (Ogren et al., 1979; Yap and Taylor, 1983; Niemegeers et 
al., 1983). Behavioural models associated with 5-HTi receptor
activation include: hypothermia induced by 5 -H T i a  agonists;
hyperphagia induced by 5 -H T i a  agonists or 5 -H T i b  agonists;
facilitation of sexual behaviour by 5 -H T i a  agonists; and 
hypoactivity induced by putative 5 -H T i b  agonists (Lucki and Frazer, 
1982; 1985). A recent report by Mittman and Geyer (1989), extended 
by Wing et al. (1990), demonstrates another potential behavioural 
model for 5-HT2 receptor activity. The test is described as 
"potentiation of the normal neophobic reaction to a novel 
environment” and was first identified as a property of 
hallucinogenic compounds, e.g. LSD (Geyer and Light, 1979). Wing et 
al. (1990) have proposed that the reduction in exploratory behaviour 
exhibited by these compounds can be reversed by selective 5-HT2
antagonists indicating a 5-HT2 receptor mediating mechanism. In 
contrast, 5 - H T i - i i k e  agonists might induce a suppression of activity 
in the novel environment but this is not blocked by the appropriate 
5-HT2 antagonists. This model was not able to detect the 
hallucinogen 5-methoxy-0-dimethyltryptamine (5Me0DMT), a known
non-selective 5-HT agonist, as a 5-HT2 agonist since the reduction 
in exploratory activity was not reversed by ketanserin. Drug 
discrimination has been used to investigate both 5-HTi and 5-HT2
receptor activation and is discussed in chapter 4.
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Although 5-HT3 receptors have been implicated in a variety 
of behavioural disorders, most notably anxiety and psychosis 
(Cooper and Abbott, 1988), the identification of a distinct 
behavioural consequence to their activation which would act as a 
model has yet to be established. Electrophysiology and radioligand 
binding remain the most useful tools in their characterization.
(See Appendix, page 320 for table of central 5-HT receptor subtypes)
CHAPTER 2. 
AIMS OF THE STUDY
52
2. AIMS OF THE STUDY
The aim of this study was to investigate the hypothesis 
that melatonin could affect the expression of 5-HT-mediated 
behaviours. This concept originated from the observation of their 
structural similarity, shared biosynthetic route, speculations from 
various authors that the mechanism of action might involve an 
interaction with the serotonergic system (e.g. Mess et al., 1983) 
and the more recent finding that 5-HT can affect a melatonin-induced 
behavioural pattern (Gaffori and Van Ree, 1985). It was quickly 
realized that the slight differences in molecular structure were 
sufficient to rule out any direct interaction with 5-HT receptors, 
but an indirect interaction could not be ruled out. In support of 
this, Dubocovich (1983, 1985) has shown that melatonin can
selectively inhibit the calcium-dependant release of [3H]-dopamine 
from rabbit and chicken retina through an action on its own 
receptor. The close relationship to circadian rhythms shared by both 
5-HT and melatonin meant that an interaction between them might 
depend on the time of day and it was therefore decided to perform 
experiments, where possible, according to this factor.
It was the intention of the work described in chapter 5 to 
further explore the role of melatonin in the regulation of 
circadian rhythms, specifically, the circadian rhythm of locomotor 
activity. Moreover, it was thought that this would provide an 
opportunity to investigate whether the serotonergic system is 
involved in mediating the effects of melatonin on free-running 
circadian locomotor activity rhythms (see Redman et al., 1983).
The failure of an interaction between melatonin and 5-HT 
to be detected from the work conducted in chapter 3 led to the
53
investigation into the effects of melatonin on 5-HT-mediated 
conditioned behaviour, in the form of drug discrimination. It also 
provided a convenient means of assessing the ability of rats to 
discriminate between various doses of melatonin and saline. This 
work is described in chapter 4.
The work described in the final chapter was based on the 
hypothesis that melatonin, being released only at night, acts as a 
co-ordinator of the internal milieu of an animal such that it 
becomes adapted to night-appropriate behaviour. If this hypothesis 
were correct then an appropriately trained animal might be expected 
to make a dark-appropriate response in the presence of melatonin. 
The origin of this concept derived from the realization that all the 
physiological responses to melatonin appear to occur at a 
subconscious ("vegetative”) level (see Herbert, 1989). The question 
as to whether melatonin might act as a discriminative stimulus
directly was answered by the work discussed in chapter 4. It was 
reasoned that melatonin might express a discriminative cue in a
slightly more subtle fashion, based on the relationship of
environmental light and dark cues with temporal cues. An
exteroceptive temporal/visual discriminative stimulus was employed 




3. MELATONIN AND 5-HT
3.1. Evidence for the Physiological/Pharmacological Interaction of 
5-HT and Melatonin
The common biosynthetic pathway shared by 5-HT and 
melatonin and hence their similar molecular structures provided the
initial impetus to justify investigation as to whether these two
compounds in some way interacted. One of the earliest studies to
support this concept was produced by Anton-Tay et al. (1968) who
reported an increase of serotonin content in the hypothalamus and 
midbrain of rats administered melatonin, though this has not proved 
to be a consistent finding (e.g. Holmes and Sugden, 1982). As 
discussed in Chapter 1, several recently published reports question 
the passive role of 5-HT as simply a precursor in melatonin 
synthesis (Aloyo and Walker, 1987; Aloyo and Walker, 1988; Sugden, 
1989). In addition, several workers have proposed that the effects 
of melatonin are mediated via the serotonergic system (e.g. Wurtman 
and Anton-Tay, 1969; Kovacs et al., 1974; Trentini et al., 1979). 
Despite this apparent interest there have been few reports published 
specifically aimed at identifying a link between melatonin and 5-HT 
in a discipline other than synthetic biochemistry.
In the periphery it has been demonstrated that high 
concentrations of melatonin inhibit the contractile response to 5-HT 
in certain isolated smooth muscles (Satake et al., 1986). Kamberi 
(1974) described evidence for an inhibitory effect of 5-HT on the 
release of luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH) which is mimicked by melatonin. Others have reported a 
positive action on the cyclic release of gonadotropins and prolactin 
secretion by 5-HT (see review by Trentini, 1979). Evidence derived
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from radioligand binding studies involving both 5-HT receptor 
ligands and [3H]-melatonin or 2-[125I]-iodomelatonin indicate that 
their small structural differences are sufficient to confer 
negligible affinity for each others putative binding sites 
(Dubocovich and Takahashi, 1987; Morgan and Williams, 1989). 
Pickering and Niles (1990), used more selective 5-HT radioligands, 
and also failed to evince inhibition of binding by 
2-[125I]-iodomelatonin. An interesting exception, however, was the 
mixed 5-HTia/5-HTib receptor agonist, RU24969, which possessed 
appreciable affinity for binding sites labelled by 
2-[125I]-iodomelatonin in the hypothalamus presumably due to its 
structure being based around an indole nucleus. This suggests that 
an interaction, if existing between the serotonergic system and 
melatonin, would be expressed via an indirect mechanism. 
Interestingly, the choroid plexus, which lies at the base of the 
pineal stalk, is reported to possess a low concentration of 
melatonin binding sites as identified by 2-[125I]-iodomelatonin 
(Vanecek, 1988) and a high concentration of 5-HTic binding sites 
(Pazos et al., 1984). Gaffori and Van Ree (1985) have advanced the 
most compelling support for an interrelationship between melatonin 
and 5-HT. They were able to show that injection of small amounts of 
melatonin directly into the nucleus accumbens elicited a distinctive 
change in rat behaviour. This "melatonin-induced” behaviour was 
characterized by an increase in grooming and sniffing 
displacement-type behaviour (Silverman, 1978) and a reduction in 
locomotor and rearing activity. Recognized dopaminergic agonists and 
antagonists were unable to affect the action of melatonin but 5-HT 
blocked the behaviour and it was reproduced by non-selective 5-HT 
antagonists.
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There has been much speculation in the literature over 
5-HT and its possible role in mediating the action of melatonin. It 
was decided to use recognized behavioural models of 5-HT receptor 
activation to investigate the potential of a modulatory role for 
melatonin in the serotonergic system. These models and any related 
actions of melatonin are considered below.
3.2. Behavioural Models of 5-HT Receptor Activation
3.2.1. The Headtwitch
The headtwitch is a component of the 5-HT behavioural 
syndrome that is considered to be mediated by activation of the 
5-HT2 receptor. Early experiments investigating the 5-HT 
behavioural syndrome induced it by the administration of a monoamine 
oxidase inhibitor (MAOI) in conjunction with a precursor of 5-HT 
(L-tryptophan or 5-HTP) but has since been reproduced with other 
compounds capable of activating 5-HT receptors. After the 
classification of 5-HT receptors into 5-HTi and 5-HT by Peroutka 
and Snyder (1979a) it was thought that manifestation of the whole 
syndrome was attributable to the activation of 5-HT2 receptors 
(Peroutka et al., 1981), however attention was focused on 5-HTi 
receptors after Lucki and Frazer (1982a) reported that chronic 
antidepressant treatment which down-regulated 5-HTi, but not 5-HT2 
receptors inhibited the ability of 5MeODMT to elicit the syndrome. 
Furthermore, the novel 5-HT2 receptor antagonist, ketanserin, failed 
to block the appearance of the syndrome induced by 5-MeODMT in 
contrast to the non-selective anatgonist metergoline (Lucki et al.,
1984). The introduction of 8-OHDPAT in 5-HT behavioural studies and 
its ability to induce the syndrome, identified the 5-HT1a receptor 
as the probable mediator (Hjorth et al., 1982; Tricklebank et al.,
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1985). Putative selective 5 -H T i b  receptor agonists (e.g. 
1-[3-(trifluoromethyl)phenyl] piperazine, TFMPP; or 1-[3-chloro- 
phenyl]piperazine, mCPP) do not readily produce the syndrome (Lucki 
and Frazer, 1982b). Inhibiting 5-HT synthesis using the tryptophan 
hydroxylase inhibitor, pCPA, depleting 5-HT stores with reserpine or 
destroying 5-HT neurons using 5,7-dihydroxytryptamine (5,7-DHT) 
fails to prevent the syndrome induced by 8-OHDPAT suggesting a 
postsynaptic receptor as its mediator (Tricklebank et al., 1985). 
Closer examination of the effects of ketanserin and other 5-HT2 
antagonists on the behavioural syndrome reveal that they are capable 
of blocking a single component, that of headtwitches (Ogren et al., 
1979; Yap and Taylor, 1983; Niemegeers et al., 1983). This would 
suggest that this symptom is induced through the activation of 5-HT2 
receptors. Certain hallucinogenic compounds known to interact with 
5-HT2 receptors are capable of eliciting headtwitches, e.g. LSD, 
mescaline and DOB (Vetulani et al., 1980; Niemegeers et al., 1983; 
Lucki et al., 1984). The ability of 5-HT antagonists to block the 
headtwitch response correlates with their affinity for 5-HT2 binding 
sites in the frontal cortex (Ogren et al., 1979; Niemegeers et al., 
1983), though it is thought that the behaviour is actually mediated 
by 5-HT receptors located in the brain stem (Bedard and Pycock, 
1977; Lucki and Minugh-Purvis, 1987).
In this series of experiments the headtwitch response was 
used as a model for 5-HT2 receptor activation with the aim of 
discovering whether it was influenced by melatonin. In addition, 
chronic administration of certain antidepressant drugs inhibits the 
head-shaking behaviour in rats if tested during drug treatment 
(Lucki and Frazer, 1985), an effect possibly caused by down- 
regulation of 5-HT2 receptors (Peroutka and Snyder, 1980). It was
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thought that melatonin might exert a similar effect in mice and 
therefore this hypothesis was also tested.
3.2.2. Hypothermia
The hypothermic response induced by 8-OHDPAT was used as a 
model for 5-HTia receptor activation. The serotonergic system has 
long been associated with a regulatory function in the maintenance 
of deep body temperature in homeothermic animals although the 
reaction to serotonergic drugs is highly dependent on dose, species 
and environmental conditions (Green and Goodwin, 1987). Activation 
of 5-HT2 receptors would appear to elicit hyperthermia since 
temperature increases induced by certain 5-HT agonists, e.g. 
quipazine, mCPP and high doses of 5MeODMT are inhibited by 
pretreatment with 5-HT2 antagonists (Gudelsky et al., 1986). In 
contrast, 8-OHDPAT, ipsapirone and low doses of 5MeODMT induce 
hypothermia (Goodwin and Green, 1985; Goodwin et al., 1985, 1986,
1987; Gudelsky et al., 1986). 8-OHDPAT-induced hypothermia can be 
attenuated by prior administration of ipsapirone, supporting 
evidence that this compound acts as a partial agonist at 5-HTi 
receptors (Goodwin et al., 1986). The hypothermic response to 
8-OHDPAT in rats can be blocked by putative 5-HTia antagonists, e.g. 
(“)-propranolol and (-)-pindolol, but not selective 5-HT2 
antagonists (Goodwin and Green, 1985; Gudelsky et al., 1986). In 
mice these same 5-HTla antagonists fail to block 8-0H- DPAT-induced 
hypothermia (Goodwin and Green, 1985). Interestingly, quipazine and 
the butyrophenone haloperidol are capable of attenuating the 
response in mice (Goodwin et al., 1985a). Since flupenthixol is 
without effect on 8-OHDPAT-induced hypothermia it would seem 
reasonable that haloperidol is acting at a butyrophenone-sensitive
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site rather than via the dopaminergic system (Goodwin et al., 
1985a), which Goodwin and Green (1985) suggest could be the 5-HT2 
receptor. It would appear that the hypothermic response to 8-OHDPAT 
results from the activation of presynaptic 5 -H T i a  receptors since it 
is abolished if 5-HT synthesis is inhibited using pCPA or 5-HT 
neurons are destroyed using 5,7-DHT (Goodwin et al., 1985a, 1987).
Melatonin and the pineal gland have also been implicated 
in the regulation of body temperature. John et al. (1978) reported 
elevated body temperature in pinealectomized pigeons in comparison 
to their intact controls. This hyperthermia was blocked by the 
subcutaneous implantation of melatonin in beeswax pellets. 
Pinealectomy abolished the circadian rhythm of body temperature of 
house sparrows housed in DD (Binkley et al., 1971). Binkley et al. 
(1971) also reported that injection of melatonin into house sparrows 
elicited a 4.7°C decrease in body temperature. The published effects 
of melatonin on body temperature in mammals are few and 
contradictory. Large doses of melatonin (50-100mg) appear to reduce 
body temperature in mice (Arutyunyan et al., 1964) though this may 
be due to a generalized reduction in activity resulting from its 
hypnotic effect (Sugden, 1980). In contrast a hyperthermic effect on 
the body temperature in rats was observed by Fioretti et al. (1974) 
using smaller doses (4-8mg/kg). Barchas et al. (1964) found no 
evidence that melatonin influenced rabbit body temperature.
It was clear that melatonin might elicit an effect on 
8-OHDPAT-induced hypothermia which was not due to any form of active 
melatonin-5-HT interaction. Thus experiments were conducted to 
establish whether melatonin at moderate doses influenced body 
temperature in mice, prior to investigating the action of melatonin 
on 5 -H T i a  receptor activation.
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3.2.3. Hyperphagia
In the past, activation of the serotonergic system was
generally considered to inhibit feeding behaviour. Drugs that 
increase the synaptic availability of 5-HT or activate 5-HT
receptors reduce food intake. Thus the 5-HT releasing agent,
fenfluramine, the 5-HT reuptake inhibitor, fluoxetine and the 5-HT 
agonists quipazine and 5-HTP all inhibit feeding (Blundell and 
Leshara, 1975; Goudie et al., 1976; Samanin et al., 1977). Moreover, 
the "classical" 5-HT antagonists (e.g. cyproheptadine) promote food 
intake (Baxter et al., 1970). The comfort of this theory was
briefly disturbed by the report that the novel 5-HT agonist
8-OHDPAT, which was a potent and selective ligand for 5 -H T i a  
receptors (Middlemiss and Fozard, 1983), induced feeding in
non-deprived rats (Dourish et al., 1985). It has since been shown 
that hyperphagia is the result of 8-OHDPAT acting on 5-HTia
autoreceptors located in the raphe nuclei to reduce serotonergic 
activity (Dourish et al., 1986a, 1986b; Hutson et al., 1986) in 
contrast with the 8-OHDPAT-induced behavioural syndrome which is 
produced by activation of postsynaptic 5 -H T i a  receptors (Tricklebank 
et al., 1984). Stimulation of these autoreceptors is thought to 
inhibit 5-HT synthesis since 8-OHDPAT fails to elicit feeding in 
rats pretreated with the 5-HT synthesis inhibitor pCPA (Dourish et 
al., 1986a). This is consistent with the inhibitory role played by 
the serotonergic system in feeding behaviour.
8-OHDPAT-induced hyperphagia was chosen as an additional 
model for 5 -H T i a  receptor activation to investigate the possible 
influence of melatonin which has not been reported to exert a 
significant effect on feeding behaviour.
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3.2.4. Locomotor Activity
The influence of melatonin on 5 -H T i b  receptor-mediated 
behaviour was investigated using RU24969-induced hyperactivity as a 
putative model for 5 -H T i b  receptor activation. As with feeding, 
activation of the serotonergic system has usually been associated 
with an inhibitory effect on locomotor activity. This is derived 
from studies that demonstrate depletion of central 5-HT (e.g. caused 
by vesicular depletion, inhibition of synthesis or destruction of 
5-HT neurons) induce hyperactivity (Gerson and Baldessarini, 1980) 
and the intracerebroventricular (i.c.v.) administration of 5-HT 
reduces locomotor activity (Green et al., 1976). This effect is 
thought to be partly mediated by the dopaminergic neurons of the 
mesolimbic system since depletion of 5-HT potentiates hyperactivity
induced by dopaminergic agonists, e.g. amphetamine, (Lucki and
Harvey, 1979) and i.v. injection of 5-HT inhibits this stimulated
locomotor activity response to amphetamine (Warbritton et al., 
1978). In addition, RU24969 has been shown to enhance the activity 
of the mesolimbic system (Oberlander, 1983), despite having no 
affinity for dopamine receptors (Tricklebank, 1986). Furthermore, 
non-sedative doses of haloperidol have been reported to inhibit 
RU24969-induced hyperactivity (Green et al., 1984). Thus it would 
appear possible that RU24969 acts by reducing an inhibitory 
serotonergic influence on dopamine neurons (Carli et al., 1988). 
RU24969 has recently been shown to possess similar affinity for both 
the 5 -H T i a  and 5 -H T i b  binding sites (Hamon et al., 1986; Tricklebank 
et al., 1986). However, the main behavioural symptoms of RU24969 
administration are hyophagia and hyperactivity (Green et al., 1984). 
In contrast, 8-OHDPAT induces components of the behavioural 
syndrome, increased sexual behaviour, hyperphagia and hypothermia
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(Ahlenius et al., 1981; Tricklebank et al., 1986; Dourish et al., 
1985; Bendotti and Samanin, 1986). This would suggest that 
RU24969-induced hyperactivity results from an interaction at 5 -H T i b  
receptors although it is possible that a difference in brain 
distribution of 5 -H T i a  and 5 -H T i b  binding sites might account for 
the differing behavioural effects of 8-OHDPAT and RU24969 (Pazos and 
Palacios, 1985; Carli et al., 1988).
Hypoactivity has also been reported as a suitable model 
for 5 -H T i b  receptor activation in contrast to hyperactivity. This is 
derived from studies that report hypoactivity as the major effect of 
the putative selective 5 -H T i b  agonists TFMPP and mCPP in 
unhabituated rats exposed to a novel environment (Lucki and Frazer, 
1982b, 1985). The response is blocked by pretreatment with
non-selective 5-HT antagonists (e.g. metergoline) but not selective 
5-HT2 antagonists (e.g. ketanserin) suggesting that it is mediated 
by 5 - H T i - n k e  receptors (Lucki and Frazer, 1985). Recently it has 
been reported that low doses of RU24969 elicit hypoactivity in the 
mouse which appeared to be due to reduced 5-HT release as a result 
of activation of the 5 -H T i b  autoreceptor (Clark et al., 1988). It 
was decided to investigate this effect in rats to ascertain whether 
it might be a more appropriate model for 5 -H T i b  receptor activation 
than RU24969-induced hyperactivity.
Information on whether melatonin has a direct effect on 
locomotor activity is not clear although several reports have been 
published documenting the effect of melatonin on the circadian 
rhythm of locomotor activity in various species (e.g. Underwood and 
Harless, 1985; Underwood, 1986; Redman et al., 1983; Cassone et al., 
1986a, 1986b). This is considered in greater detail in chapter 5. 
It has been shown that continuous infusion of melatonin from i.p.
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placed silastic capsules reduces the total amount of perch-hopping 
behaviour per 24 h in sparrows (Hendel and Turek, 1978). In addition 
wheel-running activity in rats is depressed by melatonin in 
food-deprived rats (Wong and Whiteside, 1968). Both of these
studies, however, were concerned with the circadian pattern of 
activity rather than an immediate pharmacological effect. 
Considering its putative hypnotic properties large doses might be 
expected to elicit hypoactivity. As mentioned above Gaffori and Van 
Ree (1985) have reported a reduction in locomotor activity after an 
injection of melatonin into the nucleus accumbens of rats which 
appears to be influenced by 5-HT through an unknown mechanism. 
Peripheral administration of melatonin has tended to yield negative 
results (e.g. Kastin et al., 1973; Kovacs et al., 1974).
3.3. Melatonin, 5-HT and Circadian Rhythms
Several parameters of central 5-HT function display a 
circadian variation. 5-HT concentrations in the brain express a
circadian rhythm with a zenith at approximately mid-light (ML) 
(Albrecht et al., 1956; Hillier and Redfern, 1977). Conversely the 
circadian rhythm of 5-HT release as determined by intracerebral 
analysis peaks during the dark phase (Martin and Marsden, 1985). 
This is in phase with the circadian rhythm of 5-HT reuptake 
(Wirz-Justice et al., 1983). [3H]-Spiperone binding in the frontal 
cortex also displays a 24 h variation (Wirz-Justice, 1987), peaking 
at ML. This suggestion of 5-HT2 receptor density variation is 
supported by Moser and Redfern (1985a) who demonstrated that the 
5-HT2 receptor mediated headtwitch behaviour in mice expresses a 
circadian rhythm with a maximum at ML. 5-HT1a receptor mediated 
behaviour (e.g. 5-HT behavioural syndrome and 8-OHDPAT-induced
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hypothermia) does not undergo a circadian variation (Moser, 1986). 
Since melatonin has been shown to influence the expression of 
circadian rhythms in a variety of species it was decided to conduct 
these experiments at pre-determined time-points of the LD cycle. 
Melatonin has often been described as "the hormone of darkness” and 
it was therefore hypothesized that any interaction with the 
serotonergic system might be the result of melatonin inducing 
dark-appropriate responding.
Experiments that were of relatively short duration 
(8-OHDPAT-induced hypothermia and headtwitches) were performed at 
four times: end-of-light (EOL), mid-dark (MD), end-of-dark (EOD) and 
mid-light (ML). The "end of" light or dark was taken as the last two 
hours of the phase. Thus no experiment was conducted which would 
involve the animals experiencing a sudden change of phase during its 
course. The feeding and activity experiments were of longer duration 
and were performed at two periods of the LD cycle. These experiments 
were conducted over the course of five hours of which the mid-point 
was approximately MD or ML. The effect of chronic melatonin 
treatment on L-5HTP-induced headtwitches was conducted at only one 
time point.
3.4. Materials and Methods
3.4.1. Animals
Male CFLP mice (Animal House, Bath University strain) 
weighing between 25 and 40g (unless stated otherwise), housed in 
groups of 20-25 under normal lighting conditions (12:12 LD cycle; 
lights on 06:00 h) were used in all mouse experiments. Male Wistar 
rats (Animal House, Bath University strain) weighing between 250 and 
400g, housed in groups of 4-6 in standard plastic cages, measuring
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520 x 350 x 170mm, under a 12:12 LD lighting regimen were used in 
all rat experiments. Food and water (Labsure CRM diet) were 
available ad libitum except where indicated otherwise.
3.4.2. Drugs
All drugs were dissolved or suspended in normal saline by 
sonication and administered i.p. unless otherwise stated using a 
dose-volume of 5ml/kg. Control animals received the same amount of 
drug vehicle. Drugs used were as follows: Melatonin (Sigma);
5-Methoxy-dimethyltryptamine (5Me0DMT, Sigma); 5-Hydroxy-L- 
tryptophan (L-5HTP, Sigma); 8-dihydroxy-2-(di-n-propylamino)tetralin 
(8-OHDPAT, gift from Dr. J Stolz, University of Bath), injected s.c. 
using a dose-volume of 2.5ml/kg; 5-methoxy-3(1, 2,3,6-tetrahydro- 
pyridin-4-yl) 1H indole (RU24969, Roussell); and carbidopa (gift 
from M.S.D.).
3.4.3. Methods
3.4.3.1. Investigation into the effect of melatonin on headtwitches 
induced by 5-HT agonists.
One mouse was placed into one half of a cage measuring 330 
x 130 x 160mm divided into two halves by a wooden block 2 min after 
an injection of 5MeODMT (8mg/kg) or 20 min after an injection of 
L-5HTP (160mg/kg). A second mouse was put into the other half 
thereby enabling two mice to be observed for 2 min simultaneously. 
Mice that received L-5HTP were pretreated 20 min before with 
carbidopa (50mg/kg). A range of melatonin doses (0, 0.05, 0.2, 0.8, 
1, 4, 8, 16, 32mg/kg) and pre-treatment times (10, 20, 30 min) were 
used. Control animals received the same amount of drug vehicle. The 
effect of chronic treatment with melatonin (0.05, 0.2 and 0.8mg/kg)
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was also investigated on headtwitches induced by L-5HTP. Mice 
weighing 15-25g at the start of the experiment were injected with 
melatonin daily over a 15 day period. They were weighed each day to 
ensure that any changes in the injection volume could be accomodated 
when necessary. On the 16th day the mice were pretreated with 
carbidopa, followed 10 min later by the same dose of melatonin as 
they had received chronically. 10 min after the melatonin injection 
the mice received L-5HTP and observed, as described above, 20 min 
later. The effect of melatonin (1mg/kg) on headtwitches induced by 
5MeODMT (8mg/kg) at four time-points of the LD cycle was examined. 
The points chosen were ML, EOL, MD and EOD.
3.4.3.2. Investigation into the effect of melatonin on 8-OHDPAT-
induced hypothermia.
Mice weighing 25-30g were used in all temperature 
experiments. Initial dose-response and time-response curves to 
8-OHDPAT and melatonin were constructed with rectal temperatures 
being taken immediately before injection and at predetermined times 
after injection using a vaseline-lubricated probe inserted 2.5cm 
into the rectum. Animals used for investigating the effects of 
8-OHDPAT-induced hypothermia had their rectal temperature measured 
four times: 15 min before their first injection (8-OHDPAT,
0.5mg/kg), immediately before the first injection, immediately
before their second injection (melatonin, 1mg/kg) and finally 15 min 
later. Temperatures were measured using a vaseline-lubricated probe 
inserted 2.5cm into the rectum, the mice being lightly restrained. 
All measurements were taken at room temperature (20-25°C).
Antagonism experiments were performed at four time points: ML, EOL, 
MD and EOD. Control animals received the same amount of drug
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vehicle.
3.4.3.3. Investigation into the effect of melatonin on 8-OHDPAT- 
induced hyperphagia.
Mice weighing between 42 and 47g, and rats weighing 
between 300 and 400g were used for this series of experiments. 
Animals were taken from their home cage and placed into individual 
observation plastic cages, measuring 420 x 250 x 120mm for mice and 
420 x 260 x 150mm for rats, for 2 h before the experiment was begun. 
This allowed them to habituate themselves with the experimental 
cages and also with food pellets (Labsure CRM diet) located on the 
cage floor. Water was available from a standard water bottle. Just 
prior to the start of the experiment the animals were removed from 
the cages and returned to their home cage. The experimental cages 
were then cleaned and a weighed amount of food was placed onto the 
cage floor. As the animals were put back into their respective 
experimental cages they received an injection of drug. The effect of 
melatonin on feeding was assessed using 0.1, 1 and 10mg/kg in both
mice and rats. A dose-response curve to 8-OHDPAT was constructed 
using rats. Animals used to assess the effect of melatonin on 
8-OHDPAT-induced hyperphagia were given 8-OHDPAT (0.25mg/kg) at the 
start of the experiment and then 15 min later received melatonin 
(1mg/kg). After the experiment food remnants were collected and 
weighed. Control animals received the same amount of drug vehicle.
3.4.3.4. Locomotor Activity Experiments
3.4.3.4.1. Investigation into the effect of melatonin on RU24969- 
induced hyperactivity.
Mice weighing between 35 and 45g were housed individually 
in plastic cages measuring 520 x 350 x 170mm placed on top of Animex
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locomotor activity detectors. These detectors were housed in sound 
and light attenuating environmental cabinets (see Fig. 5.1, chapter 
5) which were equipped with their own lighting and ventilation 
system (see chapter 5, section 5.2.3. for further details). The 
number of counts was collected and displayed, via a BBC Master 
computer, on a monitor screen using a short-term locomotor activity 
program (Marshall et al., 1985). The data was stored on computer 
disc as counts/min and for all experiments the total number of 
counts measured over 2 h following injection of the drug were 
recorded. A dose-response curve to RU24969 was constructed and 
potential melatonin-induced effects on locomotor activity were 
investigated at two doses (1 and 9mg/kg). Interaction experiments 
were performed with the injection of melatonin (1mg/kg) being given 
immediately after that of RU24969 (5mg/kg). This pretreatment time 
for melatonin was chosen because preliminary experiments established 
that hyperactivity induced by RU24969 began approximately 30 min 
after injection of the drug.
3.4.3.4.2. Assessment of the ability of low-dose RU24969 to induce
hypoactivity in rats
Rats weighing between 250 and 350g were housed
individually in a rectangular plastic cage measuring 900 x 600 x
350mm as described in chapter 5, section 5.2.3. (see Figs. 5.3 and
5.4). Activity was assessed by means of light-beam breakage and 
recorded as counts/2 min using specifically designed software 
(Marshall et al., 1985). Animals were allowed to habituate to the 
cage for 2 h before receiving an injection of drug. They were then 
returned to the cage and activity recorded for the following 2 h. 
The experiment was performed over the MD period.
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3.5. Results
3.5.1. Melatonin and headtwitches
Melatonin neither elicited any headtwitches nor influenced 
the number of headtwitches induced by either of the 5-HT agonists 
used at any of the time points or dosages used. Fig. 3.1a and 3.1b 
depict the dose-response curves obtained with SMeODMT and L-5HTP 
respectively. Fig. 3.2 compares a range of melatonin doses (0.2, 
1.0, 8.0, 32.0mg/kg, 20 min pretreatment time) with 5Me0DMT (8mg/kg, 
2 min pretreatment time) and L-5HTP (80mg/kg, 20 min pretreatment 
time) in their ability to induce headtwitches in mice. As can be 
seen from Fig. 3.3 chronic melatonin therapy also had no effect on 
the number of headtwitches induced by L-5HTP. Fig. 3.4 depicts the 
effect of melatonin (1mg/kg, 20 min pretreatment time) on 
5Me0DMT-induced headtwitches over four time points in the LD cycle 
( 12: 12).
3.5.2. Melatonin and temperature
Fig. 3.5 shows the dose-response curve for 8-OHDPAT- 
induced hypothermia. Melatonin failed to affect mouse rectal 
temperature at any dose employed (see Table 3.1) and also failed to 
influence hypothermia induced by 8-OHDPAT (0.5mg/kg) at any of the 
time points over the LD cycle (1 mg/kg, 15 min pretreatment time) as 
shown by Fig. 3.6.
3.5.3. Melatonin and feeding
The ability of 8-OHDPAT to induce hyperphagia was 
confirmed (see Fig. 3.7) but melatonin failed to influence feeding 
in both mice and rats (see Table 3.2) and was ineffective at 
modifying the hyperphagia induced by 8-OHDPAT in rats at both the ML
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and MD periods investigated (see Fig. 3.8).
3.5.4. Locomotor Activity Experiments
3.5.4.1. Melatonin and RU24969-induced hyperactivity
The dose-response curve to RU24969 is shown in Fig. 3.9. 
Melatonin (1mg/kg) did not influence mouse locomotor activity alone 
and was without effect on RU24969-induced hyperactivity when given 
immediately after the injection of RU24969 (5mg/kg) during either
the dark or the light phase (see Fig. 3.10).
3.5.4.2. RU24969 and hypoactivity
The ability of low doses of RU24969 to induce hypoactivity
in mice was not confirmed in the rat. Fig. 3.11 shows the mean total
activity over 30 min after receiving various doses of the drug up to 
the level when hyperactivity became discernible.
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Table 3.1. Effect of melatonin on rectal temperature in the mouse at 
mid-light using different pre-treatment times. (”+” or indicate 
increase or decrease, respectively, in rectal temperature; n=6).
Dose (mg/kg) Pretreatment Mean change in rectal
time (min) temperature (°C) +/- s.'
0 10 0 0.12
0.1 10 + 0.1 0.14
1.0 10 - 0.04 0.13
10.0 10 + 0.18 0.17
0 20 + 0.05 0.13
0.1 20 + 0.13 0.08
1.0 20 + 0.02 0.05
10.0 20 - 0.02 0.12
0 30 - 0.04 0.16
0.1 30 + 0.05 0.06
1.0 30 0 0.14
10.0 30 - 0.04 0.08
Table 3.2. Effect of melatonin on food intake of mice and
mid-light (ML) and mid-dark (MD). (
/*N■oIIG
Animal Dose (mg/kg) Time-of- Mean quantity of food
day eaten in 2 h (g) +/-





























Fig. 3.1. Dose response curves showing the induction of headtwitches in mice by (a) L-5HTP and
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Headtwitches induced by melatonin, 5MeODMT and L-5HTP.
(n=5-7, mean ± s.e.m.).
Key:
a = vehicle
b-e = 0.2, 1.0, 8.0 and 
32.0mg/kg melatonin 
repectively
f = 5MeODMT (8mg/kg) 
g = L-5HTP (80mg/kg)















Fig. 3.3. Comparison of acute melatonin and chronic melatonin treatment on
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Key:
a = vehicle: L-5HTP (80mg/kg) 
b = melatonin (0.05mg/kg): L-5HTP (80mg/kg) 
c = melatonin (0.2mg/kg): L-5HTP (80mg/kg) 
d = melatonin (l.Omg/kg): L-5HTP (80mg/kg)
All animals were given carbidopa (25mg/kg) i.p 
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Fig. 3.5. Dose-response curve showing the induction of hypothemia by 8-OHDPAT
in mice. (n=6, mean ± s.e.m.).














Fig. 3.6. Effect of melatonin on 8-OHDPAT-induced hypothermia in mice. (n=6, mean ± s.e.m.).
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Fig. 3.7. Dose-response curve showing the induction of hyperphagia by 8-OHDPAT
in rats. (n=8, mean ± s.e.m.).
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Fig. 3.8. Effect of melatonin on 8-OHDPAT-induced hyperphagia at mid-light and mid-dark in rats
(n=6-8, mean ± s.e.m.).
5 __
Key:
a = vehicle : vehicle
b = vehicle : melatonin (lmg/kg)
c = 8-OHDPAT: (0.25mg/kg) : vehicle
d = 8-OHDPAT : (0.25mg/kg) : melatonin
(lmg/kg)
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Fig. 3.9. Dose-response curve showing the induction of hyperactivity by RU24969
























Fig. 3.10. Effect of melatonin on RU24969-1nduced hyperactivity at mid-light and mid-dark in mice.
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Fig. 3.11. Effect of low-dose RU24969 on locomotor activity in mice. 




The singular ineffectiveness of melatonin in this series 
of experiments was surprising. It does not rule out, however, any 
possibility of an interaction between these two systems since the 
results may simply reflect that the sites of interaction are 
physiologically and pharmacologically distinct from the serotonergic 
sites that are responsible for 5-HT-mediated behaviour. The doses of 
melatonin used in this study could be considered low but there is 
evidence to suggest that melatonin is a potent molecule (e.g. see 
Cassone et al., 1986a; Reiter, 1983b, and references cited therein) 
and, due to its lipophil^ic nature and the free transport of plasma 
albumin-bound melatonin across the blood brain barrier, can rapidly 
penetrate the brain following i.p. injection (Reppert et al., 1979; 
Sugden, 1980; Pardridge and Mietus, 1981). Since this work was 
carried out it has been shown that similar doses of melatonin can 
affect 5-HT2 receptor mediated sleep-wakefulness regulation in the 
rat (Dugovic et al., 1989). Involvement of the serotonergic system 
in sleep is well established and has been implicated in both the 
initiation and maintenance of slow-wave sleep and paradoxical sleep 
(REM) (Morgane and Stern, 1972). Holmes and Sugden (1982) reported 
an increase in these components of sleep following a melatonin dose 
of 10mg/kg. The work of Dugovic and co-workers indicate the 
potential involvement of 5-HT2 receptors in regulating slow-wave 
sleep in the rat since ritanserin, a 5-HT2 selective antagonist, was 
found to reverse the effect of the 5-HT2 agonist DOM on deep slow 
wave sleep (Dugovic and Wauquier, 1987; Dugovic and Wauquier, 1988; 
Dugovic et al., 1989a; Dugovic et al., 1989b). An observation that 
the effectiveness of ritanserin depended on the time of 
administration during the LD cycle prompted the investigation as to
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whether it was linked to melatonin. Using a dose of 1mg/kg Dugovic 
et al. (1989a) reported that although melatonin failed to influence 
any sleep stage when given alone it antagonized the opposite effects 
of both ritanserin and DOM on deep slow-wave sleep and paradoxical 
sleep. The mechanism behind this interaction is not understood 
though Dugovic concludes that melatonin modulates 5-HT2 receptor 
sensitivity possibly through a mechanism involving arginine 
vasotocin (AVT). The lack of affinity of melatonin for 5-HT2 
receptors effectively eliminates "classical" pharmacological 
explanations that melatonin might be a partial agonist at this site 
(Dugovic et al., 1989b; Pickering and Niles, 1990). Activation of 
the same 5-HT receptors located in the brain stem are thought 
responsible for controlling 5-HT-mediated headtwitches (Bedard and 
Pycock, 1977), but the failure of melatonin to influence their 
manifestation would suggest that it exerts no influence on these 
receptors. An investigation into the effects of melatonin treatment 
on 5-HT2 binding sites and their putative high and low-affinity
components is required. It should be remembered that "slow-wave 
sleep" and "paradoxical sleep" are classified according to the
pattern of electrical activity in the brain and are therefore the
products of the electrical activity of many interacting
neurotransmitter systems. Thus melatonin may simply act via a 
compensatory mechanism unconnected with the serotonergic system to 
restore the balance disturbed by abnormal serotonergic activity. It 
would be of interest to study the effects of putative melatonin 
antagonists in this model, since it would give an indication as to 
whether melatonin acts through its own receptor or exerts a 
generalized hypnotic action. 5-HT-agonist induced headtwitches is 
more specific as a model for investigating a potential interaction
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between melatonin and 5-HT. Although a variety of compounds can 
induce head shaking behaviour, e.g. carbachol, TRH (thyrotropin- 
releasing hormone) and opiates (Wei et al., 1977; Prange et al., 
1974; Handley and Singh, et al., 1986) these do not appear to 
involve a serotonergic mechanism (Bedard and Pycock, 1977; Drust and 
Connor, 1983).
The effect of prolonged melatonin treatment (either as a 
single bolus daily dose or continuous infusion) in 5-HT-mediated 
behavioural models merits further investigation. Despite the lack of 
effect of chronic melatonin therapy on 5-HTP-induced headtwitches it 
does not eliminate the involvement of other 5-HT receptor subtypes - 
(although it should be mentioned that diminution of the 5-HT- 
syndrome induced in conjunction with the headtwitches by 5-HTP was 
not apparent during the course of the experiment in comparison to 
acute melatonin treatment). Much attention has been paid to the 
relationship between melatonin, depression and antidepressants in 
recent years notwithstanding the established, if little understood, 
role of the serotonergic system in major affective disorder. Acute 
treatment with tricyclic antidepressants increasesplasma melatonin 
levels as a result of increasing the availability of noradrenaline 
to stimulate beta-adrenoceptors in the pineal gland by blocking 
noradrenaline reuptake (Parfitt and Klein, 1977; Burns and Brown, 
1984; Franey, et al., 1986). Chronic antidepressant treatment 
elicits adaptive changes at adrenoceptors, the most consistent being 
a reduction in either the number of beta-adrenoceptors or their 
coupling to the cAMP second messenger system (Sulser et al., 1984; 
Moyer et al., 1979; Heydorn et al., 1982). This leads to a 
concomitant decrease in pineal and plasma melatonin levels (Heydorn 
et al., 1982; Friedman et al., 1984). Reduced levels of circulating
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melatonin in depressed patients has been repeatedly observed as a 
feature of depression (Lewy et al., 1979; Wirz-Justice and Arendt, 
1979; Wetterberg, 1983; Steiner and Brown, 1985) and may be the 
result of reduced central noradrenergic tone associated with 
depressive illness and perhaps deficiency in the melatonin precursor 
5-HT (Heninger et al., 1984; Arendt, 1989). Conversely, Thompson et 
al. (1988) have recently reported no differences in the timing or 
amplitude of melatonin secretion between depressives and controls 
which suggests that melatonin is unlikely to be involved in the 
aetiology of depression. Moreover, reduced melatonin production 
caused by chronic antidepressant treatment does not affect their 
clinical efficacy. However, melatonin does demonstrate potential for 
use as a diagnostic aid in certain psychiatric conditions (Miles and 
Thomas, 1988; Arendt, 1989). It is generally recognized that an 
important contributory factor in the action of certain
antidepressants is their ability to increase central serotonergic 
tone (Sulser et al., 1978; Sulser, 1983) either through reduction of
5-HT catabolism or inhibition of reuptake mechanisms. Anti­
depressants have mixed actions on 5-HT receptors; tricyclic
antidepressants (TCAs; e.g. amitryptiline, nortryptiline) tend to 
inhibit headtwitches (Ogren et al., 1979) whereas MAOIs (monoamine 
oxidase inhibitors) and 5-HT reuptake inhibitors (e.g. fluoxetine) 
potentiate head-shaking behaviour (Matthews and Smith, 1980).
Chronic administration of antidepressants, however, lead to
inhibition of headshaking behaviour if tested during treatment - a 
response thought to result from the down-regulation of 5-HT2 
receptors (Lucki and Frazer, 1985; Peroutka and Snyder, 1980) (it 
should be noted though that prolonged antidepressant therapy 
down-regulates alpha2 adrenoceptors too and these receptors are also
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thought to be involved in the mediation of headtwitches (Glennon and 
Lucki, 1988)). The 5-HT syndrome induced by 5-HT agonists is reduced 
following chronic MAOI therapy, an action thought to be related to 
their ability to down-regulate 5-HTi receptors in the brain stem or 
spinal cord (Lucki and Frazer, 1982). This leads on to the 
observations that repeated administration of antidepressants 
inhibits the hypothermic response to 8-OHDPAT (Goodwin et al., 
1985), and chronic MAOI treatment (but not TCAs) blocks the activity- 
suppressant effects of mCPP and TFMPP - putative 5-HTib/5-HTic 
selective agonists (Lucki and Frazer, 1985). Furthermore, Gaffori 
and Van Ree (1985) demonstrated that behavioural changes induced by 
melatonin injected into the rat nucleus accumbens were reversed by 
acute treatment with 5-HT and antidepressants but not by dopamine 
antagonists. It would therefore be justified to investigate further 
the relationship between chronic melatonin therapy and the 
serotonergic system to establish whether their mutual involvement 
with depression and antidepressants is active or coincidental.
The absence of any effect of melatonin on the rectal 
temperature of mice ruled out the possibility that melatonin might 
accentuate or reverse 8-OHDPAT-induced hypothermia by an indirect 
mechanism. The concept that melatonin fails to interact with 5-HT 
due to its inability to reach the appropriate serotonergic site as 
mentioned above is also less tenable as an explanation for its lack 
of influence on 8-OHDPAT-induced hypothermia. This is because the 
hypothalamus, generally recognized as the thermoregulatory centre of 
the body, is likely to be the ultimate site of action for 5-HT, 
since hypothalamic depletion of 5-HT by 5,7-DHT or pCPA attenuates 
the hypothermic response to 8-OHDPAT (Goodwin et al., 1985). It is 
thought that 8-OHDPAT activates the 5-HTla somatodendritic receptor
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located on the 5-HT cell bodies of the raphe nuclei leading to the 
inhibition of 5-HT synthesis which causes the hypothermic response 
(Goodwin et al., 1985; Goodwin et al., 1987). Current evidence
indicates the hypothalamus as being the most likely major CNS site
of action for the physiological effects of melatonin (Armstrong, 
1989; Morgan and Williams, 1989). The same subclass of 5-HTi 
receptors are thought to be involved in the hyperphagic effect of 
8-OHDPAT. Interestingly, though, food-deprived animals display
hypophagia after 8-OHDPAT administration (Bendotti and Samanin,
1987). There are several examples of irregularities recorded in the 
literature concerning monoamine involvement of thermoregulatory 
control and feeding behaviour (e.g. Bligh et al., 1971; Milton, 
1978). More selective 5-HT antagonists are required to help resolve 
the situation, although the dichotomous nature of the action of 
8-OHDPAT may well be explained by internal adjustment of receptor 
sensitivity resulting from the change in food availability. 
Inter-species variation in responsiveness to manipulation of the 
serotonergic system may be due to slight anatomical differences in 
the arrangement of neuronal pathways, or the ease of penetration of 
the drug to the active site, or the temperature of the external 
environment which in turn influences the sensitivity of the organism 
to drug treatment (Goodwin et al., 1985). Gudelsky et al. (1986) has 
provided evidence for opposing roles of 5-HTia and 5-HT2 receptors 
in temperature regulation whereby activation of the 5-HTz receptor 
subtype elicits hyperthermia. This proposal was based on the 
observation that 5-HT2 antagonists countered the hyperthermia 
induced by 5-HT agonists, e.g. quipazine, 5MeODMT (high doses),
6-chloro-2-(1-piperazinyl)- pyrazine (MK-212). Additionally, prior 
to their recognition as reasonably selective 5-HT2 agonists, DOM and
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DOB were known to cause hyperthermia in rodents (Aldous et al., 
1974). A more appropriate model, therefore, for studying potential 
5-HT2 receptor/melatonin interactions might be 5-HT2 receptor- 
mediated hyperthermia rather than headtwitches due to the common 
locality of action - the hypothalamus.
8-OHDPAT-induced feeding was also considered to be a 
suitable model to assess the effect of melatonin on the activation 
of 5-HTia receptors. Melatonin alone did not alter the amount of 
food eaten in comparison to control animals. The inability of 
melatonin to affect 8-OHDPAT-induced hyperphagia does not 
necessarily suggest that it plays no role in regulating the 
serotonergic aspect of feeding behaviour. Activation of the 
serotonergic system using, for example, 5-HT releasing agents such 
as fenfluramine, was previously thought to cause anorexia rather 
than hyperphagia (Blundell, 1977). It has also recently been shown 
that putative 5-HTib and 5-HTic selective agonists induce anorexia - 
an action apparently effected through the paraventricular nuclus of 
the hypothalamus (Hutson et al., 1988). Kennett and Curzon (1988a, 
1988b, 1988c) published a number of reports which extended the 
results of Hutson et al. (1988) to evince a complex relationship 
between 5-HTi receptor subtypes and the serotonergic input into the 
regulation of feeding behaviour. Their effect would appear to be due 
to a direct action on the hypothalamus rather than the raphe nuclei 
which provide serotonergic input to this region (Hutson et al., 
1988). An extended study would be desirable to investigate whether 
melatonin interferes with the involvement of these other 5-HTi 
receptor subtypes.
The hypnotic properties of melatonin would lead one to 
expect that hyperactivity induced by RU24969 might be attenuated by
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melatonin treatment. Its lack of effect suggests that melatonin 
exerts no influence on the expression of 5-HTIB-mediated behaviour. 
This conclusion, however, may not be considered absolute for three 
reasons. Firstly, as discussed above, the effect of chronic 
melatonin treatment was not investigated in this paradigm. Secondly, 
it has recently been shown that RU24969 exhibits nanomolar affinity 
for melatonin binding sites in the hypothalamus (Pickering and 
Niles, 1990). This is probably due to the common indole nucleus 
shared by the compounds, though it is not yet known in what capacity 
RU24969 acts, if indeed the melatonin binding site is a functional 
receptor. Melatonin has negligible affinity for the 5 -H T i b  receptor. 
Thirdly, RU24969-induced hyperactivity is not an ideal model for 
5 -H T i b  receptor activation (e.g. Tricklebank, 1985) since 
centrally-acting beta-adrenoceptor antagonists (e.g.
(-)-propranolol), used here in their capacity as 5 -H T i a / 5 - H T i b  
receptor antagonists, fail to consistently block its appearance 
(Green et al., 1984; Tricklebank, 1984). Indeed, it is now 
considered that RU24969-induced anorexia is a more appropriate 
indicator of 5 -H T i b  receptor activation (Kennett et al., 1987; 
Kennett and Curzon, 1988b), an effect thought to be mediated through 
a post-synaptic site mechanism due to its persistence after pCPA * 
treatment (Kennett et al., 1987). Additionally, hypoactivity and 
anorexia induced by the putative 5 -H T i b  and 5-HTic selective 
agonists (TFMPP and mCPP) appear to result from 5-HTic receptor 
activation. This has been presumed because (-)-propranolol fails to 
inhibit mCPP or TFMPP-induced hypoactivity (Kennett and Curzon,
1988). Furthermore, metergoline and mianserin, recognized 5-HT 
antagonists with high affinity for 5-HTic receptors (Hoyer et al., 
1985; Sanders-Bush and Breeding, 1988), reversed this behaviour and
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inhibited mCPP-induced hypophagia (Kennett and Curzon, 1988). 5-HTic 
mediation of hypoactivity would also explain why RU24969 failed to 
produce this behaviour in rats when tested.
It was thought that circadian variation in the sensitivity 
of either the serotonergic system or putative melatonin receptors 
might determine the extent of an interaction between melatonin and 
5-HT. Several reports indicate that the absence of melatonin in the 
plasma during the daylight hours might render the body most 
receptive to melatonin treatment at the end of the light phase (e.g. 
Reiter, 1983b; Redman et al., 1983; Armstrong, 1989). (It should be 
noted, however, that the literature concerning the quotidian 
variation in sensitivity towards melatonin is inconsistent. Zisapel 
et al. (1988) have reported that melatonin binding in the 
hypothalamus is maximal at the end of the light phase. Conversely, 
the work of Laitinen et al. (1989) suggests that sensitivity, as 
measured by receptor affinity, reaches a zenith at the end of the 
dark phase). Despite conducting the temperature and headtwitch 
experiments at four time points spaced evenly apart along the 24 h 
LD cycle there was no observation of an interaction. Feeding and 
activity experiments, conducted at ML and MD also failed to 
demonstrate an interaction, though a late afternoon experiment might 
have been a more appropriate observation time in these instances. 
These results do, however, demonstrate a curious feature of 
8-OHDPAT-induced hyperphagia. The amount of food consumed by 
8-OHDPAT-treated animals at MD does not differ from control animals, 
unlike those treated at ML. Similar results have recently been 
reported by Sleight et al. (1988) who found that animals exhibited 
hypophagia if given 8-OHDPAT during their dark phase. This suggests 
that the 5-HT receptors involved in the stimulation of feeding are
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maximally stimulated at night, which would concur with the nocturnal 
feeding habits of these rodents. The hypophagia detected by Sleight 
et al. (1988) is attributed to an inhibitory action mediated via a 
peripheral mechanism. Conversely, the hyperactivity induced by 
RU24969, at the doses employed, does not suggest that the receptors 
responsible for mediating this activity are maximally stimulated 
during the dark phase despite this being their normally active 
phase. This, in turn, suggests that hyperactivity is induced via a
mechanism not shared by the system responsible for initiating
night-time associated activity.
In conclusion, it can be said that melatonin had no effect 
on the behavioural models of 5-HT mediated behaviour used in this 
study. However, recent work by Dugovic and co-workers (Dugovic and
Wauquier, 1988; Dugovic et al., 1989a; Dugovic et al., 1989b) on the
sleep-wake cycle suggest that an indirect interaction may exist, 






Behaviour expressed by an animal in normal circumstances 
can be described as being "emitted" or "elicited" according to 
whether it has been induced by a stimulus or not. Emitted behaviour
is said to occur when there is no apparent, simple to describe,
stimulus. Its analysis prior to artificial modification is within
the realms of the ethologist, observing and recording each element
of the expressed behaviour, e.g. grooming, running, headtwitches, 
posture etc. Elicited behaviour is that element which can be seen 
to be caused by a readily definable stimulus, the classic example 
being the retraction of a limb when placed on a hot surface. Both 
types of behaviour can be suitably modified by experimenters such 
that a discrete "package" of behavioural elements can be reliably 
repeated. This process is known as conditioning. This form of 
simplifying behavioural parameters into discrete measureable, 
automated responses has had a major impact on the science of 
psychology. Exploitation of these conditioning experiments in turn 
has made an equally profound impact on the study of the influence of 
drugs on behaviour - psychopharmacology. Two types of conditioning 
exist: classical (also known as "Pavlovian", respondent, or Type 1) 
and Operant (Instrumental or Type 2). Analysing the influence of 
drugs on conditioned behaviour has permitted a quantitative 
evaluation of an essentially qualitative behavioural characteristic. 
For example, the well known pairing of a bell ringing at the 
presentation of food leads to salivation in an animal after only the 
bell has been rung. The food was the initial unconditioned stimulus 
which causes the unconditioned response of salivation. However, once
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pairing has been established, the sound of the bell, the conditioned 
stimulus, induces the response (now known as a conditioned 
response). Thus an elicitted behaviour has been conditioned by way 
of the classical technique. Emitted behaviours are conditioned using 
the operant technique. That is if a certain behaviour expressed by 
an animal results in a pleasurable experience then the probability 
of the animal repeating that element is increased (reinforcement). 
If however, it results in a painful experience then the probability 
of it happening again is reduced (punishment). Anthropomorphically 
it can be seen that there is a blurred edge to the differentiation 
of what constitutes an operant technique of conditioning and what is 
a classic technique. For example the removal of a limb from a hot 
surface is an operantly-defined act if one considers the pleasure 
experienced at the relief of pain. Philosophical arguments on the 
complexity of whether an animal is operantly or classically
conditioned are beyond the scope of this thesis. Suffice to say that 
although this chapter represents work that is an example of
psychopharmacological exploitation of operant conditioning, an 
element of classical conditioning is present.
The T-maze has become synonomous with discrimination. 
Under the influence of an exteroceptive or interoceptive stimulus an 
animal has to make a choice at the junction of the "T" whether it is 
more advantageous to travel along the left arm or the right. The 
emitted behaviour, that of running, is capitalized upon and 
encouraged by the experimenter. The animal is required to find the 
"reinforcement” area. To encourage the search an animal is usually
provided with a recognizable "motivation factor", e.g. escaping a
mild electric shock or, as a result of "deprivation", a "satisfier". 
Thus the term "reinforcement area" has been chosen to describe a
95
site whereby an animal can, for example, acquire food or water or 
escape a shock. The introduction of the Skinner box into the field 
of drug discrimination by Barry (1968) added a further dimension to 
its study. Workers could now assimilate a much greater wealth of 
information as a result of analyzing the effects of a test drug on 
response latency and response rate in conjunction with its 
discriminability. The emitted behaviour in this case is the 
depression of a lever which brings either relief from deprivation or 
relief from shock. Although it is possible to study discriminative 
behaviour with just one lever in the operating chamber, the standard 
practice is to use two. For example the illumination of a coloured 
light (exteroceptive cue) might be indicative of reinforcement being 
available if the left lever is pressed whereas if the light is off 
the right lever must be pressed. This principle is the same for 
interoceptive cues where if an animal has been given either a drug 
or saline (or in some instances another type of drug) - the drug 
must evoke some form of identifiable "state" to the animal to 
distinguish it from the "control", undrugged, "state". Despite a 
patchwork of research into various aspects of discrimination since 
the science of psychology and even philosophy, began, 
pharmacological interest was minimal until the 1960's when Overton 
commenced a series of investigations into what was described as 
State Dependent Learning (SDL) (Overton, 1961). SDL is said to occur 
when an animal, trained to perform a certain task under the 
influence of a specific condition (usually an internal "state" 
evoked by the administration of a centrally-acting drug), is unable 
to repeat the task in the absence of that condition.
SDL and drug discrimination are further examples of 
overlapping techniques/ disciplines, though it can be argued that
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the latter is a subset, a more refined element, of State Dependent 
Learning. They tend to be separated more on methodological grounds 
than by discrepancies in descriptions of the internal milieu by 
which an animal must discriminate from an opposing condition. This 
is because both depend on the animal behaving in one manner under 
the influence of the drugged condition and in another mutually 
exclusive manner in the undrugged state. The use of one lever in the 
Skinnerian method of drug discrimination exemplifies the fragile 
delineation between it and SDL. In this method a group of animals 
are trained to press the lever in the drugged state (often referred 
to as S+), but not to respond when given saline (often referred to 
as S-). The procedure is reversed for a second group. Hence the 
preponderance of dual lever responding in drug discrimination 
studies. Colpaert (1977) discusses the evidence pertaining to 
differentiating between SDL and drug discrimination. Part of the 
argument resides with the concept that for a drug to induce SDL, it 
must create a "state" within the animal via a central mechanism,
i.e. the drug must act centrally. Drug discrimination learning, it 
is reasoned, does not require this criteria. Thus a peripherally 
acting drug can provide a discriminative cue, e.g. arthritic rats 
can distinguish between saline and aspirin. However this situation 
could be considered as a type of "reversed discrimination" since the 
disease arthritis has established a "state" within the organism 
which has become the norm (presumably comprised of an awareness of 
reduced mobility and consequential pain). The removal of this state 
therefore establishes a novel awareness - the "drugged" state, that 
is to say that indirectly the drug has acted centrally to change the 
internal perceptual environment of the animal. Hence the ability of 
a non-narcotic agent to provide a discriminable stimulus that is
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dependent upon the internal state of the organism. Thus, although it 
is widely accepted that drug discrimination can occasionally be 
expressed by peripherally acting drugs, their discriminability is 
dependent upon some perceived change in the internal environment of 
the animal regardless of the manner by which it is brought about. 
This statement is substantiated by the fact that there are very few 
reports of a drug incapable of penetrating the blood-brain barrier 
acting as a discriminative cue. The vast majority of reports
describe the discriminative characteristics of centrally acting
drugs. The ability of these drugs to elicit an identifiable internal 
state upon an organism varies and is related to the pharmacological
potency of the compound under study. The doses involved, however,
are generally lower than those required to elicit an observable 
change in the unconditioned behaviour of a subject animal.
The use of drug discrimination as a research tool of the 
behavioural pharmacologist has rapidly increased since the mid 
1970's and become a standard technique for the screening of 
potential psychoactive drugs within the pharmaceutical industry. 
Drugs of similar action are indistinguishable from the original 
training compound by the animal, i.e. its response to receiving the 
novel drug is the same as if it had been given the training drug. 
This is the basis of generalization studies (also known as transfer 
studies). Antagonism studies investigate the ability of a compound 
to interfere with the expression of the training drug's cue in much 
the same way as conventional antagonism studies, and therefore the 
animal is expected to make the response appropriate to its undrugged 
state. Indeed the drug discrimination procedure has widespread use 
in industry as a means of classifying novel compounds with respect 
to existing psychoactive drugs.
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Dose response curves can be constructed both with the test 
and training compounds. The gradient of the curve derived from the 
training drug reveals the dose range over which the “drugged state” 
of the animal can act as a cue for a drug-appropriate response. This 
range bears no relationship to the dose range of a drug required to 
influence unconditioned behaviour and is usually below the minimal 
dose required to influence unconditioned behaviour. Dose response 
curves generated by test drugs reveal the nature of their own 
influence on the inner state of the animal. Drugs of a different 
pharmacological class to the training compound tend to induce a 
saline-appropriate response. It is possible to achieve partial 
generalization with a compound - an effect under an increasing 
amount of investigation (Colpaert, 1988, Stolerman et al., 1987) 
which in turn is suggestive of partial agonist activity on the 
receptor(s) responsible for cue generation. However, drug 
discrimination can be as "fickle" as standard pharmacology, 
producing a complete generalization at one dose and partial 
generalization at a higher one. This is often the result of 
behavioural disruption incapacitating a percentage of the animals, 
e.g. the action of 5MeODMT on L-5HTP trained animals. A more 
interesting example of the potential for varying generalization 
characteristics has been described by Stolerman et al. (1984). The 
two groups of rats used, one trained to discriminate 0.1mg/kg 
nicotine from saline and the other trained to differentiate between 
0.4mg/kg nicotine and saline, expressed dissimilar stimulus transfer 
characteristics for anabasine, the lower dose nicotine group 
reaching 100% generalization at the appropriate anabasine dose, 
while the other could achieve no more than 50%. This suggests that 
the nature of the cue itself generated by a test compound can be
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dose dependent. It would have been interesting to find out whether a 
third group of animals could differentiate between the lower and 
upper doses of nicotine employed. Antagonists produce similar 
dose-response curves directed towards inhibiting the expression of 
the cue and may also exhibit partial antagonism. As with any 
classical test for a competitive antagonist the dose response curve 
(in this case dose-generalization curve) is shifted to the right 
(see Colpaert and Janssen, 1983).
The serotonergic system has long been associated with drug 
discrimination, initially through the study of the discriminative 
properties of the hallucinogen LSD, and provides a good example of 
the contribution that drug discrimination can make towards 
understanding the functional aspects of receptors. Hirschhorn and 
Winter demonstrated the similarity of cues induced by LSD and 
mescaline as early as 1971. Since then various workers have made 
progress towards the goal of establishing its origin. The 
transferance of the mescaline-induced cue to non-hallucinogenic 
compounds nullified theories that such a characteristic was common 
only to hallucinogens (Kuhn, 1977). This would agree with the view 
that the ability to discriminate between a drugged and non-drugged 
state depends on a conscious awareness by the animal of that change 
in state. If, for example, discrimination only depended on the level 
of consciousness as perceived by an animal when given a CNS 
depressant then the demonstration of specificity in discrimination 
studies would be rare. That is, sedation, would act as a cue whether 
caused by a barbiturate, benzodiazepine or centrally acting 
antihistamine - the route to discrimination may be different as a 
result of action on different systems, but the destination is the 
same. However, the use of different drug tools allow the specificity
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of a compound, with respect to its cue-generating properties, to be 
determined by antagonism studies (e.g. see Young and Dewey, 1982). 
The discrimination between mescaline and LSD suggests that despite 
acting on apparently different neurotransmitter systems the internal 
manifestation of the cue is essentially the same, which in turn 
implies the existence of a common pathway for the cue at some point 
from its neuronal origins to cognizance, and that this pathway is 
shared by non-hallucinogenic (but still psychoactive) drugs. In 
this, drug discrimination can be viewed as a pharmacological effect 
that requires as much thought and caution as any other in vivo or in 
vitro technique. This concept is discussed further in detail by 
Rosecrans et al. (1978).
LSD is now recognized to act as a central 5-HT agonist, 
despite initial evidence to the contrary based on the findings of 
Gaddum and Piccarelli (1957) who demonstrated that it antagonised 
the action of 5-HT on intestinal smooth muscle. Aghajanian et al. 
(1970) found that LSD, mimicking the effect of 5-HT, increased the 
firing rate of those brainstem neurons that received afferents from 
5-HT-containing cells of the raphe nucleus. Additionally, LSD, like 
5-HT, inhibits the firing rate of 5-HT neurons in the raphe. 
Receptor binding studies have shown LSD to be effective in 
displacing 5-HT from both 5-HTi and 5-HT2 receptors (Leysen et al., 
1981; Peroutka and Snyder, 1979). This contrasted with certain 
behavioural studies concerning the activity of LSD, most notably 
drug discrimination, which suggested that the 5-HT2 receptor was the 
most influential with regards to the LSD generated cue. 
Pirenperone, a 5-HT2 selective antagonist, was shown by Colpaert et 
al. (1982) to inhibit the the LSD cue followed by ritanserin, 
another highly selective 5-HT2 antagonist, (Colpaert et al. 1985).
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In addition to this, the cue properties of DOM and quipazine, both 
of which generalize to LSD (Kuhn et al., 1978; White and Appel, 
1982) were antagonised by pirenperone (Friedman et al. 1984; Glennon 
et al. 1983). More recently, Cunningham and Appel (1987) have 
investigated the LSD cue with reference to 5-HTi selective agonists. 
The 5 -H T i a  receptor agonist 8-OHDPAT, the mixed 5 -H T i a / 5 - H T i b  
agonist RU24969 and the mixed 5 -H T i b / 5 - H T i c  agonists TFMPP and mCPP 
did not induce LSD-appropriate responding. Interestingly, the 
non-selective 5-HT-receptor agonist/hallucinogen, 5MeODMT, and the 
purported 5-HT2 agonist DOM, also a hallucinogen, have been shown to 
express discriminative cues indistinguishable from LSD regardless of 
the training drug (Glennon et al. 1979; 1983a; 1983b; 1984b).
Standard behavioural studies have shown 5MeODMT to be a potent 
promoter of the so-called serotonin syndrome (Jacobs, 1976) which 
has components induced by 5 -H T i a , 5 -H T i b  and 5-HT2 receptor 
activation (see chapter 3, this thesis). Identifying the focal point 
of the discriminative cue has proved difficult. The LSD cue 
generalizes only to agents that have been recognized to have 5-HT2 
receptor agonist properties. Neither TFMPP nor 8-OHDPAT share 
stimulus transfer characteristics with LSD (Cunningham and Appel, 
1987; Tricklebank et al. 1987) despite displaying partial (in the 
case of 8-OHDPAT) or full generalization with 5MeODMT. Thus, the cue 
generated by 5MeODMT must have both 5-HTi and 5-HT2 receptor 
involvement with the 5-HT2 receptor mediated cue taking precedence 
over the 5-HTi otherwise LSD would display partial rather than full 
transfer characteristics. Circumstantial evidence for this view is 
given by Stolerman (1987) who used a mixture of nicotine and 
midazolam to generate a discriminative cue. Once trained, rats 
displayed partial generalization to midazolam and nicotine if given
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separately and partial antagonism if given mecamylamine (nicotine 
antagonist) or Ro 15-1788 (benzodiazepine antagonist) separately. 
Complete inhibition of the midazolam/nicotine cue was achieved if a 
mixture of the antagonists was administered.
The more selective 5-HT receptor ligands have themselves 
been subjected to drug discrimination analysis but have yielded 
contradictory data. Tricklebank et al. (1987) investigated the 
origin of the cue generated by 8-OHDPAT and concluded that 
activation of the 5-HTia receptor appeared to be the sole source. 
Similarly, the 5 -H T i a  receptor has been implicated in the derivation 
of the cue induced by the novel non-benzodiazepine anxiolytic 
buspirone (Mansbach and Barrett, 1987). TFMPP serves also as a 
discriminative stimulus (Glennon et al. 1984) as determined by its 
action on 5 -H T i b , and possibly 5-HTic, receptors (Cunningham and 
Appel, 1986; McKenney and Glennon, 1986; Glennon et al., 1988). 
Further work on TFMPP by Glennon et al. (1988) in the field of drug 
discrimination has questioned the 5 -H T i a / 5 - H T i b  antagonism 
properties of propranolol and pindolol as a result of their stimulus 
generalization to TFMPP. Glennon et al. (1988) suggested that 
centrally acting non-selective beta-adrenoceptor antagonists may 
possess agonist characteristics at certain populations of 5-HT 
receptors, an idea indirectly supported by the work of Cunningham 
et al. (1987) who failed to block 8-OHDPAT cue with propranolol. 
This deserves further investigation since it may be that TFMPP (the 
training drug used in the study by Glennon et al. (1988)) is 
displaying partial agonist characteristics. This contention is 
supported by the results of Tricklebank et al. (1987) who were able 
to demonstrate dose dependent antagonism of the 8-OHDPAT-induced cue 
by pindolol.
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L-5HTP was first used successfully as a training drug by 
Barrett et al. (1982), who suggested that its use in operant 
behaviour prior to this was restricted due to disruptive behavioural 
effects attributed to a peripherally-mediated action. By employing a 
decarboxylase inhibitor, R04-4602, that was unable to penetrate the 
blood-brain barrier, Barrett was able to demonstrate that the cue 
involved "centrally formed decarboxylated products". This was 
further supported in the same paper by showing that the inhibition 
of brain L-amino acid decarboxylase with NSD-1015 completely 
inhibited the generation of the cue. The classical 5-HT antagonists, 
cyproheptadine, metergoline, methiothepin and methysergide failed to 
inhibit L-5HTP-appropriate responding and it was suggested that, 
along with evidence presented in a subsequent publication (Friedman 
et al., 1983), the L-5HTP cue was mediated by a unique 5-HT 
receptor. Cunningham et al. (1985) reported that L-5HTP induced a 
complex cue derived from both 5-HTi and 5-HT2 receptor activation as 
defined by Peroutka et al. (1981). The basis for this proposal was 
the inhibition of LSD substitution by the 5-HT2-selective antagonist 
ketanserin in L-5HTP trained rats. The development of more selective 
5-HTi agonists enabled Moser and Redfern (1985b) to assign 
responsibility for the cue to the 5-HTi receptor since attempts to 
inhibit it with various 5-HT2 antagonists failed. Additionally, 
TFMPP, RU24969 and 5MeODMT fully substituted for L-5HTP while 
8-OHDPAT expressed partial generalization. This result led Moser 
and Redfern to propose the 5 -H T i b  receptor subtype being primarily 
responsible despite the rather contradictory failure of (-)pindolol 
to antagonize the cue.
Melatonin has not been the subject of a comprehensive drug 
discrimination study despite evidence in the literature that it
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possesses behaviour-modifying properties (see chapter 1, section 
this thesis; see also Datta and King, 1980; Redman et al., 
1983; Gaffori and Van Ree, 1985). The lack of effect of melatonin in 
interacting with overt 5-HT mediated behaviour (see chapter 3) 
prompted the use of the drug discrimination technique which, it was 
thought, would be more sensitive. It would also serve to investigate 
the discriminative cue properties of melatonin. The availability of 
both T-maze and Skinner box paradigms was considered an opportunity
to look at whether one technique was more sensitive than the other
based on the rate of discriminative cue acquisition. Procedural 
variations between shock avoidance and hunger relief have been 
studied before for instance by Krimmer (1974) who noted that
drug-appropriate responding using pentobarbital as the training 
compound continued to apply at lower doses using the shock escape 
method rather than food pellets. Krimmer also reported that
pentobarbital-appropriate responding occurred using sufficiently 
high doses of alcohol in animals trained by shock escape rather than 
by hunger relief. Generally however, results obtained in studies of 
the same drugs with different unconditional stimuli, responses and 
test situations are remarkably consistent (Kubena and Barry, 1969; 
Barry, 1974). This implies that drug discrimination is not based on 
perception of the drug effect on a specific attribute of the 
response such as its coordination or vigour. Time prevented a more 
substantial comparison of the cue generated by L-5HTP using the 
T-maze (shock avoidance) paradigm as opposed to the Skinner box 
(hunger relief) technique. The use of the Skinner box it was thought 
would yield additional data with respect to melatonin concerning its 
possible effects on an FR schedule. Although not covered in this 
thesis there is also a need for a more substantial investigation
105
into the effects of melatonin on performance in an operant
conditioning context. Melatonin is thought to act as a hypnotic
which would imply a non-specific discriminative stimulus in the
sedative/tranquillizer class of drugs.
The opportunity was also taken to investigate whether or 
not the discriminative properties of L-5HTP displayed a circadian 
rhythm. In addition to the general chronobiological interest that a 
positive result would initiate, it was felt that the absence of a 
rhythm would provide circumstantial evidence in support of two 
aspects of 5-HT research. These are: firstly, 5-HTi receptor
activity does not express a circadian rhythm; and secondly, the 
5-HT2 receptor is not involved in the discriminative properties of 
L-5HTP. If a positive result were obtained then further 
investigation would be necessary in order to assess whether either 
of these two hypotheses are correct or or if another factor is 
involved. The experiment was performed using rats whose 
discriminative ability with regard to L-5HTP versus saline had been 
well-established. Moser (1986) had previously obtained a negative 
result when he investigated the potential for the L-5HTP cue to 
display a circadian rhythm by training the animals at six different 
time points. The assumption was that the rate of cue acquisition 
would vary according to the time of training if a rhythm was 
present. This method did not test a possible diurnal variation in 
the cue with trained rats. It is possible that a cue assumes 
different perceptual characteristics between novice and experienced 
animals.
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4.2. Materials and Methods
4.2.1. Drugs
All drugs were given in normal saline. At the 1mg/kg dose 
melatonin (Sigma) was dissolved by sonication. Doses 10mg/kg and 
50mg/kg were suspended in 0.1% w/v tragacanth in normal saline by 
sonication. (L-5HTP (Sigma), 5MeODMT (Sigma) and 8-OHDPAT (Research 
Biochemicals Incorporated) were dissolved by gentle heating. 
Carbidopa (M.S.D.) was suspended in normal saline by sonication. All 
drugs and saline controls were injected i.p. using a dose volume of 
5ml/kg, except 8-OHDPAT which was injected s.c. using a dose volume 
of 2.5ral/kg.
4.2.2. Apparatus
Standard operant conditioning chambers, containing two 
levers, were used (Campden Instruments) as shown by Fig. 4.1. A 
reinforcement delivery chamber was located between the levers. The 
liquid food reinforcement consisted of 0.02ml of sweetened condensed 
milk:water 1:1 dilution delivered by a motorized dipper from a food 
reservoir located below. Presentation of the food and recording of 
behavioural responses was achieved using a BBC Master computer in 
conjunction with a SPIDER cartridge (Paul Fray Ltd.) and software 
designed and written by the author (for details see Appendix). The 
T-maze (Fig. 4.2) consisted of 7-plywood walls 30cm high and an 
electrified (0.5mA) grid floor. The floor of the hidden safe areas 
located at either ends of the arms of the T were constructed of 
7-plywood and admission to them could be prohibited using a wooden 
gate. Deliverance of the shock was achieved using a constant current 
shock generator (Campden Instruments, Model 521C) in conjunction 
with a scrambler (Campden Instruments, Model 521S).
Fig. 4.1. Diagram showing the main features of the operant conditioning chamber (Skinner Box) 












Fig. 4.2. Diagram of the T-maze used in the drug discrimination 
studies.
= safe area
S = start point
C = choice point
= position of barriers
h = 10 cm
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4.2.3. Animals
Male Wistar rats (Animal House, University of Bath strain) 
weighing between 150 and 200g at the start of the experiment were 
housed in groups of five in standard cages (520 x 350 x 170mm), on a 
LD cycle of 12:12 (lights on 05:00 h). Water was freely available 
both to rats to be trained via the T-maze and to those trained via 
the Skinner box paradigm. Food (Labsure CRM diet) was freely 
available to those trained using the T-maze apparatus.
4.2.4. Training procedure for Skinner box paradigm
Rats were gradually acclimatized to a restricted diet 
schedule comprising of a 2 h food presentation period commencing' 
just after the final training session (17:00 h). Training sessions
were conducted at the EOL stage between the 13:00 h and 17:00 h. The 
weight of the animals was monitored every week and their general 
condition and health observed daily. One rat had to be withdrawn due 
to middle-ear infection. Once lever-pressing ability had been 
established using continuous reinforcement (i.e. each lever press 
was reinforced), training sessions lasting 15 min were introduced 
and the contingency was changed such that only the correct lever was 
rewarded if pressed a pre-programmed number of times. Once familiar 
with this task the FR contingency was gradually increased until 
response on a FR10 schedule was satisfactory. At this point 
discrimination training began in earnest, with each session limited 
to 15 min The procedure is similar to that required for 
discrimination training using the T-maze paradigm. Rats are required 
to press one lever for a food-reward under the influence of saline 
and the other when given drug. Half of a group are trained to press, 
for example, the left lever when given saline and half the right
lever to control for positional preferences. To control for
potential odour cues influencing lever choice (Extance and Goudie, 
1981) after each training session the levers were wiped with
alcohol. One group of rats were trained to discriminate 5-HTP 
(35mg/kg) from saline and another group melatonin (1, 10 and
50mg/kg) from saline. The group receiving melatonin were given 20 
training sessions at each dose, the 10 and 50mg/kg sessions required 
the use of saline/tragacanth mixture in place of saline on the 
appropriate non-drug-training days. Once a day training sessions 
were conducted 5-7 days a week, drug and saline days being randomly 
arranged such that for no more than two successive sessions did 
animals receive the same treatment. Animals were injected with the 
appropriate drug 30 min before being put into the chamber. The group 
receiving L-5HTP as the training drug were pretreated with carbidopa 
(25mg/kg) 60 min prior to the start of a training session on both 
saline and drug days. Animals were deemed to have reached criterion 
if they made 8 correct choices in 10 consecutive sessions. Once 
discrimination had been established a dose-response curve was 
constructed.
4.2.5. Training procedure for T-maze paradigm
Animals were initially trained to avoid the electrified
grid floor of the T-maze by turning left or right at the "choice 
point" to reach a hidden safe area. Once familiar with the 
procedure, discrimination training began. The concept involved is 
the same as that used for the Skinnerian discrimination procedure 
outlined above. Rats are required to turn in one direction if given 
saline and in the other if given drug. Positional preferences were 
controlled for as described above, and odour cues by wiping the grid
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floor with alcohol after each rat's training session. Training 
sessions consisted of 8 trials 1 min apart. Rats trained to 
discriminate L-5HTP from saline were given carbidopa (25mg/kg) 60 
min prior to the training session and either L-5HTP (50mg/kg) or 
saline 30 min before the start of the session (Moser and Redfern, 
1985b). The threshold for criterion was set at 8 correct choices in 
10 consecutive sessions. Once discrimination had been established a 
dose response curve was constructed. Animals in the melatonin 
training sessions were given either saline or melatonin, 1mg/kg, 
10mg/kg or 50mg/kg, 30 min before the start of the session. The 
threshold for criterion was again designated as 8 correct responses 
in 10 consecutive sessions.
4.2.6. Testing of stimulus generalization and antagonism
Experiments were carried out on Tuesdays and Fridays once 
animals had achieved the discrimination criterion; training 
continued on the other days to maintain discriminative stimulus 
control. If the performance of a rat fell below the criterion level 
then it was withdrawn from experiments until the appropriate level 
had been restored. For test sessions involving the Skinner box 
paradigm animals were put into the chambers for 5 min only during 
which time either lever, if pressed ten times, would provide 
reinforcement. The first lever to be pressed ten times was 
designated the chosen lever and became the reinforcement lever. 
Responses on the other lever were recorded but had no programmed 
consequences. Only a dose-respnse curve to L-5HTP was constructed 
using this apparatus. To prevent animals from being able to 
differentiate between training and experimental sessions due to 
their unequal duration, they were put into a "neutral" plastic cage
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(420 x 260 x 150mra) immediately after the experiment for the 10 min 
remaining of an equivalent training session before being returned to 
the home cage.
The T-maze paradigm was used to establish the 
dose-response curve and time-response curve to L-5HTP and also 
characterization of the L-5HTP cue itself. Experimental sessions 
consisted of only one trial during which either safe area could be 
reached. The chosen direction was designated that which the animal 
entered up to the base of its tail. Generalization studies were 
carried in the absence of carbidopa using 5Me0DMT (0.5, 1, 2, 4
mg/kg), using a 10 min pretreatment time, 8-OHDPAT (0.5, 1, 2, 4 
mg/kg) using a 30 min pretreatment time and melatonin (1, 10, 50 
mg/kg) also with a 30 min pretreatment time. An antagonism study was 
conducted using melatonin (1, 10, 50 mg/kg) given immediately after 
the L-5HTP injection, i.e. 30 min before the start of the 
experimental session.
4.2.7. Investigation into the discriminative ability of L-5HTP over 
24 h.
Only the T-maze was used in this experiment. A second dose 
response curve was constructed in animals whose ability at 
distinguishing 50mg/kg L-5HTP from saline was well-established. 
Using the approximate EDso derived from this curve and two 
additional doses, one above and one below the EDso, the 
discriminative ability of the animals was tested at four time points 




Discrimination during training was expressed as a 
percentage of correct choices in 5 consecutive sessions with respect 
to both the T-maze and Skinner box paradigms. During training the 
"Vicarious Trial and Error" (VTE) characteristic was measured. This 
is said to occur when, on the first trial of a training session the 
animal halts at the choice point and looks down both arms of the "T" 
before making a choice as if trying to decide or remember which 
route might lead to the safe area. It is used to define the 
confidence displayed by an animal in its reinforcement choice with 
respect to the T-maze paradigm. The FRF value (ratio of correct 
lever presses against incorrect lever presses until the FR number is 
reached on the reward lever expressed as a percentage of the total) 
was used as a measure of this "confidence" parameter for the Skinner 
box. The Skinner box was able to provide additional data in the form 
of response latency and response rate. The latter was defined as the 
rate of lever presses on the correct lever per min after the first 
reinforcement; response latency is the time taken for an animal to 
press the correct lever the appropriate number of times as defined 
by the FR ratio in this context. Since two Skinner boxes were 
operative both possessing non-retractable levers response latency 
was measured on alternate animals for each daily training session - 
rats belonging to the designated group were put into their 
experimental chamber first and the timer started. The rat from the 
second group was then put into its chamber and the response latency 
factor ignored. Graphically this is expressed as the mean response 
latency derived from two successive sessions of the same treatment. 
During test sessions only the response rate was measurable.
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4.4. Results
4.4.1. Acquisition of the L-5HTP/saline discriminative stimulus
Animals trained on both paradigms achieved satisfactory 
discriminative ability though it took those animals using the T-maze 
paradigm considerably longer than their Skinner box counterparts. 
T-maze rats took upwards of 50 (mean = 53 +/- 3.9 s.e.m.) sessions 
to reach criterion while the Skinner box rats took 20 sessions (mean 
= 20.7 +/- 2.3 s.e.m.). The acquisition curves to the L-5HTP cue are 
shown in Fig. 4.3a (T-maze) and 4.3b (Skinner box). The dose 
response curves of L-5HTP for each paradigm are depicted in Figs. 
4.4a and 4.4b.
4.4.2. Acquisition of the melatonin/saline discriminative stimulus
Only one rat in the Skinner box group managed to achieve 
criterion but this proved unstable. The overall failure of the group 
to achieve a satisfactory and reliable response at 1mg/kg led to the 
susbsequent increments in melatonin dosage to 10mg/kg and 50mg/kg, 
after giving 20 sessions to the animals at each dosage. None of the 
rats in the T-raaze group achieved criterion, of which there were two 
groups; those treated with melatonin 1mg/kg for 50 sessions and 
those treated with 10mg/kg for 40 sessions initially, the dose then 
being increased to 50mg/kg for a following 70 sessions. The training 
plots for melatonin are shown in Fig. 4.5a (T-maze) and 4.5b 
(Skinner box) which, for comparative purposes, also shows the 
training plots for L-5HTP. Acquisition curves for melatonin are 
shown in Figs. 4.6a (melatonin 1mg/kg, T-maze), 4.6b (melatonin 10 
and 50mg/kg; T-maze) and 4.6c (melatonin 1, 10 and 50mg/kg; Skinner 
box).
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4.4.3. Compounds generalizing to the L-5HTP discriminative stimulus
Only the T-maze paradigm was used in this study. At the 
highest doses used 8-OHDPAT and 5MeODMT produced discriminative 
cues indiscernible from L-5HTP (see Fig. 4.7). All doses of 
melatonin, however, induced saline-appropriate responding (see Fig. 
4.8).
4.4.4. Antagonism study of the L-5HTP cue using melatonin
Only the T-maze paradigm was used in this study. Melatonin 
failed to antagonize the L-5HTP discriminative cue at all the doses 
employed (see Fig. 4.8).
4.4.5. Effect of L-5HTP and melatonin on response latency, rate of 
response and the FRF characteristic on the correct Lever
For obvious reasons only the Skinner box paradigm yielded 
data to this behavioural characteristic. Once training had become 
established, L-5HTP training days displayed no difference to saline 
training days. However, the first two L-5HTP training sessions 
heralded a major inhibition in responding (see Fig. 4.9) with only 
four rats attaining the FR value after a long period of nil 
responding. This prompted a reduction in the initial L-5HTP dose 
used from 50mg/kg to 35mg/kg. Melatonin had no effect on the 
response latency parameter (see Fig. 4.10). L-5HTP also suppressed 
the overall response rate throughout the course of the 
discriminative training. Once again melatonin had no effect (see 
Fig. 4.11). The rapid acquisition of the L-5HTP cue is demonstrated 
in Fig. 4.12 which plots the FRF value for saline and drug days.
Fig. 4.13 depicts the dose response curves for the FRF 
value for the drug-appropriate lever and the response rate obtained
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during the determination of the L-5HTP discriminative stimulus dose 
response curve using the Skinner box paradigm.
4.4.6. Effect of time-of-day on the cue-generating properties of 
L-5HTP
No discernible diurnal variation in the response to L-5HTP 





















Fig. 4.3a. Acquisition of discrimination between saline and L-5HTP (50mg/kg) using the
T-maze paradigm. (n=ll). Solid line = drug training days, dashed line = sali 
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Fig. 4.3b. Acquisition of discrimination between saline and L-5HTP (35mg/kg)
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Fig. 4.4. Dose response curves of L-5HTP for (a) Skinner box paradigm (training dose = 35mg/kg, 

















Fig.4.5a. Training curve to melatonin and L-5HTP using the T-maze paradigm.
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F1g. 4.6a. Acquisition of discrimination between saline and melatonin (lmg/kg) using the T-maze 
paradigm. (n=9-ll). Solid line = drug training days, dashed line = saline training 
days, ■ = VTE characteristic.






















Fig. 4.6b. Acquisition of discrimination between melatonin (10 and 50mg/kg) using the T-maze paradigm, 
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Fig. 4.6c. Acquisition of discrimination between melatonin (1, 10 and 50mg/kg) using the Skinner box 
paradigm. Solid line = drug training days, dashed line = saline training days. (n=8 ).
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Fig. 4.8. Melatonin and the discriminative cue properties of L-5HTP. (n=10). 
■ = substitution of L-5HTP by melatonin 
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Fig. 4.9. Comparison of response latency times between rats undergoing training to discriminate 
L-5HTP (35mg/kg) from saline and rats undergoing training to discriminate melatonin 
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Fig. 4.10. Comparison of response latency times between rats undergoing training to 
discriminate melatonin (1, 10 and 50mg/kg) from saline. (Values represent 
means of 6-8 rats).
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Fig. 4.11. Comparison of mean response rates (lever presses/min) between rats undergoing training to
discriminate L-5HTP (35mg/kg) from saline and rats undergoing training to discriminate 
melatonin (1, 10 and 50mg/kg) from saline. (Values represent means of 6-8 rats).
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Fig. 4.12. Comparison of FRF values for rats undergoing training to discriminate L-5HTP (35mg/kg) 
from saline and rats undergoing training to discriminate melatonin (1, 10 and 50mg/kg) 
from saline. (n=6-8 ).
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Fig. 4.13. Dose response curve for rate of response and drug-appropriate FRF value 
in rats trained to discriminate L-5HTP (Training dose = 35mg/kg) from 
saline. Open circles = rate of response (lever press/min), closed 




















































Fig. 4.14. Effect of time-of-day on the discriminative cue to L-5HTP in rats using the T-maze 
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The most intriguing aspect of this work is the finding 
that melatonin was unable to evoke an internal state distinguishable 
from that of saline even at the relatively high dose of 50mg/kg. No 
difference in the rate of responding or the response latency was 
detected between saline and melatonin training days which provides 
additional, albeit circumstantial, evidence that the internal 
cognitive state of the animals was no more disturbed by melatonin 
treatment than by saline treatment. The primary site of stimulus 
control of behaviour by most drugs appears to be of central rather 
than peripheral origin (Holtzman and Locke, 1988). The behavioural 
effects of melatonin as described by Gaffori and Van Ree (1985) 
together with the mounting evidence that the neuroendocrine effects 
of melatonin are centrally mediated through its interaction with the 
hypothalamus and the pituitary gland suggest that the compound would 
be a promising candidate for a drug discrimination study. The 
failure of melatonin to evoke a discriminative stimulus indicates 
that this ability of a compound depends on the activation of 
centres (or receptors) distinct from those that are involved in the 
neuroendocrine and behavioural effects of melatonin. Moreover, the 
suggestion by Namboo/'diri et al. (1983) that, since exogenous 5-HTP 
elevates plasma melatonin levels, some of the clinical effects of 
5-HTP might be mediated by melatonin, does not apply to the 
discriminative stimulus properties of L-5HTP. Attempts to identify 
the specific neuroanatomical sites responsible for the 
discriminability of various centrally-active drugs have met with 
limited success (e.g. Shannon and Holtzman, 1977; Rosecrans and 
Glennon, 1979). This is most likely due to cuing properties of drugs 
representing a compound stimulus derived from a wide spectrum of
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drug actions and neurotransmitter interactions.
It is unlikely that a greater number of trials for each 
session or a greater number of training sessions would have made 
much difference to the result. The number of trials given to an 
animal after the first is simply used as a means of reinforcing the 
required response. It follows that discriminative proficiency prior 
to the delivery of the first reinforcer must be controlled by the 
drug-elicitted state, while discriminative proficiency on subsequent 
trials reflects control by either the drug cue, the cue elicitted by 
the reinforcer, or a combination of both. In theory this suggests 
that one-trial training would develop a response that is more 
drug-orientated than reinforcer-orientated and therefore reflects 
drug actions more appropriately. In practice, it has been found that 
although the single-trial training procedure can produce a stable 
and reliable acquisition, the technique also retards the rate at 
which a discriminative cue can be acquired (Barry and Krimmer, 
1978; Tomie et al., 1987). Tomie et al. (1987) have confirmed that 
the multiple-trials training procedure leads to a shift in dominance 
between the drug and reinforcer cues after the first reinforcement 
rendering all subsequent choice behaviour per session 
uninterpretable (Tomie et al., 1987). The most common number of 
trials per session used in drug discrimination studies is between 8 
and 10. More than this does not add to the ability of an animal to 
discriminate a drug-induced cue since by the eighth trial the drug 
influence has been almost entirely replaced by the cue exerted by 
the reinforcer.
Increasing the dose of a drug tends to reduce the time to 
criterion except when toxicity or disruptive behavioural effects 
emerge to inhibit appropriate responding (Overton, 1982). No change
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was observed in the overt behaviour expressed by the animals when 
given melatonin regardless of dose and training paradigm. It is 
usual for discrimination to be acquired within 40 sessions (i.e. 20 
drug and 20 saline sessions) (Overton, 1982) and this was therefore 
chosen as a suitable point at which the dose of melatonin could be 
increased if no sign of cue acquisition was apparent. The training 
dose can also affect the pharmacological nature of the cue, lower 
doses are likely to be more specific with respect to the origins of 
the cue than higher doses (e.g. Colpaert, 1982; Stolerman, 1984). It 
was therefore considered that, provided a sufficiently high enough 
dose was chosen, it would be possible to establish a discriminative 
cue to melatonin based on its hypnotic effects. Since this was not 
found to be the case the most likely and plausible conclusion is 
that the final dose used was not great enough to elicit a 
discriminative stimulus. That sedation was not induced is also 
supported by the lack of effect on response latency and reponse 
rate. Several other reasons can also be offered. A drug 
administered via the i.p. route relies almost entirely on the 
mesenteric circulation for absorption and would be immediately 
transported to the liver. Since hepatic metabolism is the major 
route of peripheral melatonin elimination then a high proportion of 
the dose can be expected to be metabolized before reaching its site 
of action. This explanation is unlikely following previous reports 
concerning hypnotic effects of melatonin by Holmes and Sugden (1982) 
and Dugovic et al. (1989b), both of which used much lower doses 
administered i.p. The most simple possibility is that melatonin does 
not act as a discriminative cue. This might be derived from a rather 
more speculative interpretation involving closer examination of the 
hypnotic effects of melatonin. Unlike the barbiturate and
136
benzodiazepine sedatives/hypnotics melatonin has been reported as 
being free from "hangover" effects. Melatonin is supposed to elicit 
sedation by reducing the time to sleep onset and not interfering to 
any great extent with the regular pattern of alternating slow wave 
sleep and REM sleep episodes (Cramer et al., 1974; Waldhauser et 
al., 1990). International travellers have reported a more 
comfortable transition between time-zones when taking melatonin as 
opposed to placebo, i.e. their internal state returns to normal more 
rapidly. Thus failure to evoke a discriminative stimulus might 
simply reflect the possibility that melatonin, although capable of 
affecting central processes, does so at a level imperceptible to the 
animal. Using a method analogous to that chosen by Weissman (1976) 
to demonstrate the difference in discriminability of aspirin in 
arthritic rats and non-arthritic rats it might be possible to create 
a state within an animal that can subsequently be resolved by 
melatonin and not saline if any melatonin-derived discriminative cue 
is to be assessed.
The discriminative stimulus induced by L-5HTP is generally 
thought of as being derived from the activation of 5-HTi receptors, 
though the subclass has yet to be identified due to the lack of 
specific antagonists for the 5-HTia and 5-HTib receptors. Cunningham 
et al. (1985) suggested that there might also be a role for the 
5-HT2 receptor since although ketanserin does not block the L-5HTP
cue directly it is capable of inhibiting the generalization of LSD
to L-5HTP. Another interpretation is that this property of
ketanserin, rather than reflecting a common origin to the LSD and 
L-5HTP discriminative cues, is due to the antagonism of 5-HT2 
receptors "upstream" to the 5-HTi receptors activated by L-5HTP. It 
is thought that 5-HT is the actual compound that mediates the L-5HTP
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cue since build-up of brain 5-HT correlates with L-5HTP-appropriate 
responding (Friedman et al., 1983). This would lead to the random 
activation of 5-HT receptors, whereas the use of LSD results in a 
more selective action which is more susceptible to antagonism by 
suitable agents. Such a concept might also explain the failure of 
melatonin to affect the discriminative cue induced by L-5HTP. The 
generalization characteristics of 8-OHDPAT and 5MeODMT to the L-5HTP 
discriminative stimulus are in agreement with the results of Moser 
and Redfern (1985b) who had previously found that the cue 
generalizes fully to RU24969 and 5MeODMT. Partial transfer of the 
stimulus was reported to occur with 8-OHDPAT and TFMPP. These 
results suggest that the L-5HTP may possess two components, one 
derived from 5 -H T i a  receptor activation and one from 5 -H T i b  
activation. This would explain why RU24969, which has approximately 
equal affinity for these two 5-HT receptor subtypes, is able to 
demonstrate full generalization to the L-5HTP cue along with the
non-selective 5-HT agonist 5MeODMT. 8-OHDPAT is selective for the 
5 -H T i a  receptor, while the action of TFMPP is reported as being 
selective for 5 -H T i b  and 5-HTiC, having little or no activity on 
the 5 -H T i a  receptor (Kennett and Curzon, 1988b). Thus, from the work 
of Stolerman (1984) on shared stimulus characteristics as discussed 
in the introduction, both these compounds can be expected to display 
partial rather than full generalization to the L-5HTP discriminative 
cue.
The failure of melatonin to substitute for, or antagonize, 
the L-5HTP stimulus, supports the evidence presented in the previous
chapter that there is little or no interaction between the
behavioural aspects of 5-HTi receptor activation and melatonin. The 
development of compounds with greater selectivity towards the
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various 5-HTi receptor subtypes will allow for a more comprehensive 
study into possible 5-HT/melatonin interactions using the drug 
discrimination technique. For example, Tricklebank et al. (1985) 
demonstrated the discriminative properties produced by 8-OHDPAT were 
most likely the result of 5 -H T i a  receptor activation. It is likely 
that the stimulus induced by TFMPP, the putative 5 -H T i b / 5 - H T i c  
agonist, is effected by 5 -H T i b  receptors since no generalization 
occurs with 8-OHDPAT, but the stimulus does transfer to RU24969, 
which has no practical affinity for the 5-HTic receptor. 
Discriminative studies using 8-OHDPAT and TFMPP as training 
compounds would allow a more definitive assessment of any potential 
behavioural interaction that melatonin might have with 5-HTi 
receptor subtypes. The discriminative stimulus properties of the 
hallucinogenic compounds DOI, DOB and DOM have been attributed to 
their selective agonist action on the 5-HT2 receptor (Glennon et 
al., 1982; Glennon et al., 1983b; Glennon et al., 1984b; Glennon et 
al., 1986). The results obtained by Dugovic et al. (1988; 1989a, 
1989b) suggest that an investigation into whether melatonin can 
compromise the cue generated by these compounds would be 
interesting.
In this series of experiments the Skinner box was used to 
give a food-reward to deprived rats as a reinforcement for the 
correct response. The T-maze paradigm used escape from a painful 
stimulus as reinforcement for the correct response. Most drug 
discrimination studies conform to this arrangement, although some 
workers have utilized the T-maze as a food-reward procedure (e.g. 
Barry et al., 1965) and the Skinner box as a shock-escape procedure 
(e.g. Krimmer, 1974). Since two contingencies have been used in two 
paradigms direct comparison between the T-maze and the Skinner box
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is difficult. However, there are clear methodological advantages of 
the Skinner box over the T-maze as a means of conducting drug 
discrimination experiments. The Skinner box yields a greater amount 
of information concerning the action of an animal and, with the 
benefit of operant conditioning, offers a greater versatility in the 
method by which an animal can gain its reinforcement, which can 
potentially yield more information on the psychoactive properties of 
the training compound. Automation of the procedure and 
computer-assisted data-analysis provide additional practical 
advantages over the T-maze. Actual results obtained from the two
paradigms once the animals have been trained are generally
compatible but Barry and Krimmer (1978) have found that the
food-reward technique as opposed to shock escape can affect the 
sensitivity of discrimination which could presumably in turn affect 
acquisition.
An outstanding feature of the data generated by L-5HTP is 
the high number of sessions required to reach criterion when used as 
the training drug for the T-maze paradigm in comparison to the
Skinner box (53 +/- 3.9 s.e.m. and 20.7 +/- 2.3 s.e.m.,
respectively). Such a result is not easily explained by a difference 
in methodology since previous studies have reported similar rates of 
acquisition for the L-5HTP cue regardless of the paradigm (Barrett 
et al., 1982; Friedman et al., 1983; Moser and Redfern, 1985b). The
most likely explanation is that in the T-maze the rats were trained,
essentially, according to a single trial procedure which, as 
mentioned above, leads to a stable cue but one which is more slowly 
acquired (Barry and Krimmer, 1978; Tomie et al., 1987). This was 
brought about by an inherent disadvantage in the wooden construction 
of the T-maze apparatus used in this series of experiments. Rats
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subjected to stress (e.g. an electric shock) commonly, urinate and 
defaecate. It was realized at the beginning that this posed a 
potential threat to the integrity of the shock intended for delivery 
through the steel rods used as a floor for the T-maze. To avoid any 
possible short-circuiting caused by urine and faecal material 
deposited on the rods from seeping into the wooden walls after all 
trials the floor was wiped with dry tissue. This may have proved to 
be inadequate with the result that certain trials were conducted 
with reduced effectiveness of the reinforcing cue.
The response rate and response latency are examples of 
further data provided by the Skinner box and not the T-maze, 
although an equivalent parameter for response latency could be 
obtained with the latter paradigm if animals were timed from the 
moment they were placed into the T-maze to when they entered the 
safe area. It was found that the early L-5HTP training days greatly 
affected response latency to the extent that several animals failed 
to respond at all in their 15 min training session. Persistence of 
this continued in three animals despite the reduction in L-5HTP dose 
from 50mg/kg to 35mg/kg and so were withdrawn from the experiments. 
The response latency parameter on L-5HTP days quickly adopts a 
similar level to saline days with repeated training. Interestingly, 
this is not shared by the response rate which remained at a 
significantly reduced level during L-5HTP training sessions in 
comparison to saline training periods. The reason for this 
discrepancy is not clear but it may reflect differing levels of 
influence for the action of L-5HTP. It is a reasonable assumption 
that the response latency characteristic represents a quantitive 
measurement of the decision-making process for the animal. 
Therefore, the response latency measured in early training sessions
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can be expected to reflect the time spent by the rodent pressing the 
wrong lever before moving to the correct one. As training progresses 
and the animal becomes confident of making the correct decision the 
first reinforcement is quickly obtained. This would result in all
early training days for all drug treatments having large response
latency times which become progressively smaller as training
continues, assuming a successful acquisition of the discriminative 
cue. Fig. 4.9 shows clearly that this was only partially obtained. 
Animals that received melatonin demonstrated a similar level of 
response latency on both saline and melatonin training days 
throughout the experiment. Those rats undergoing training to 
discriminate saline from L-5HTP expressed a much higher response 
latency on the early L-5HTP training days than on saline training 
days. The disruptive effect that L-5HTP possesses on motor behaviour 
is likely to be responsible for the reduced rate of lever pressing 
apparent on drug training days - an effect reproduced elsewhere 
(e.g. Cunningham et al., 1985). This also probably accounts for the 
high response latency of the early L-5HTP training sessions.
However, the development of tolerance to the cognitive effects of 
the drug may well be responsible for the subsequent reduction in the 
response latency parameter. Tolerance to the centrally-mediated 
effects of L-5HTP on motor behaviour has not been reported which 
would explain the persistence of the reduced response rate. It 
should be noted that some residual effect on response latency caused 
by drug-induced disruption of motor behaviour probably persisted 
throughout the experiment since drug-training days tended to yield 
higher response latency values than non-drug-training days (see Fig. 
4.9). Tolerance looks the most probable reason for the shift in 
gradient of the dose response curve (see Fig. 4.7) for L-5HTP. It
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may be that continued training ’’fine tunes*' the discriminative 
stimulus, though this observation has not been reported elsewhere 
with respect to L-5HTP.
The work of Holloway and Wansley (1973a; 1973b; Wansley
and Holloway, 1976) suggest that circadian and/or ultradian rhythmic 
processes may produce state dependent oscillations in retention 
performance of learned behaviours in animals. Awareness of these 
studies and others (e.g. Davies et al., 1973) suggest that any 
circadian fluctuation observed in the discriminative stimulus of any 
drug may be related to a biological rhythm of performance (in this 
instance reflecting learning, retention and recall) rather than 
variability in the degree of strength expressed by the stimulus. 
Since Moser (1986) had already shown that a group of animals trained 
at a specific time phase of the LD cycle did not learn the 
discrimination task any more quickly than another group trained at 
another time, it was decided to test signal strength variability in 
pre-trained rodents. Neither of these two methods rule out the 
performance factor which is difficult to control. The middle and 
high dose used evinced no appreciable variability in performance/ 
stimulus strength. At the lowest dose used an apparent reduction in 
the percentage of correct choices was observed over the ML and MD 
periods. A more extensive study is required, however, before any 
significance can be attached to these results.
CHAPTER 5.
MELATONIN AND CIRCADIAN RHYTHMS
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5. MELATONIN AND THE CIRCADIAN RHYTHM OF LOCOMOTOR ACTIVITY
5.1. Introduction
Melatonin may have ambiguous effects with regard to 
affecting locomotor activity directly but it demonstrates an 
intriguing ability to modify the expression of the circadian rhythm 
of locomotor activity. Early studies investigated the pineal gland 
as a potential biological clock. This concept, first proposed by 
Wurtman and Axelrod (1965), has been sustained in lower vertabrate 
classes of animals (e.g. sparrows) but not mammals. Responsibility 
for circadian time-keeping in mammals appears to have been '’taken 
over” by the SCN and its surrounding structures. Quay (1970a) found 
that pinealectomy increased the rate of re-entrainment of the 
locomotor activity rhythm following a phase-shift in the 24 h LD 
cycle, a property which appears dependent upon the age of the animal 
(Quay, 1970b, 1972). Conversely, Cheung and McCormack (1982)
demonstrated that pinealectomy or continuous melatonin treatment via 
a subcutaneous silastic implant failed to affect the period of 
free-running locomotor activity rhythms in dim LL in rats. In 
addition, they found that this period lengthened when animals were 
shifted from DD to LL and shortened when shifted back to DD to the 
same extent in both pinealectomized or non-pinealectomized rats, in 
keeping with Aschoff's Rule. These results would suggest that 
despite the importance of the LD cycle on the function of the pineal 
gland the integrity of the gland is not important in the generation 
and maintenance of mammalian circadian activity rhythms. Since this 
time, however, it has been shown that melatonin entrains 
free-running locomotor activity rhythms but only if given as a pulse 
during a narrow window of sensitivity in the cycle. This sensitive
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phase corresponds to the end of the subjective day when 
diurnally-active animals enter their quiescent period and nocturnal 
animals become active (Redman et al., 1983; Gwinner and Benzinger, 
1978). Cassone et al. (1986a, 1986b) confirmed and extended the
results of Redman et al., identifying that this reaction to 
melatonin requires an intact SCN and is dose-dependent. To a limited 
extent melatonin is capable of re-establishing disrupted rhythms 
induced by gradual lengthening of the photoperiod to LL conditions 
but fails to entrain those animals whose free-running activity 
rhythms remain intact in LL (Chesworth et al., 1987).
It is interesting to note that the failure of continuous 
melatonin release to affect free-running activity rhythms compares 
with the ability of similar treatment to inhibit pulsatile 
melatonin-induced gonadal regression (Goldman et al., 1979). 
Additionally, Armstrong and Redman (1985) have reported that the 
period of activity in rats maintained under free-running (DD) 
conditions is extended if melatonin is administered in the drinking 
water. This is not quite the same, though, as continuous therapy 
since rats drink mostly during their active phase and no entrainraent 
of their locomotor activity rhythm was detected. Melatonin would 
appear to execute entrainment by inducing phase-advances between 
CT10 and CT11 (circadian time 10 and 11, respectively, where CT12 
corresponds to the start of the active phase)(Armstrong, 1989). 
There remains some doubt as to whether this is the correct 
interpretation since a number of vehicle-treated animals displayed 
small phase-advances when injected at CT10. It would appear that 
this phase point in the activity cycle is particularly sensitive to 
potential zeitgeber irrespective of whether they are internally or 
externally derived. The phase response curve (PRC) is a plot that
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indicates how the extent and direction of a phase-shift induced by a 
single stimulus depends on the phase at which the stimulus is 
applied. PRCs generally have phase-advance and phase-delay 
components. The mammalian PRC for melatonin is unusual in that it is 
characterized almost entirely by phase advances which occur at a 
time when light pulses would induce phase-delays and is devoid of 
activity in this respect at other times of day (Armstrong, 1989), 
although this does ignore two anomalous results reported by 
Armstrong in the same article where melatonin produced a 50 min 
phase advance in one rat at CT22 and a 20 min phase-delay in another 
animal at CT18. The influence of melatonin as an internal zeitgeber 
for locomotor activity in lower classes of vertabrates has been less 
controversial; e.g. Underwood (1986) has described a full PRC which 
possesses phase-advance and phase-delay components for melatonin in 
lizards; continuous melatonin therapy can lengthen the period in 
certain species of lizard (Underwood, 1979, 1981); and it has been 
reported that continuous melatonin reduces the period of activity of 
sparrows in both free-running and entrained conditions (Turek et 
al., 1976b; Hendel and Turek, 1978). The action of melatonin on the 
activity rhythm of mammals under entrained conditions has yielded 
more practical results. A recent study has found that small doses of 
melatonin given to Djungarian hamsters housed under a long 
photoperiod regime (16:8 LD cycle) 12 h after the onset of the light 
phase induces a short-day response in activity in receptive animals 
(Puchalski and Lynch, 1988). That is, in conjunction with the 
physiological adjustments such as gonadal regression, moulting and 
body weight loss associated with short-days, the period of locomotor 
activity was advanced and its duration extended. Armstrong (1989) 
has presented data that suggests melatonin may phase advance the
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onset of locomotor activity in the rat if given during the late 
afternoon before the onset of darkness in a 12:12LD cycle provided 
there is not a phase angle difference between activity onset and 
dark onset greater than 3 h (45°), though this has not yet been 
reproduced elsewhere.
The internal synchronizing properties of melatonin on the 
biological clock have lent credence to the concept of melatonin as a 
"jet-lag alleviator". Early studies describing the effects of 
pinealectomy and melatonin on the rate of re-entrainment after a 
phase-shift of the LD cycle were less promising. Pinealectomized 
animals re-entrained at a faster rate than controls (Kind et al., 
1970) and Quay (1972) showed that this rate reduced with age. 
Interestingly, Benus et al. (1988) has recently found that
aggression and rate of re-entrainment are connected. Wild house mice 
selected for their high aggression levels entrained to a 12 h 
phase-shift in the LD cycle less quickly than mice selected for 
their low levels of aggression. Benus et al. have proposed that 
aggressive mice have stronger links with their endogenous pacemakers 
making them more resistant to changes in environmental time-cues. In 
a social context these results suggest that subordinate animals 
would be forced to live to the vagaries of the dominant group member 
and entrain to new environmental conditions at the rate determined 
by the behaviour of the dominant member. The impact of social 
interactions on entrainment has been considered in greater detail by 
Mrosovsky (see Mrosovsky and Salmon, 1987; Mrosovsky, 1988).
Treatment with melatonin itself has provided ambigous 
data in the study of synchronizing rhythms to a new LD cycle. If 
removal of the pineal gland and therefore most of the circulating 
melatonin increases the rate of re-entrainment, one might expect
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melatonin treatment to decrease it. However, Murakami et al. (1983) 
reported that a melatonin pellet implanted near the SCN of intact 
and pinealectomized rats accelerated re-entrainment of the circadian 
rhythm of blood corticosterone after inversion of the LD cycle. 
Redman and Armstrong (1988) were unable to provide consistent data 
in support of their claims that melatonin could affect the rate and 
direction of re-entrainment according to the time of injection 
relative to the original or intended LD cycle. However, Arendt and 
co-workers have produced persuasive evidence in support of a role 
for melatonin alleviating the symptoms of jet-lag (Arendt et al., 
1987). Human subjects were transported across eight time-zones in an 
eastward direction which required an 8 h advance of their circadian 
rhythms for synchronization to the new time period. An oral dose of 
melatonin (5mg) or placebo was taken for three days prior to and on 
the day of travel at 18:00 h according to their current time zone. 
This would correspond to the latter half of their active phase. 
Treatment was continued for four days after arrival at their 
destination but the dose was taken between 22:00 h and 24:00 h 
according to their new time zone. This would approximately 
correspond to the end of their newly-adjusted active period, which 
is consistent with studies conducted by Gwinner (Gwinner and 
Benzinger, 1978) in diurnally active starlings and Underwood (1986) 
using lizards as being the most appropriate time to entrain 
free-running locomotor activity rhythms of a diurnally active 
species using a bolus dose of melatonin. Melatonin-treated subjects 
suffered significantly less symptoms of jet-lag as determined by a 
subjective analysis using a visual analogue scale and were reported 
as being less depressed and more alert than placebo-treated 
subjects. Additionally, urinary analysis of endogenous melatonin and
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cortisol rhythms demonstrated a more rapid resynchronization in 
melatonin-treated subjects than controls (Arendt et al., 1987; 
Arendt, 1988). The beneficial effects of melatonin in the prevention 
of jet-lag were repeated in a larger double-blind cross-over trial 
among 61 subjects travelling from Britain to Australia and back.
It was decided to investigate further the potential of 
melatonin as a co-ordinator of circadian rhythms using long-term 
monitoring of locomotor activity since it effectively presents a 
window to the internal circadian state of an organism and, due to 
the ease by which it can be recorded, is the most commonly used
method of analyzing circadian rhythms and their manipulation. The
use of a 180° phase-shift in the LD cycle to investigate the effect 
of a particular treatment on the rate of re-entrainment to the new 
cycle has been criticized with the argument that animals may 
phase-advance or phase-delay to re-establish their internal rhythms 
to the time cues provided by the external environment (Armstrong and 
Redman, 1985). This procedure was adopted, however, as a means of 
causing temporary rhythm disruption to the organism with the 
intention of analyzing the rate at which melatonin may restore 
synchrony irrespective of the direction of re-entrainment. It was 
also considered that melatonin might influence the direction of
re-entrainment after a 12 h environmentally-induced disruption of 
circadian rhythms - which, if apparent, could dictate future
experiments.
The results published by Redman et al. in 1983 concerning 
the entrainment of a free-running rhythm by melatonin were 
intriguing on their own and their reproducibility was considered 
important. Moreover, stress, induced by the presence of a laboratory 
worker in the vicinity of the animals at regular time-points in
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addition to the stress induced by injection, might be sufficient to 
entrain free-running rhythms rather than treatment with melatonin. 
Hence a further series of experiments were conducted to verify the 
work of Redman et al. Four animals were monitored using the Animex 
system of locomotor activity analysis while the other group of six 
animals were monitored using light beams. Both systems relied upon 
the BBC Model B computer for data collection and the series of 
programs developed by Marshall et al. (1985) and Mitchell (1989) for 
data analysis.
A third series of experiments was initiated with the 
intention of determining the effect of melatonin on the phase-shift 
of a free-running locomotor activity rhythm induced by a 15 min 
light pulse. The PRC generated by administering light pulses at 
different time points of the activity-rest cycle in constant 
(free-running) conditions has three components. If the pulse is 
given during the early subjective night, or at the end of the 
subjective day, when the animal just becomes active (i.e. at CT12) 
the rhythm is phase-delayed, that is, the beginning of the next 
activity period is delayed with respect to the expected time of 
commencement. If the pulse is given during the late subjective night 
a phase-advance is observed, that is, the inchoation of the activity 
phase occurs earlier than expected. The maximum degree of 
phase-shift of the onset of activity from the anticipated time point 
if no pulse had been administered might take several cycles to 
become apparent. The third component of the PRC is the 
non-responsive phase. A light pulse given between approximately CT3 
and CT8, the subjective day, or rest phase, for a nocturnally active 
mammal, elicits no phase-shift in either direction. The overall 
shape of the PRC generated by light pulses is dependent on the
duration of the pulse and the species under investigation (Honma et 
al., 1978; Turek, 1987: Daan and Pittendrigh, 1976) The hypothesis
was that if melatonin provided the signal of darkness to the
internal environment of the organism, as demonstrated by the work of 
Gwinner and Benzinger (1978) and Redman et al. (1983), a bolus dose 
of melatonin might counter the effect of a 15 min light pulse. Time 
prevented the testing of this hypothesis over a range of phase
points in the circadian cycle. Examination of past papers revealed
that the phase-delay induced by a 15 min light pulse at CT12 might 
be the most convenient direction of shift to investigate in 
consideration of the extent of shift and the immediacy of the 
response (Honma et al., 1978) and it was also considered the most 
likely period for melatonin to elicit an effect.
The ambiguous results generated by previous studies of the 
effects of melatonin on locomotor activity prompted an additional 
investigation into this behaviour. Two types of locomotor activity 
were analysed. Exploratory locomotor activity (ELA), defined as that 
level of activity occurring within the first 10 min of an animal 
being placed into a novel environment, was measured at four time 
points (ML, EOL, MD and EOD). Spontaneous locomotor activity (SLA) 
was assumed to be the level of activity occuring in the course of 2 
h after an equal period of acclimatization to a novel environment. 
Spontaneous activity was measured at two time points, ML and MD. The 
effect of melatonin on activity after a 6 h phase advance of the 
light or the dark period was also investigated.
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5.2. Materials and Methods
5.2.1. Animals
Male Wistar rats (Animal House, University of Bath strain) 
weighing between 150 and 200g at the start were used in all long-term 
locomotor activity experiments. Animals were housed individually in 
standard plastic cages measuring 520x350x170mm with food and water 
available ad libitum. Animals weighing between 250 and 350g were
used for the short-term analysis of exploratory and spontaneous
locomotor activity. They were housed in standard plastic cages in 
groups of 4-6 until the time of the experiment which was conducted 
using individual animals. Food (Labsure CRM diet) and water was 
available ad libitum. Since rats were removed from a colony 
familiarized to a 14:10 LD schedule, all animals were maintained
under a 12:12 LD cycle for at least two weeks prior to use, unless
experimental conditions required an alternative lighting regimen.
5.2.2. Drugs
Melatonin (Sigma) up to doses of 1mg/kg was dissolved in 
normal saline by sonication and larger doses suspended in 0.1% w/v 
tragacanth in normal saline, also by sonication. All injections were 
administered i.p. using a dose volume of 1ml per 200g. Control 
animals received the same volume of vehicle.
5.2.3. Apparatus
Long-term locomotor activity experiments were conducted 
with locomotor activity cages housed in the environmental cabinet 
first described by Hillier et al. (1973). These units, as depicted 
in Fig. 5.1, were constructed from either 17mm blockboard with the 
dimensions 610 x 450 x 615mm. Animals were further insulated from
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external events by 12mm polystyrene sheets covering the walls and 
door, and draft-excluder tape lining the door frame. Ventilation was 
provided by an extractor fan (Philips, Type HR3408) feeding 2-3 
cabinets via 30mm-bore plastic tubing connected to the rear of a 
cabinet. A second plastic tube attached to the side of the units 
allowed passage of a flexible pipe to the interior for the provision 
of water from a reservoir located above the cabinet if required. 
Internal lighting, achieved using a 12 inch 8W white-light 
fluorescent tube (Thorn EMI, Type FLJ 1008) attached to the ceiling 
of a cabinet provided an illumination intensity of between 650 and 
850 lux (Macam Photometries Ltd., Model Radiometer/Photometer R101) 
at cage-floor height and was controlled by an externally mounted 
time switch (Sangamo, Type 524-1-171 or Smith Industries, Type 
TS500). The choke was also mounted externally on a metal heat-sink 
to prevent heating the internal environment. VARIMEX activity 
monitors were used for recording the circadian rhythm of locomotor 
activity during experiments involving the effect melatonin on the 
rate of re-entrainment and the first entrainment of free-running 
rhythms experiment. Animals could be left in these cages for three 
weeks before the sawdust had to be replaced. This procedure was 
carried out during the active phase of the rat in the experimental 
room under dim red light (6 lux). The second entrainment experiment 
used photocells located in the walls of standard grid-based plastic 
cages (320 x 500 x 165mm), 40mm above the floor and mid-way between 
the food-hopper and rear of the cage. The cage was placed on small 
wooden platforms to allow easy access to the sawdust tray. Some 
modification to the interior of the environmental cabinet was 
instigated for the phase-shift experiments and is shown in Fig.
5.2. Four wooden square pillars, 32mm x 32mra x 420mm, two on either
153
side spaced 300mm apart were used to support four wooden rails (17 x 
10 x 510mm). These were used to mount metal grids (with 10mm
apertures) using plastic ties. This allowed the photodetectors and 
photoemitters to be mounted opposite each other outside the activity 
cage with a high degree of manoeuvrability. This modification
necessitated a smaller activity cage (130 x 250 x 420mm) which was 
placed on a wooden platform across the lower rails. The lid to the 
cage was raised permitting a full activity cage height of 205mm. Two 
0.5 inch diameter holes were drilled into opposite sides of the 
activity cage 40mm from the base and 210mm from the rear of the cage 
to permit the passage of the light beam. Rats were prevented from 
chewing the vulnurable plastic area surrounding the holes by 
attaching two aluminium plates with 0.5 inch holes in their centre 
to the interior walls of the cage. Since the cage had a solid 
plastic floor it was found necessary to replenish sawdust once every 
two weeks during an experiment. This was performed in the 
experimental room under dim red light (6 lux). In each experiment
sufficient laboratory chow was provided to accomodate the feeding
requirements of a single rat for 7 days. Water was dispensed from a 
standard water bottle and checked every other day. Care was taken to 
refill water bottles and food, if required, at irregular times of 
the day.
A second type of environmental cabinet, described by 
Mitchell (1989), contained the activity monitor used for the 
short-term analysis of locomotor activity (see Fig. 5.3). The 
chamber was constructed from 17mm plywood with dimensions 1300 x 
900 x 1400mm. Penetration of light and sound were minimized by 
lining the walls and door with 12mm polystyrene sheets and the door 
frame with draft-excluder tape. Ventilation was provided by a single
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extractor fan (Philips, Type HR3408) connected to the rear of the 
chamber via 30mm-bore plastic tubes. Internal lighting (100 lux) was 
achieved using a wall-mounted 12 inch 8W white light fluorescent 
tube (Osram), controlled by an externally-mounted time switch (Smith 
Industries, Type TS500). The choke was located outside of the 
chamber on a metal heat-sink to prevent heating the internal 
environment. The door to this cabinet was kept open during the 
analysis of exploratory locomotor activity and closed during 
spontaneous locomotor activity experiments. The locomotor activity 
monitor, as described by Mitchell (1989), was constructed from 5mm 
black perspex with the dimensions 900 x 600 x 350mm (see Fig. 5.4). 
Three infrared photoemitters and three photodetectors were located 
at 300mm intervals along the walls of the cage, 50mm above a 
stainless steel metal-grid floor. A removable perspex tray placed 
beneath the grid floor was used to hold sawdust. The lid was 
constructed from clear perspex and housed two descending pillars, 
120 x 120 x 300mm, with their respective centres 340mm apart. These 
contained the partner photoemitters and photodetectors to those 
located in the walls of the cage such that the infrared light beams 
were positioned to divide the cage floor area into six equal parts. 
An additional photoemitter and photodetector were placed in the 
facing sides of the pillars 50mm above the cage floor. Each 
photocell was connected to a D-socket mounted in the wall of the 
environmental cabinet. A food hopper and water bottle were attached 
to the side of the' activity monitor for the provision of nourishment 
ad libitum.
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Fig. 5.1. Diagram showing the main features of the environmental cabinet 













Fig. 5.3. Diagram showing the main features of the environmental cabinet 
used in the spontaneous and exploratory locomotor activity of 
individual rats.
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Fig. 5.4. Diagram showing the main features of the locomotor activity monitor used to record spontaneous 
and exploratory locomotor activity of individual rats.
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Two methods of recording locomotor activity were employed
in this series of experiments - ANIMEX and Photocells - both of
which communicated with a computer (Acorn BBC, Model B) via an 
interface and software designed by R. Marshall, University of Wales 
College of Medicine, Cardiff (Marshall et al., 1985), thereby 
enabling the storage of data on 5.25 inch floppy discs.
The ANIMEX system consisted of a VARIMEX horizontal
activity electromagnetic sensor (Columbus Instruments Ltd.) placed 
in the environmental cabinets beneath the plastic animal cages. A 
signal from the sensors was recorded by an activity counter 
(Columbus Instruments Ltd.) and registered as a count on the 
computer.
The photocell system consisted of two types of photocell 
per animal cage. The photoemitters (Scan-A-matic, Model L33007) were 
energized by a 5 volt DC power supply (Radio Spares switched-mode 
70W). The response of photodetectors (Scan-A-Matic, Model P33001) 
to a breakage of an infrared light beam was registered as a count on 
the computer. Counts were collected for a predetermined time before 
storage on floppy disc.
5.3. Data Analysis
Long-term locomotor activity experiments generate vast 
quantities of numbers which represent the level of activity 
occurring over a predetermined sampling interval. The actual numbers 
are of secondary importance. Accurate analysis depends on the 
recognition of trends and patterns derived from the variation in
their magnitude. The actogram is the most common means of displaying 
long-term circadian locomotor activity data and represents the
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distribution of activity over a 24 h period. Activity recorded at a 
level greater than a predetermined threshold is registered as a 
solid block of width equivalent to the sampling interval printed at 
its corresponding time. For greater clarity actograms are double­
plotted (e.g. see Fig. 5.5a). The main weakness of this method of 
data presentation is the bias introduced by the experimenter 
resulting from their choice in threshold. This source of influence 
was avoided by using the calculated daily median of activity as the 
threshold. Thus for each 24 h cycle plotted on the actogram there is 
an independently chosen threshold. Actograms were used in
combination with daily activity plots to estimate the onset of 
activity periods. Assessing the onset of activity in both the rate
of entrainment and free-running rhythm entrainment experiments was
achieved by the visual inspection of actogram data and, where 
possible, visual inspection of daily (24 h) activity profiles (e.g. 
see Figs. 5.7a-5.8b).
A more complicated mathematical technique applied to 
circadian locomotor activity data is that of periodogram analysis, 
which is used to determine the period expressed by a rhythm. 
Periodogram analysis comes under the more general term of "time 
series analysis” which is used to characterize time series data 
(i.e. observations made sequentially in time) mathematically. The 
reader is referred to Chatfield (1985) and De Prins et al. (1986) 
for background reading and the applications of time series analysis 
to chronobiology. Periodogram analysis was used to determine the
period of the circadian rhythms in locomotor activity. Periodogram 
profiles were found to be of poor and inadequate resolution if they 
had been calculated on the basis of less than 8 days data. This is 
due to accuracy in the determination of the primary period of a
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rhythm being dependent on little change occurring over the interval 
under analysis. Thus this technique was used for determining the 
period of the locomotor rhythms in experiment 2 where treatment was 
continued for 14 days and a suitable number of days before and
after treatment could also be analysed.
Software for the generation of median determined actograms 
and periodogram analysis were kindly provided by P. Mitchell (1989).
5.4. Experimental Protocol
5.4.1. Experiment 1: To determine the effect of melatonin on the 
rate of re-entrainment of the rat circadian locomotor activity 
rhythm after a 180° inversion of the LD cycle.
Individual animals were housed in environmental cabinets 
under a 12:12 LD cycle. In view of the results presented by Redman 
et al. (1983) melatonin (1mg/kg) was injected for three days prior 
to the phase-shift at the time point corresponding to the
post-phase-shift future end of light phase. The phase-shift itself 
was conducted after a suitable period of time had elapsed to produce 
a stable actogram trace. The timing of the phase-shift was designed 
such that the rats were forced to endure 24 h of darkness before the 
lights came on again, which was just after their daily dose of 
melatonin. This could be viewed as a 12 h phase advance of the dark
(active) phase or a 12 h delay of the light (rest) phase. (In line
with this reasoning 24 h of illumination would be described as a 12 
h phase advance of the light (rest) phase or a 12 h delay of the 
dark phase). Treatment with melatonin was continued at the new end 
of light phase time point until the end of the experiment. Four 
animals could be experimented on at one time, two drug-treated and 
two controls. Details concerning the day and time of the injections
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are given with Figs. 5.5a-f.
5.4.2. Experiment 2: To determine the ability of melatonin to 
entrain free-running rat circadian locomotor activity rhythms.
Individual animals were maintained in environmental 
cabinets under DD and allowed to free-run until an actogram trace 
was produced which demonstrated a free-running rhythm of locomotor 
activity. The onset of activity was predicted by examination of the 
actogram trace in combination with a program designed to plot the 
profile of activity over any 24 h period (an example plot can be 
seen in Fig. 5.7a). Injections of melatonin (1mg/kg) began an hour 
after the approximated time of activity onset with the anticipation 
that entrainment would occur within 2-3 days when activity onset 
coincided with the dose of melatonin. Treatment was continued at the 
same time for 14 days (i.e. each animal received a total of 14 
injections). Following the final injection the animals were 
maintained under DD and left undisturbed (except for necessary 
hygiene and nourishment requirements) for a further period of time 
to re-establish free-running activity rhythms. Four animals were 
monitored using the ANIMEX system of activity analysis (two drug, 
two controls; rats 1-4) and a further six animals were monitored 
using photocells (three drug, three controls; rats 5-10). Details 
concerning the days and times of injection are given with Figs. 
5.9a-j.
5.4.3. Experiment 3: To determine the effect of melatonin on the 
ability of light to elicit a phase-shift in rats.
Animals were housed in modified environmental cabinets and 
activity cages as described above and shown in Figs. 5.1 and 5.2
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under DD. This condition was maintained until a free-running rhythm 
was obtained with sufficient data to allow as accurate an estimation 
as possible of the onset of activity using the procedure described 
in Experiment 2. A 15 min pulse of white light (between 650 and 850 
lux) was then administered at the expected time of the onset of 
activity (CT12) the day following its estimation. Details concerning 
the day and time when a pulse was given to a particular animal are 
provided with Figs. 5.12a-h. It is regrettable that equipment and 
data complications prevented further progress with this experiment. 
The reasons for this are considered in the discussion.
5.4.4. Experiment 4: Effect of melatonin on exploratory locomotor 
activity (ELA) in the rat.
Single rats were given melatonin (1, 10 and 50mg/kg) or
vehicle, 10 or 30 min prior to being put into the activity monitor 
(as depicted in Fig. 5.4). The total number of counts registered in 
10 min was taken as a measure for exploratory locomotor activity and 
recorded for later analysis. Experiments were conducted at ML, E0L, 
MD and EOD.
5.4.5. Experiment 5: Effect of melatonin on spontaneous locomotor 
activity (SLA) in the rat.
Single rats were allowed to familiarize themselves with 
the activity monitor (as depicted in Fig. 5.4) for 2 h before being 
injected with melatonin (1, 10 and 50mg/kg) or vehicle. They were
then left for a further 2 h and the total number of counts generated 
in that time taken as a measure of SLA and recorded for later 
analysis. Experiments were conducted across the ML and MD periods, 
that is injections were given at ML or MD. The effect of melatonin
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on a 6 h advance of the dark phase and a 6 h advance of the light 
phase was also investigated. Thus, for example a 6 h phase advance 
of the dark phase was effected by allowing rats to acclimatize to 
the activity cabinet for 2 h with the lights on upto their ML phase 
position, they were then removed for injection and then returned to 
the cabinet with the lights now extinguished. Activity was monitored 
for the following 2 h. Injections during the dark phase were carried 
out under dim red light (6 lux).
5.5. Results
5.5.1. Experiment 1: Effect of melatonin on rate of entrainment.
No effect of melatonin on the rate of entrainment was 
observed. Both control and melatonin-treated rats accomplished 
re-synchronization to the new LD cycle by small daily phase-delays 
and took an average of 6.2 (+/- 0.75 s.e.m.) and 6.8 (+/- 0.31
s.e.m.) days respectively. Figs. 5.5a-5.5f depict the actograms 
pertaining to this experiment. Although there was a noticeable but 
transient drop in total daily activity apparent following the day of 
the phase-shift there was no difference between the melatonin- 
treated and control groups (see Fig. 5.6). Figs. 5.7a-b and 5.8a-b 
show an example sequence of 24 h activity profiles of single animals 
starting from two days before the first injection was given, for a 
melatonin-treated rat and a saline-treated rat, respectively.
Fig. 5.5a. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: actograms of the
circadian rhythm of locomotor activity expressed by rats 1 (top) and 
2 (bottom), melatonin (1mg/kg) and saline treated, respectively. 
Solid blocks indicate where the activity counts per epoch (15 rain)
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
Initial LD cycle: 12:12 (lights on: 09:00 h)
Final LD cycle: 12:12 (lights on: 21:00 h)
Injections begun: day 12 at 08:30 h




































Fig. 5.5b. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: actograms of the 
circadian rhythm of locomotor activity expressed by rats 3 (top) and 
4 (bottom), melatonin (1mg/kg) and saline treated, respectively.
Solid blocks indicate where the activity counts per epoch (15 min)
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
Initial LD cycle: 12:12 (lights on: 09 00 h)
Final LD cycle: 12:12 (lights on: 21:00 h)
Injections begun: day 12 at 08:30 h
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Fig. 5.5c. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: actograms of the
circadian rhythm of locomotor activity expressed by rats 5 (top) and 
6 (bottom), saline and melatonin (1mg/kg) treated, respectively. 
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
Initial LD cycle: 12:12 (lights on: noon)
Final LD cycle: 12:12 (lights on: midnight)
Injections begun: day 12 at 11:30 h
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Fig. 5.5d. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: actograms of the 
circadian rhythm of locomotor activity expressed by rats 7 (top) and 
8 (bottom), saline and melatonin (1mg/kg) treated, respectively. 
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
Initial LD cycle: 12:12 (lights on: noon)
Final LD cycle: 12:12 (lights on: midnight)
Injections begun: day 12 at 11:30 h
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Fig. 5.5d. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: actograms of the 
circadian rhythm of locomotor activity expressed by rats 7 (top) and 
8 (bottom), saline and melatonin (1mg/kg) treated, respectively. 
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
Initial LD cycle: 12:12 (lights on: noon)
Final LD cycle: 12:12 (lights on: midnight)
Injections begun: day 12 at 11:30 h
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Fig. 5.5e. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: actograms of the 
circadian rhythm of locomotor activity expressed by rats 9 (top) and 
10 (bottom), melatonin (1mg/kg) and saline treated, respectively. 
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
Initial LD cycle: 12:12 (lights on: noon)
Final LD cycle: 12:12 (lights on: midnight)
Injections begun: day 8 at 11:30 h
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Fig. 5.5f. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: actograms of the
circadian rhythm of locomotor activity expressed by rats 11 (top) 
and 12 (bottom), melatonin (1mg/kg) and saline treated, 
respectively.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
Initial LD cycle: 12:12 (lights on: noon)
Final LD cycle: 12:12 (lights on: midnight)
Injections begun: day 8 at 11:30 h
Phase inversion: day 11 at noon (24 h of dark)
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Fig. 5 .6 . Rate of entrainment experiment - effect of melatonin (lmg/kg) on mean total daily 
activity in rats before and after a 180° phase-shift of the LD cycle. (o= saline, 
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Fig. 5.7a. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: sequence of locomotor 
activity profiles over 24 h from day 10 to 17 for rat treated with 
saline.
For actogram, see Fig 5.5b.
Abscissa: Time (h). Ordinate: Counts per epoch (15 min).
Day number depicted beneath abscissa.
Initial LD cycle: 12:12 (lights on: 09:00 h)
Final LD cycle: 12:12 (lights on: 21:00 h)
Injections begun: day 12 at 08:30 h
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Fig. 5.7b. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: sequence of locomotor 
activity profiles over 24 h from day 18 to 25 for rat treated with 
saline.
For actogram, see Fig 5.5b.
Abscissa: Time (h). Ordinate: Counts per epoch (15 min).
Day number depicted beneath abscissa.
Initial LD cycle: 12:12 (lights on: 09:00 h)
Final LD cycle: 12:12 (lights on: 21:00 h)
Injections begun: day 12 at 08:30 h
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Fig. 5.8a. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: sequence of locomotor 
activity profiles over 24 h from day 10 to 17 for rat treated with 
melatonin (1mg/kg).
For actogram, see Fig 5.5a.
Abscissa: Time (h). Ordinate: Counts per epoch (15 min).
Day number depicted beneath abscissa.
Initial LD cycle: 12:12 (lights on: 09:00 h)
Final LD cycle: 12:12 (lights on: 21:00 h)
Injections begun: day 12 at 08:30 h
Phase inversion: day 15 at 09:00 h (24 h of dark)
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Fig. 5.8b. Effect of melatonin on the rate of re-entrainment 
following a phase inversion of the LD cycle: sequence of locomotor 
activity profiles over 24 h from day 18 to 25 for rat treated with 
melatonin (1mg/kg).
For actogram, see Fig 5.5a.
Abscissa: Time (h). Ordinate: Counts per epoch (15 min).
Day number depicted beneath abscissa.
Initial LD cycle: 12:12 (lights on: 09:00 h)
Final LD cycle: 12:12 (lights on: 21:00 h)
Injections begun: day 12 at 08:30 h
Phase inversion: day 15 at 09:00 h (24 h of dark)
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5.5.2. Experiment 2: Effect of melatonin on free-running locomotor 
activity rhythms.
A degree of entrainment was obtained in all animals 
treated with melatonin. Visual examination of the actogram trace 
produced by one melatonin-treated animal suggests that entrainment 
to an approximate 24 h period persisted after cessation of therapy 
(see Fig. 5.9d), although it is not possible to determine whether 
this simply reflects a reduced free-running period induced by 
melatonin since a further trace depicts a similar but less 
pronounced change (see Fig. 5.9e). One animal of the control group 
entrained to the treatment - entrainment persisting beyond the last 
day of injection to the end of the experiment (see Fig. 5.9b). One 
saline-treated animal displayed partial de-synchronization as 
depicted in Fig. 5.9j. Periodogram analysis of the data failed to 
substantiate estimates of the periods made by visual inspection of 
actograms (see Figs. 5.10a-5.10i and also Figs. 5.11a and 5.11b). 
Periods, as revealed by periodogram analysis, are shown in Tables 
5.1 and 5.2.
Fig. 5.9a. Effect of melatonin on free-running circadian rhythms:
actogram of the circadian rhythm of locomotor activity expressed by
rat 1.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using Animex.
DD from day 1.
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Fig. 5.9b. Effect of melatonin on free-running circadian rhythms:
actogram of the circadian rhythm of locomotor activity expressed by
rat 2.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using ANIMEX.
DD from day 1.
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Fig. 5.9c. Effect of melatonin on free-running circadian rhythms:
actogram of the circadian rhythm of locomotor activity expressed by
rat 3.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using AN1MEX.
DD from day 1.
Treatment: melatonin 1mg/kg at 18:00 h, days 47-60 inclusive.
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Fig. 5.9d. Effect of melatonin on free-running circadian rhythms:
actogram of the circadian rhythm of locomotor activity expressed by
rat 4.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using ANIMEX.
DD from day 1.
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Fig. 5.9e. Effect of melatonin on free-running circadian rhythms:
actogram of the circadian rhythm of locomotor activity expressed by
rat 5.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using PHOTOCELLS.
DD from day 1.
Treatment: melatonin 1mg/kg at midnight, days 47-60 inclusive.
Fig. 5.9f. Effect of melatonin on free-running circadian rhythms: 
actogram of the circadian rhythm of locomotor activity expressed by 
rat 6.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using PHOTOCELLS.
DD from day 1.
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Fig. 5.9g. Effect of melatonin on free-running circadian rhythms:
actogram of the circadian rhythm of locomotor activity expressed by
rat 7.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using PHOTOCELLS.
DD from day 1.
Treatment: melatonin 1mg/kg at 21:30 h, days 14-27 inclusive.
Fig. 5.9h. Effect of melatonin on free-running circadian rhythms: 
actogram of the circadian rhythm of locomotor activity expressed by 
rat 8.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using PHOTOCELLS.
DD from day 1
Treatment: saline at 10:00 h, days 14-27 inclusive.
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Fig. 5.9i. Effect of melatonin on free-running circadian rhythms:
actogram of the circadian rhythm of locomotor activity expressed by
rat 9.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using PHOTOCELLS.
DD from day 1
Treatment: melatonin 1mg/kg at 17:00 h, days 14-27 inclusive.
Fig. 5.9j. Effect of melatonin on free-running circadian rhythms: 
actogram of the circadian rhythm of locomotor activity expressed by 
rat 10.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram. Activity monitored using PHOTOCELLS.
DD from day 1
Treatment: saline at 20:30 h, days 14-27 inclusive.
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Animal T Interval Predominant Periods (h)
Analysed Secondaries Fundamental
(days)
1 Pre 10 (37-46) 3.50, 6.00 24.25 (24.35)
S 10 (50-59) 12.00 24.50 (24.35)
Post 10 (62-71) 3.50, 28.50 24.75 (24.35)
Pre 20 (25-44) 22.75 24.50
Post 20 (62-81) 3.25, 12.25 24.50
2 Pre 10 (37-46) 4.00, 6.00, 12.00 23.75 (24.15)
S 10 (50-59) 4.00, 6.00, 12.25 23.75 (24.00)
Post 10 (62-71) 3.50, 4.00, 6.00 23.75 (24.00)
Pre 20 (25-44) 6.00, 12.00 24.00
Post 20 (62-81) 4.00, 6.00, 12.00 23.75
3 Pre 10 (37-46) 4.00, 6.00, 12.00 23.75 (24.20)
M 10 (50-59) 4.00, 6.00, 12.00 23.50 (24.00)
Post 10 (62-71) 4.00, 6.00, 12.00 23.75 (24.10)
Pre 20 (25-44) 6.00, 12.00 24.25
Post 20 (62-81) 4.00, 4.75, 6.00, 24.00
12.00
4 Pre 10 (37-46) 3.50, 5.00, 21.00 24.00 (24.30)
M 10 (50-59) 4.00, 6.00, 12.00 23.75 (24.00)
Post 10 (62-71) 3.00, 6.00, 12.00 24.00 (24.00)
Pre 20 (25-44) 22.75 24.25
Post 20 (62-81) 3.00, 4.00, 6.00 24.00
Table 5.1. Effect of melatonin on f ree--running circadian rhythms
periodogram analysis of the circadian rhythm of locomotor activity 
expressed by rats using the ANIMEX activity monitoring system.
T=Treatment, Pre=Pre-treatment period, S=Saline, M=melatonin 1mg/kg,
Post=Post-t.reatment period.
Interval analysis: DD from day 1; values in parenthesis indicate
days used for spectral analysis.
Periodogram analysis: values indicate the fundamental and secondary 
periods of rhythmic activity. Visual estimate of periods are shown 
in parenthesis.
The actogram and derived periodogram functions are shown in Figs.
5.9a-5.9d and 5.10a-5.10d respectively.
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Animal T Interval Predominant Periods (h)
Analysed Secondaries Fundamental
(days)
5 Pre 10 (4-13) 3.50, 10.50, 12.25 24.00 (24.40)
M 10 (17-26) 3.00, 4.00, 6.00 23.75 (24.00)
Post 10 (29-38) 4.00, 4.50, 6.00 24.25 (24.10)
6 Animal withdrawn
7 Pre 10 (4-13) 3.50, 4.50, 12.25 24.50 (24.30)
M 10 (17-26) 4.00, 6.00, 12.00 23.75 (24.00)
Post 10 (29-38) 3.50, 4.75, 12.00 24.25 (24.30)
8 Pre 10 (4-13) 4.00, 4.50, 28.00 24.00 (24.20)
S 10 (17-26) 6.00 24.25 (24.20)
Post 10 (29-38) 4.00, 4.75, 12.25 24.25 (24.20)
9 Pre 10 (4-13) 1.75, 8.00, 21.00 24.00 (24.35)
M 10 (17-26) 12.50 , 15.25 , 27.50 23.25 (24.00)
Post 10 (29-38) 4.25, 12.00 24.00 (24.20)
10 Pre 10 (4-13) 12.50 , 21.25 24.25 (N/E)
S 10 (17-26) 13.50 23.75 (N/E)
Post 10 (29-38) 6.00, 8.00, 12.00 23.75 (N/E)
Table 5.2. Effect of melatonin on f ree-running circadian rhythm;
periodogram analysis of the circadian rhythm of locomotor activity 
expressed by rats using the PHOTOCELL activity monitoring system.
T=Treatment, Pre=Pre-treatment period, S=Saline, M=melatonin 1mg/kg, 
Post=Post-treatment period.
Interval analysis: DD from day 1; values in parenthesis indicate
days used for spectral analysis.
Periodogram analysis: values indicate the fundamental and secondary 
periods of rhythmic activity. Visual estimate of periods are shown 
in parenthesis (N/E=Not Estimated).
The actogram and derived periodogram functions are shown in Figs. 
5.9e-5.9j and 5.10e-5.10i respectively.
Fig. 5.10a. Effect of melatonin on free-running circadian rhythms
periodogram analysis of rat 1.
For actogram, see Fig. 5.9a.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: saline at 03:15 h, days 48-61.
a). DD days 37-46 (pre-treatment).
b). DD days 50-59 (during treatment).
c). DD days 62-71 (post-treatment).
Fig. 5.10b. Effect of melatonin on free-running circadian rhythms 
periodogram analysis of rat 2.
For actogram, see Fig. 5.9b.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: saline at 18:00 h, days 47-60.
a). DD days 37-46 (pre-treatment).
b). DD days 50-59 (during treatment).
c). DD days 62-71 (post-treatment).
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Fig. 5.10c. Effect of melatonin on free-running circadian rhythms
periodogram analysis of rat 3.
For actogram, see Fig. 5.9c.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: melatonin 1mg/kg at 18:00 h, days 47-60.
a). DD days 37-46 (pre-treatment).
b). DD days 50-59 (during treatment).
c). DD days 62-71 (post-treatment).
Fig. 5.10d. Effect of melatonin on free-running circadian rhythms 
periodogram analysis of rat 4.
For actogram, see Fig. 5.9d.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: melatonin 1mg/kg at 10:15 h, days 47-60.
a). DD days 37-46 (pre-treatment).
b). DD days 50-59 (during treatment).
c). DD days 62-71 (post-treatment).
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Fig. 5.10e. Effect of melatonin on free-running circadian rhythms
periodogram analysis of rat 5.
For actogram, see Fig. 5.9e.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: melatonin 1mg/kg at midnight, days 14-27.
a). DD days 4-13 (pre-treatment).
b). DD days 17-26 (during treatment).
c). DD days 29-38 (post-treatment).
Fig. 5.10f. Effect of melatonin on free-running circadian rhythms 
periodogram analysis of rat 7.
For actogram, see Fig. 5.9g.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: melatonin 1mg/kg at 21:30 h, days 14-27.
a). DD days 4-13 (pre-treatment).
b). DD days 17-26 (during treatment).
c). DD days 29-38 (post-treatment).
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Fig. 5.10g. Effect of melatonin on free-running circadian rhythms
periodogram analysis of rat 8.
For actogram, see Fig. 5.9h.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: saline at 10:00 h, days 14-27.
a). DD days 4-13 (pre-treatment).
b). DD days 17-26 (during treatment).
c). DD days 29-38 (post-treatment).
Fig. 5.10h. Effect of melatonin on free-running circadian rhythms 
periodogram analysis of rat 9.
For actogram, see Fig. 5.9i.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: melatonin 1mg/kg at 17:00 h, days 14-27.
a). DD days 4-13 (pre-treatment).
b). DD days 17-26 (during treatment).
c). DD days 29-38 (post-treatment).
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Fig. 5.10i. Effect of melatonin on free-running circadian rhythms
periodogram analysis of rat 10.
For actogram, see Fig. 5.9j.
Abscissa: Period length (h). Ordinate: Relative power (x103). 
Treatment: saline at 20:30 h, days 14-27.
a). DD days 4-13 (pre-treatment).
b). DD days 17-26 (during treatment).
c). DD days 29-38 (post-treatment).
For a summary of the derived periodogram function, see Table 5.2.
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Fig. 5.11a. Effect of melatonin on free-running circadian rhythms:
periodogram analysis of rats 1 and 2 using an extended interval.
For actograms, see Figs. 5.9a and 5.9b.
Abscissa: Period length (h). Ordinate: Relative power (x103).
Rat 1 Treatment: saline at 03:15 h, days 48-61.
Rat 2 Treatment: saline at 18:00 h, days 47-60.
a). Rat 1, DD days 25-44 (pre-treatment).
b). Rat 1, DD days 62-81 (post-treatment).
c). Rat 2, DD days 25-44 (pre-treatment).
d). Rat 2, DD days 62-81 (post-treatment).
Fig. 5.11b. Effect of melatonin on free-running circadian rhythms: 
periodogram analysis of rats 3 and 4 using an extended interval.
For actograms, see Figs. 5.9c and 5.9d.
Abscissa: Period length (h). Ordinate: Relative power (x103).
Rat 3 Treatment: melatonin 1 mg/kg at 18:00 h, days 48-61.
Rat 4 Treatment: melatonin 1mg/kg at 10:15 h, days 47-60.
a). Rat 3, DD days 25-44 (pre-treatment).
b). Rat 3, DD days 62-81 (post-treatment).
c). Rat 4, DD days 25-44 (pre-treatment).
d). Rat 4, DD days 62-81 (post-treatment).
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5.5.3. Experiment 3: Effect of melatonin on the phase-shifting
ability of light.
Actograms relating to this experiment are shown in Figs. 
5.12a-5.12h. A light pulse of 15 min given at CT12 on day 28 failed 
to effect the anticipated phase-delay of the free-running locomotor 
activity rhythm in 7 out of 8 animals. Four animals responded to the 
pulse with an apparent shortening of the free-running period. A 
phase-delay was obtained in one animal but sickness forced its 
withdrawal from the experiment (Fig. 5.12b). No further results were 
obtained in this series of experiments due to equipment failure.
Fig. 5.12a. Effect of melatonin on the phase-shifting ability of
light on free-running circadian rhythms: actogram of the circadian
rhythm of locomotor activity expressed by rat 1.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
DD from day 1
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Fig. 5.12b. Effect of melatonin on the phase-shifting ability of
light on free-running circadian rhythms: actogram of the circadian
rhythm of locomotor activity expressed by rat 2.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
DD from day 1
Treatment: 15 min light pulse at 13:00 h (CT12) given on day 28 
(animal withdrawn at beginning of day 42).
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Fig. 5.12c. Effect of melatonin on the phase-shifting ability of
light on free-running circadian rhythms: actogram of the circadian
rhythm of locomotor activity expressed by rat 3.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
DD from day 1
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Fig. 5.12d. Effect of melatonin on the phase-shifting ability of
light on free-running circadian rhythms: actogram of the circadian
rhythm of locomotor activity expressed by rat 4.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
DD from day 1
Treatment: 15 min light pulse at 16:00 h (CT12) given on day 28
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Fig. 5.12e. Effect of melatonin on the phase-shifting ability of
light on free-running circadian rhythms: actogram of the circadian
rhythm of locomotor activity expressed by rat 5.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
DD from day 1
Treatment: 15 min light pulse at 15:00 h (CT12) given on day 28
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Fig. 5.12f. Effect of melatonin on the phase-shifting ability of
light on free-running circadian rhythms: actogram of the circadian
rhythm of locomotor activity expressed by rat 6.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
DD from day 1
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Fig. 5.12g. Effect of melatonin on the phase-shifting ability of
light on free-running circadian rhythms: actogram of the circadian
rhythm of locomotor activity expressed by rat 7.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
DD from day 1














































Fig. 5.12h. Effect of melatonin on the phase-shifting ability of
light on free-running circadian rhythms: actogram of the circadian
rhythm of locomotor activity expressed by rat 8.
Solid blocks indicate where the activity counts per epoch (15 min) 
were equal to or greater than the daily median threshold printed to 
the right of the actogram.
DD from day 1
















































5.5.4. Experiment 4: Effect of melatonin on ELA.
Melatonin did not influence ELA in rats at doses up to 
50mg/kg at any of the time points investigated (see Fig. 5.13 and 
Table 5.3).
5.5.5. Experiment 5: Effect of melatonin on SLA.
Melatonin had no significant effect on SLA in rats at 
doses upto 10mg/kg at either of the two time points investigated 
(see Table 5.4). Melatonin (1mg/kg) also failed to affect the SLA of 
rats subjected to a 6 h phase advance of the light or a 6 h phase 
advance of the dark phase in comparison to saline-treated controls 
(see Fig. 5.14). It was noted from this work that the sudden change 
in environmental lighting conditions equilibrated the differing 
activity levels of MD and ML. Fig. 5.15 shows the melatonin and 
saline results from each ’’light" treatment (i.e. phase-shift or no 
phase-shift) combined.
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N Mean Counts 
in 10 min (+/-
vehicle 30 ML 5 153 (+/- 10.5)
0.1 30 ML 5 221 (+/- 28)
1 30 ML 6 175 (+/- 13.3)
10 30 ML 5 166 (+/- 30.6)
50 30 ML 5 131 (+/- 22.8)
vehicle 30 MD 6 176 (+/- 25.1)
0.1 30 MD 6 144 (+/- 10)
1 30 MD 6 149 (♦/- 29)
10 30 MD 6 185 (+/- 14.7)
50 30 MD 5 204 (+/- 34.3)
Table 5.4. Effect of melatonin on SLA in rats.
Melatonin Time-of-day N Mean Counts
Dose (mg/kg) in 2h (+/- s.e.m.
vehicle ML 5 78.8 (+/- 23.9)
1 ML 5 79.4 (+/- 22.5)










383.2 (+/- 84.1) 









Fig. 5.13. Effect of melatonin (lmg/kg) on exploratory locomotor activity in rats over 24 h.











































Fig. 5.14. Effect of melatonin (lmg/kg) on the spontaneous locomotor activity of the







a = saline at mid-light
b = melatonin at mid-light
c = saline at mid-light with a 6 h 
phase advance of the dark phase
d = melatonin at mid-light with a 6 h 
phase advance of the dark phase
e = saline at mid-dark
f = melatonin at mid-dark
g = saline at mid-dark with a 6 h
phase advance of the light phase
h = melatonin at mid-dark with a 6 h 
phase advance of the light phase
0
a b e d  e f g h
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Fig. 5.15. Effect of a 6-hr phase shift of the LD cycle on spontaneous locomotor
















a = activity at mid-light
b = activity after a 6 h phase 
advance of the dark phase
c = activity at mid-dark
d = activity after a 6 h phase
advance of the light phase
* p.< 0.05 (t-test)






The results generated by this series of experiments concur 
with previous published work on the effect of melatonin on the 
circadian rhythm of locomotor activity (e.g. Redman et al., 1983). 
Melatonin is unable to affect the rate or direction of re- 
entrainment of the locomotor activity circadian rhythm following a 
180° phase-shift of the LD cycle. The protocol used in assessing 
the effect of melatonin on the rate of entrainment depended on 
dosing the animals prior to the phase-shift at the end of their 
current activity phase (dark phase). Thus plasma levels of melatonin 
would have been approaching daytime (i.e. negligible) amounts. It 
was considered a reasonable hypothesis that a sudden unexpected peak 
of melatonin might condition the biological clock of the animal to 
adjust to levels more appropriate to dark-onset. The subsequent 12 h 
phase-advance of the scotoperiod meant that this time of injection 
corresponded to the onset of the dark phase. In retrospect this may 
not have been the most appropriate procedure to adopt. Assuming that 
the SCN of the hypothalamus is the loci of action for melatonin with 
regard to its effects on the expression of circadian rhythms, 
putative melatonin receptors in this region have been shown to 
undergo a circadian rhythm such that their density is greatest 
during the transition period from light to dark (Vanecek et al., 
1988) and least during the transition from dark to light. The 
reduction in receptor density during the latter half of the 
scotoperiod is thought to be initiated by melatonin itself (Reiter 
et al., 1978). This is thought to explain the effectiveness of late 
afternoon injections of melatonin in eliciting gonadal regression 
rather than at other times (Tamarkin et al., 1976; Glass and Lynch, 
1982; Vanecek et al., 1988). Despite no apparent change in binding
207
site affinity, an increase of receptor number would increase the 
sensitivity of the hypothalamus to the presence of melatonin. 
Therefore, although melatonin was given at the forthcoming sensitive 
stage of the melatonin receptor rhythm the timing of initial 
injections fell upon the least responsive stage. It is not known how 
long it takes for the circadian rhythm of melatonin receptor density 
to re-entrain to a new cycle. Presumably it might take as long as 
other physiological cycles, e.g. temperature, adrenocortical rhythm, 
in which case 14-21 days is often taken as a safe period to allow 
the establishment of equilibrium. Thus it is possible that the 
injections of melatonin were being given at the least appropriate 
time throughout the critical stage of the experiment. The 
assumption made at the beginning of the experiment was that the
presence of melatonin in the plasma at an atypical time would be
registered in some way by the organism thereby rendering it more or 
less adaptable to a phase-shift. This does not appear to have 
happened. The successful strategy adopted by Arendt and colleagues 
(Arendt et al., 1986) in their jet-lag experiments with human 
subjects involved synchronizing the pulse of exogenous melatonin to 
the responsive phase of the initial LD cycle and then changing the
time of injection to correspond to the new responsive phase. It is
possible that the exposure to exogenous melatonin caused a premature 
down-regulation of hypothalamic melatonin receptors. This induced a 
phase-advance of the following period of high melatonin receptor 
sensitivity leading to those physiological cycles driven by the 
hypothalamus to also shift. Interestingly, simulated jet-lag studies 
have reported less success using melatonin though the equivalence of 
phase-shifts using subject isolation techniques with genuine 
time-zone transition methods has been questioned (Wever et al.,
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1986; Arendt, 1988). The most difficult question to answer 
concerning jet-lag is whether or not the phase-advancing effects of 
melatonin are genuine reflections of the master oscillator. By 
monitoring several circadian parameters Arendt et al. (1987) 
endeavoured to circumvent this problem. They demonstrated more rapid 
re-entrainment of the adrenocortical rhythm and of the endogenous
melatonin rhythm itself in subjects given melatonin as opposed to
placebo (there is no evidence as yet to suppose that melatonin 
influences its own synthesis by an action other than indirectly 
through the circadian pacemaker). Additionally, results from 
psychological tests and sleep data suggested that these subjects 
adjusted more rapidly and endured less jet-lag symptoms from the 
shift than those that received placebo. This, however, may not 
necessarily be attributed to an effect on the pacemaker. The
phenomenon of masking may account for the results. This is said to 
occur when the true phase of a circadian cycle, as dictated by the 
actual phase of the pacemaker, is obscured by an action of 
endogenous or exogenous orign that affects the apparent
phase-position of the overt cycle but not the underlying 
oscillator-controlled rhythm. For example, locomotor activity (the 
visible rhythmic characteristic) can be suppressed by a sedative 
(e.g. haloperidol) and body temperature is affected by activity. 
Melatonin has been reported as having a suppressive effect on the 
adrenal glands and cortisol production (Vaughan et al., 1972; Ogle 
and Kitay, 1977; Relkin et al., 1983), though this is disputed since 
Waldhauser et al. (1984b) found that melatonin induced no response 
in human serum cortisol levels. This latter result may be more 
pertinent since the earlier studies used rodents. Melatonin also 
exhibits a sleep-promoting action which is believed to be a
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pharmacological rather than a physiological property though this has 
yet to be proven (see Leiberman and Lea, 1988). For practical 
purposes, however, "masking" may well be a phenomenon that can be 
ignored if melatonin improves the symptoms of the jet-lagged 
passenger without the induction of the "hangover" attributed to the 
benzodiazepine hypnotics that also evince phase-shifting properties, 
e.g. triazolam (Turek and Losee-Olson, 1986; Turek and Van Reeth, 
1988; Van Reeth and Turek, 1989a; Van Reeth and Turek, 1989b).
Unfortunately a comprehensive and systematic approach to 
the study of the effect of melatonin on entrainment has yet to be 
conducted. Several questions remain unanswered. For example, 
assuming that the effects of melatonin on jet-lag are the result of 
an action on the biological clock can melatonin only increase the 
rate of entrainment? Would continued treatment with melatonin at the 
old responsive time reduce the rate of entrainment? Would melatonin 
affect the rate of re-entrainment for a rhythm coupled to a 
zeitgeber other than light? And, ultimately, is melatonin affecting 
the "hands" or the "clock" mechanism of the master oscillator?
A further observation made in this series of experiments 
is that all animals answered the new phase position of the LD cycle 
by adjusting the onset of their activity period with sequential 
phase-delays until synchrony had been re-established. It is 
possible that the direction, in this situation which concerned a 
reversal of the LD cycle, had been dictated by the 24 h of darkness 
and the experiment is therefore worth repeating using 24 h of light 
to effect the 180° phase-shift.
Melatonin was shown to entrain a free-running locomotor 
activity rhythm if given at a time which coincided with the 
approximate onset of activity (CT12). To effect such a response
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melatonin essentially performed small phase-advances. Cessation of 
melatonin treatment tended to return the cycle to its previous 
free-running state. This did not occur in every case, however, and 
also one saline-treated rat appeared to entrain to the injection. 
The first set of results (see Figs. 5.9a-5.9d, corresponding to rats 
1-4) were generated using equipment far more sensitive to activity 
than the second set which used light beam breakages (Figs. 
5.9e-5.9j, corresponding to rats 5-10). This sensitivity is clearly 
demonstrated by comparison of the median levels of each day's 
activity printed on the right of the actogram. Due to this change in 
activity recording equipment, comparison of the total daily activity 
between melatonin and saline-treated animals cannot be made. The 
first set of data is difficult to evaluate because entrainment has
persisted following the last injection of drug or placebo in two of 
the animals (rats 1-4). Some unidentified environmental factor is 
probably responsible for this effect. In the entrained state the 
epocrepuscular nature of the animals appears to be accentuated, 
which may be partly due to an extended period of activity in
comparison to the rest phase. It may also be explained by a
differential effect on the "morning" and "evening" oscillators of 
Pittendrigh and Daan's "dual oscillator" hypothesis for the 
physiological control of circadian rhythms (Pittendrigh and Daan, 
1976). The clear free-running rhythm expressed by the rat in Fig. 
5.9a demonstrates the potential source of confusion resulting from 
stress-induced activity which occurs upon the administration of the 
drug and the return of the animal to its cage. Both the onset and 
offset of the activity phase should be monitored for a more
reliable picture with regards to the effect of a given treatment. 
Complicating the proceedings further is the suggestion by Armstrong
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(1989) that, because of the "narrow window of sensitivity" in the 
circadian phase of the pacemaker during which melatonin can act as a 
zeitgeber, if the free-running period is too great entrainment may 
not occur.
The low level of data generated by the second set of
animals (see daily median values of Figs. 5.9e-5.9j) ruled out the 
use of daily activity plots as a means of analysing the onset and 
offset of activity. This also had an adverse effect on the
resolution and accuracy of the periodogram (compare Figs. 5.10a-
5.10d with Figs. 5.10e-5.10i). Inspection of the actograms reveals
that at least one animal entrained both the onset and the offset of
its activity cycle to melatonin treatment (see Fig. 5.9e). However, 
its free-running period post-treatment appears to be much reduced 
in comparison to its period prior to the administration of 
melatonin. The periodogram estimates the period for days 4-13 (pre­
melatonin treatment) as being 24 hrs, for days 17-26 (during
melatonin treatment) it is 23.75 hrs and for days 29-38 (post­
melatonin treatment) it is recorded as 24.25 hrs. Additionally, the 
graphs depicting the fundamental period and its harmonics are
clearly less well resolved in comparison to those referring to the
earlier set of entrainment experiments (note scale on ordinate axis
of Figs. 5.10a-5.10d and Fig. 5.10e). It would appear that,
comparing visual inspection of actogram data and periodogram
analysis, the latter technique tends to underestimate the apparent 
period. Figs. 5.11a and 5.11b and Table 5.1 depict the period 
derived from periodogram analysis using a twenty day interval. This 
could only be obtained before and after treatment for rats 1 to 4 
since the time schedule of the subsequent experiment was not long 
enough. A more reliable approximation of the period is obtained with
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improved resolution of the fundamental. However, over the same time 
intervals, there remains some discrepancy between the periodogram 
calculated estimate of the period and that obtained by simply 
drawing an eye-fitted line on the actogram that approximates 
successive onset of activity times and measuring the gradient (see 
Tables 5.1 and 5.2).
An additional problem which concerns the reliability of 
the data generated by animals 5-10 is the emergence of "foreign 
counts”. These are most clear on Fig. 5.9f since the animal was 
actually withdrawn from the experiment at the end of day 23. Thus no 
activity should have been registered. Interference from an unknown 
electrical source probably accounts for the thin vertical lines 
prominent in Figs. 5.9e, 5.9g, 5.9h, 5.9i, and 5.9j. In these
figures the trend of locomotor activity is still clearly discernible 
but the severity of the malfunction increased during the subsequent 
experiment designed to investigate the effect of melatonin on a 
light-induced phase-shift of the circadian rhythm in locomotor 
activity. Figs. 5.12a to 5.12c and 5.12e to 5.12h which relate to 
this experiment show thick vertical bands of putative activity. This 
problem remained insuperable despite the dismantling and rebuilding 
of the equipment, and changing the interior design of the 
environmental cabinets which allowed the photoreceivers and 
phototransmitters to be mounted closer together (a means of 
increasing the signal-to-noise ratio). A current dampener was also 
employed on the power lines to the computer and interface to no 
avail. Despite this it is possible to distinguish trends in the 
activity profile of a particular animal using the actogram. When 
given a 15 min light pulse at CT12 on day 28 of the experiment only 
one animal appears to have responded with the expected phase-delay
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(see Fig. 3) which actually manifested as a series of phase-delays; 
subsequent ill-health forced its early withdrawal. The responses 
made by the rest, that can be reasonably distinguished, were a 
shortening of the free-running period even to the extent that it 
became, in at least two cases (Figs. j and k), shorter than 24 h (as 
shown by an actogram with an onset of activity time gradient running 
right to left). Reasons for the dichotomous nature of the results
following identical treatment is not clear. It is known that the 
shape of a light-induced PRC is a function of the period which
varies between individual animals (Daan and Pittendrigh, 1976).
There is also variation of the shape of the PRC according to the
species under study (Honma et al., 1978; Daan and Pittendrigh, 
1976). However, a single light pulse used to elicit a phase-shift 
should not also evoke a lasting change in period. Following recovery 
from the shift the original period should have been restored.
Time restrictions, caused by endeavours to overcome the 
problem of Mcross-talkingM (counts recorded by the breakage of one 
light beam being registered by the computer as if two or more beams 
had been broken) and the registering of foreign counts, was a major 
limiting factor in this experiment. Eventually only one time point 
could be chosen for investigation. CT12 is on the borderline of the 
subjective day in a nocturnal rodent such as the rat. This point 
also corresponds to a phase position that is most receptive to a 
pulse of melatonin and follows soon after the "dead zone" of 
responsiveness to light (Daan and Pittendrigh, 1976). However, using 
a phase point more responsive to light would have been to risk 
losing the sensitivity to melatonin if it was to possess an 
observable effect. Clearly a comprehensive answer to the original 
question of whether melatonin can influence a light-induced
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phase-shift requires more time and equipment less subject to 
spurious counts. Ideal conditions would have allowed the 
construction of a 15 min light pulse-induced PRC followed by its 
repeat using bolus doses of melatonin/placebo as pretreatment.
Exploratory locomotor activity was not affected by 
melatonin and did not exhibit a circadian rhythm. Exploration is a 
fundamental aspect of animal behaviour and is described by Silverman 
(1978) as ’’information-seeking independent of associated motor 
activity”. The strength of motivation in assessing a novel 
environment for food and drink sources, danger and escape routes 
provides enough impetus to override or bypass any dampening effect 
on locomotor activity the biological clock might exert. This is 
borne out when a comparison with spontaneous locomotor activity is 
made. Although only two time points were investigated there is a 
clear difference between the level of locomotor activity expressed 
at ML in comparison to MD. The lack of effect of melatonin in both 
paradigms would suggest that it not only exerts no influence on 
locomotor activity at the time points investigated but also that it 
lacks influence on exploratory drive, though further verification 
with regard to this behavioural parameter was beyond the scope of 
this thesis.
The most striking result obtained during the investigation 
of short-term locomotor activity was the influence that a 6 h 
phase-advance of the light or dark phase had on SLA. Either 
treatment resulted in an equilibration of activity, regardless of 
whether the animals received saline or melatonin. Thus light 
suppressed activity and darkness evoked activity though not to the 
extremes that would be expected according to the appropriate phase. 
This reaction is most likely to be a consequence of adaptive
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behaviour rather than a direct action on the biological pacemaker. 
For example, using an anthropomorphic analogy, a well-known lighted 
environment becomes almost novel to a human suddenly plunged into 
darkness and would suppress activity until acclimatization to the 
surroundings had been achieved. Rats are known to favour a dark 
environment to a well-lit one. It might therefore be expected for a 
rat to explore the vicinity after extinguishing the lights which 
would be detected as ELA rather than SLA. Conversely, rat locomotor 
activity would be suppressed following the sudden illumination of a 
darkened cage. The result highlights the problem in correctly 
evaluating the origin of an overt behavioural response elicited 
when, in this instance under entrained conditions, a sudden change 
in the environmental conditions is imposed. Analysis of the pattern 
of locomotor activity using actograms may fail to reveal a simple 
direct effect on animal behaviour rather than on the underlying 
circadian rhythm. However, it should be said that this change in 
behaviour may itself subsequently affect the major oscillator. For 
example, Van Reeth and Turek (1989a) found that by forcibly 
restricting the activity of hamsters the phase-shifting ability of 
dark pulses and the benzodiazepine, triazolam, can be inhibited. The 
conclusion, though, that their results bring into question the 
current hypotheses, that dark pulses and certain drugs influence the 
neural pathways that mediate environmental LD information, may be 
rather parochial. It is more probable that a variety of systems of 






Light is acknowledged as the most important zeitgeber of 
circadian rhythms in mammals. The relationship of light to 
melatonin secretion was first established by the work of Wurtman et 
al. (1963, 1964). Constant light (LL) suppresses melatonin synthesis 
and hence the rhythm, though the extent of suppression varies 
according to the intensity of light employed and the species 
concerned (Lewy et al., 1980; Reiter, 1985). The rhythmic production 
of melatonin persists in constant darkness (Ralph et al., 1971), 
indicating its authenticity as a circadian rhythm. Short pulses of 
light of appropriate intensity can phase-advance or phase-delay 
melatonin production according to the time of the pulse in relation 
to the phase of the LD cycle (Czeisler et al., 1986; Broadway et 
al., 1987; Lewy et al., 1987). Melatonin itself has been shown to 
induce phase-advances of nocturnal melatonin secretion if given 
towards the end of the normal light phase (Arendt et al., 1985). The 
LD cycle has a third effect on the rhythm of melatonin production. 
As day-length increases, the duration of the melatonin signal is 
reduced (see Rollagond Niswender, 1976), i.e. melatonin secretion 
exhibits photoperiodism, the implications of which have been 
discussed in chapter 1. To briefly recapitulate, precisely-timed 
manipulation of plasma melatonin levels can elicit short-day (i.e. 
winter) appropriate responses in susceptible species when the 
environmental LD cycle directs otherwise. Such responses can be in 
the form of advancing the oestrus cycle in short-day breeders (e.g. 
ewes) or inducing winter coat growth in mink. The essential feature 
of these responses is that the biological processes controlling them
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under normal circumstances have been deceived, by the presence of 
melatonin, into behaving in a manner inappropriate to external 
conditions. This interpretation can be applied to the work of Redman 
et al. (1983) who demonstrated the ability of exogenous melatonin to 
entrain free-running locomotor activity rhythms of rats. The time of 
activity onset of the animals studied by Redman and co-workers 
occurred slightly later each day (indicating a period greater than 
24 h). However, when the injection of melatonin coincided with this 
time entrainment took place. The implication of this is that the 
presence of melatonin, or the rapid rise of melatonin plasma levels, 
indicated to the rodents the onset of subjective night. Earlier work 
by Gwinner and Benzinger (1978) showed that pinealectomized European 
starlings, normally diurnally active, synchronized their activity 
rhythms after melatonin injection at the end of their active phase. 
The capacity for melatonin to elicit what would appear to be a 
general co-ordinating signal for circadian rhythms initiated the 
following investigation into the degree of awareness that the animal 
had of this effect. This question has already been partially 
addressed in the previous chapters, but it was thought that a more 
direct approach might yield more promising results. In essence, the 
hypothesis which the investigation hoped to prove or disprove was 
whether melatonin, as the "darkness hormone", might change 
light-appropriate behaviour into dark-appropriate behaviour.
Animal behaviour can be split chronologically into two 
fundamental components - that which is expressed during the dark 
phase and that expressed during the light phase of a LD cycle, e.g. 
rats are active and consume most of their 24 h input of food and 
drink in the scotoperiod while rest is confined to the light phase. 
For diurnal animals the reverse is true. If melatonin caused animals
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to express behaviour normally associated with darkness then it would 
be expected to increase spontaneous activity and food consumption in 
the light phase. Additionally, since the number of headtwitches 
induced by certain serotonergic agonists is maximal at ML, 
pretreatment with melatonin might be expected to reduce that number 
to a level associated with MD. The results from experiments 
conducted in the preceding chapters (3 and 5) indicate that 
melatonin elicits no such effect. This may be due to the 
insensitivity of target receptors for melatonin which would appear 
to be responsive only at the end of the light phase (Reiter, 1983b, 
Armstrong, 1989; Zisapel et al, 1988). However, it can be argued 
that the type of behaviours being investigated in these experiments 
is not suitable for resolving the hypothesis. For example, 
mCPP-induced hypoactivity in rodents has been interpreted as not 
being due to a direct action on the biological clock but rather 
derived from an action on 5-HTic receptors (Kennett and Curzon, 
1988a). 8-OHDPAT-induced hyperphagia is attributed to an effect on 
central (Hutson et al., 1986; Bendotti and Saminin, 1986) and, 
possibly, peripheral (Sleight et al., 1988) serotonergic components 
of the feeding mechanism. It must be said, though, that these 
compounds have yet to be subjected to long-term studies to 
investigate potential effects on the circadian rhythms of locomotor 
activity and feeding.
It was considered that drug discrimination might prove a 
more suitable behavioural technique to investigate whether melatonin 
can affect an animal's interpretation of an exteroceptive stimulus. 
Data previously obtained from the drug discrimination studies 
described in chapter 3 suggest that melatonin, on its own, fails to 
affect cognition. However, it seemed possible that animals trained
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to discriminate the exteroceptive stimuli of light and dark, in 
certain circumstances might be prompted to make a dark-appropriate 
response if given melatonin during a ’’light" session. The use of 
exteroceptive stimuli precedes drug-induced interoceptive cues in 
discrimination experiments though this area tends to concentrate on 
pattern and colour recognition. More recently Jarbe and co-workers 
have initiated a series of studies investigating the interaction 
between drug discriminative stimuli and exteroceptive sensory 
signals (Jarbe et al., 1981; Jarbe et al., 1983; Jarbe and 
Johansson, 1984). These experiments, however, examined the effects 
of pairing exteroceptive stimuli with drug cues during training. 
Jarbe and Johansson (1984), for instance, were able to show that the 
exteroceptive stimuli of light and dark provided a stronger 
discriminative cue than 10rag/kg of pentobarbital. Thus animals were 
trained to respond on one lever in the presence of light and drug 
and on the other lever in the presence of dark and saline. Under 
test conditions of dark and drug or light and saline the subjects 
chose the lever appropriate to the external evironmental conditions. 
Sound (in the form of a low and high frequency tone), paired with 
10mg/kg of pentobarbital, had no ability to influence the 
interoceptive stimulus provided by the drug. Closer to the 
experimental work described in this chapter, and independent of 
Jarbe, Koek and Slangen (1984) reported the effects of various 
centrally-active agents on the discriminative ability of rats using 
visual and tactile stimuli. In this study training was characterized 
by a grid or wooden floor being paired with an illuminated or 
darkened conditioning chamber. Drugs were then administered to 
examine their effects on accurate responding. Cross-testing between 
the external stimuli was also carried out, i.e. an animal trained to
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differentiate between an illuminated chamber paired with a wooden 
floor from a darkened chamber paired with a grid floor was tested in 
a darkened chamber with a wooden floor. The results suggested that 
in this situation individual component stimuli controlled responding 
equally in most rats of the group.
6.2. Materials and Methods
6.2.1. Drugs
Melatonin (Sigma), 1mg/kg, was dissolved in normal saline 
by sonication. Melatonin, 10mg/kg, was suspended in 0.1% w/w 
tragacanth in normal saline. Control animals were given vehicle. All 
injections were given i.p. using a dose volume of 5ml/kg.
6.2.2. Apparatus
Standard operant conditioning chambers containing two 
levers were used (Campden instruments). Liquid food (0.02ml, 1:1 
sweetened condensed milk:water) was delivered via a motorized dipper 
from a food reservoir located below (see Fig. 4.1, chapter 4). The 
reinforcement delivery chamber was situated midway between the 
levers. Presentation of the food and recording of behavioural 
responses was achieved using a BBC Master computer and software 
designed and written by the author (for details see Appendix). 
Control of the lighting within the interior of the Skinner box was 
achieved by the construction of wooden lighting cabinets (see Fig.
6.1) which fitted snugly in front of the opening to the Skinner box 
chambers. An 11W fluorescent bulb was used as a source of white 
light which provided 600 lux as measured in the operant conditioning 
chamber. Light intensity within the chamber when the fluorescent 
bulb of the lighting cabinet was off and the experimental room light 
on was <1 lux.





8 Male Wistar rats (Animal House, University of Bath 
strain) matched for age and weighing between 150 and 200g at the 
start of the study were housed in groups of 4 in standard plastic 
cages (520 x 350 x 170mm). The animals were maintained on a 12:12 LD 
cycle (lights on 05:00 h) with light intensity during the
photoperiod being 2001ux (measured at cage height; Macam
Photometries Ltd., Radiometer/Photometer R101). Dim red light (<1 
lux, measured at cage height) was provided during the dark phase. 
Water was provided ad libitum and food was made available according 
to the requirements of the experiment with at least one continuous 
hour of feeding provided provided in any 24 h period. Animals were 
examined daily for signs of ill-health and their weight was
monitored weekly.
6.2.4. Training Procedure
Rats were gradually acclimatized to a restricted diet
schedule which initially comprised a 2 h food presentation 
immediately following their training session. Once lever-pressing 
had been established (using continuous reinforcement training 
conditions during the light phase), training sessions lasting 15 min 
were introduced. The criterion for reward was gradually increased 
until the animals were responding satisfactorily on a FR20 schedule. 
At this point light-dark discrimination training began in earnest 
with each session limited to 15 min, the provision of food being 
dictated by the training schedule. In order to overcome the possible 
cue properties of an aversive i.p. injection given during future 
experimental sessions, rats were pretreated with saline, i.p., 30 
min before the start of a training session.
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Clearly, animals could not simply be trained to
discriminate between light and dark per se since this does not take
into account the change in behaviour associated with the change in 
phase from light to dark. The difference in behaviour expressed 
during the dark phase and the light phase was considered to be as 
important as the environmental stimulus in determining the 
discriminative cue. Therefore, training sessions were designed to 
accommodate the time of day. Due to the ease of use and the greater 
wealth of data that it yields the Skinner box paradigm was chosen as 
the technique for conducting this experiment (for a diagram of this 
apparatus see chapter 4, Fig. 4.1). A 12:12 LD cycle (with the 
lights on time of 05:00 h) was chosen so that training sessions 
could be conducted at any time between 09:00 h and 01:00 h. Thus in 
any given 24 h cycle there were 8 h of light followed by 8 h of dark 
during which training sessions could be carried out. The same 
randomized sequence of training sessions used for the drug 
discrimination experiments was employed in this study. To avoid 
light and dark becoming the dominant discriminative stimuli the 
number of training sessions performed during any 16 h period varied 
between one and three up to a maximum of two in a row in any
particular phase. That is, during one 24 h cycle there might be two
’’light1’ training sessions followed by one ’’dark” training session, 
while on a subsequent day there may be only one "dark” training 
session. Animals were usually fed immediately after the last 
training session of the day unless a "light" training session was 
planned for the following day. In this instance, food was withheld 
until after that session. As expected, rats quickly learnt to feed 
as soon as nourishment was provided. It was also found that food 
given before midday did not affect a "dark" training session. One
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rat was forced to be withdrawn during the course of the study 
through ill-health but subsequent recovery allowed it to be 
reinstated following re-training.
Positional preferences were controlled for by training 
half the animals to press on the right lever in response to darkness 
and the other half the left lever. To prevent odour cues from 
influencing choice the levers were wiped with alcohol prior to each 
session with an animal (Extance and Goudie, 1981). The threshold for 
criterion, when animals could be used for experiments, was set at 
80%, that is 8 correct choices in 10 consecutive sessions.
6.2.5. Experimental Procedure
Training sessions were conducted on weekdays until a 
satisfactory response rate had been attained. Experimental sessions 
were then introduced and performed on Tuesdays and Fridays with the 
remainder of the week reserved for continued training. Experimental 
sessions were 5 min long during which either lever if pressed 20 
times would provide reinforcement. The first lever to receive 20 
presses was designated the chosen lever and became the reinforcement 
lever. Further responses on the other lever were recorded but had no 
programmed consequences. If the performance of a rat dropped below 
the criterion level during training it was not used in experiments 
until the appropriate standard had returned. To prevent animals 
being able to differentiate between experimental and training 
sessions, after each experimental session subjects were placed in a 
"neutral" plastic cage for the 10 min remaining of the 15 min 
associated with a training session rather than being directly 
returned to the home environment.
The first series of experiments involved animals being
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given melatonin (0, 1, or 10mg/kg) 30 min before a test session,
which lasted 60 min.These sessions were timed to begin 60 min before 
the ML, EOL, MD and EOD phases of the LD cycle. The lighting 
conditions in the operant conditioning chamber corresponded to the 
appropriate time. In the second series of experiments melatonin (0, 
1 or 10mg/kg) was administered to the animals again 30 min before 
the start of a test session which was conducted at ML or MD but this 
time the lighting conditions in the experimental chamber were 
reversed. Thus, an animal taken from the home cage at ML was placed 
in a darkened experimental chamber. This, in essence, was a 
"temporary'1 6 h phase advance of the dark phase. The final series of 
experiments involved pretreating the animals with 30 min of the 
opposite environmental condition to what time dictated in addition 
to receiving saline or melatonin (1mg/kg) before being placed in the 
chamber which continued this condition. Thus an animal taken from 
the home cage at MD was put into a standard plastic cage (420 x 260 
x 150mm) housed in an environmental cabinet (see chapter 5, Fig.
5.1) and given 30 min of light (850 lux) before being tested in the 
illuminated operant conditioning chamber. Animals used at ML were 
given the opposite treatment. The experimental room was maintained 
according to the normal LD schedule such that immediately after an 
experimental session the rat was returned to its pre-experimental 
light or dark phase. At least 72 h separated experimental sessions 
involving a change in phase.
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6.3. Data Analysis
Discrimination during training was expressed as a 
percentage of correct choices in 5 consecutive sessions. Three
parameters were used as measures of performance during training
sessions: the FRF value (ratio of correct lever presses against
incorrect lever presses until the FR number is reached on the
reinforcement lever expressed as a percentage of the total), the 
response latency (time taken to gain the first reinforcement), and 
the response rate (rate of correct lever presses after the first 
reinforcement until the end of the session). These parameters were 
only used if an animal had pressed a lever a sufficient number of 
times to gain at least one reinforcement. For training sessions the 
response rate parameter and the FRF value have been represented as 
the mean of 5 consecutive sessions from those rats that pressed the 
lever sufficiently to gain at least one reinforcement. During lever 
press training it was found that some animals tended to press the 
levers almost as soon as they were put into the chamber. It was 
therefore decided to record the response latency from one group of 
rats in one session and the other in the next session which shared 
the same environmental stimulus. The animal from the group whose 
response latency factor was to be measured was put into its chamber 
first and the timer started immediately afterwards. The second rat 
was then put into the other chamber and its response latency 
characteristic ignored. This has been expressed graphically as the 
mean of two successive sessions of the same environmental treatment. 
During test sessions only the time-appropriate FRF characteristic 
and the response rate were considered and have been expressed as the 
mean value for each experimental session.
227
6.4. Results
6.4.1. Acquisition of the light/dark discriminative stimulus
The high rate of acquisition of the light/dark cue can be 
seen in Figs. 6.2 and 6.3, the mean number of sessions to reach 
criterion being 22.5 (+/- 6.1 s.e.m.). However, there followed soon 
after a period of below par performance when not enough animals 
remained at criterion for experiments to be conducted. This raised 
the mean number of sessions to criterion to 31.25 (+/- 8.3 s.e.m.).
6.4.2. Effect of light and dark training sessions on performance
Response rates during both light and dark periods showed a 
gradual increase as training progressed with initially a higher rate 
apparent in the dark phase of the LD cycle. This is depicted in Fig. 
6.4 which also shows, in the form of the FRF value, that the quality 
of responding was similar regardless of the time of the training 
session and increased as training progressed. Similarly, the 
response latency parameter, portrayed in Fig. 6.5, was not found to 
be affected by the lighting/temporal conditions during training.
6.4.3. Effect of melatonin on time-of-day appropriate responding
Melatonin was not found to affect the response rate or the 
accuracy of responding as measured by the proportion of rats 
choosing the time-appropriate lever at any of the four time points 
over the LD cycle investigated (see Figs. 6.6 and 6.7, 
respectively). The "confidence" characteristic, the time-appropriate 
FRF value also did not reveal any drug-induced change (see Fig.
6.8). However, the accuracy of animals responding at the EOL stage 
experiment, which finished before the lights actually went out, was 
found to be significantly reduced compared to the accuracy of the
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animals during experiments conducted at the other four time points 
(generalized linear regression with binomial error; chi-squared=
24.05, DF=3).
6.4.4. Effect of melatonin on time-of-day appropriate responding 
with conflicting environmental cue.
Once again, melatonin was found to be without significant 
effect on the rate, accuracy and confidence of responding in either 
those rats given the change in lighting in the experimental chamber 
or those that were pretreated with the appropriate lighting 
condition (see Figs. 6.9, 6.10, 6.11, respectively). The
time-of-day factor was found to be significantly different with 
respect to the response rate parameter between experiments 
conducted in light environmental conditions at MD in comparison to 
those conducted at ML under darkness (one-way ANOVA; p<0.01, 
F=12.3, DF=1, 34). Pre-treatment with the appropriate lighting
condition for 30 min equilibrated the response rates (see Fig.
6.9). The proportion of animals selecting the time-appropriate 
treatment at MD and ML approached 100%. Reversing the lighting 
conditions in the experimental chamber had the effect of reducing 
the proportion of animals choosing the time-appropriate lever 
regardless of the time-of-day. Although this proportion increased 
further when animals were previously exposed to 30 min of light or 
dark (according to whether the experiment was conducted at MD or ML 
respectively) at least two animals of the seven in each treatment 














Fig. 6.2. Training curve to light-dark discrimination. (n=7-8).























































Fig. 6.4. Comparison of FRF values between light and dark training days and comparison of response rate 
parameter between light and dark training days. Open circles = FRF value light training days, 
closed circles = FRF value dark training days; open squares = response rate parameter light 
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Fig. 6.5. Comparison of response latency times between light and 4ay-training sessions. 
(Values represent means of 6-8 rats).


























Fig. 6.6. Effect of melatonin on mean response rates (lever press/min) for experiments conducted over







S = Saline 
Ml = Melatonin lmg/kg
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Fig. 6.7. Effect of melatonin on lever choice for experiments conducted at four time points
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Fig. 6.8. Effect of melatonin on the FRF value for experiments conducted over four time points
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Fig. 6.9. Effect of melatonin on mean response rates (lever presses/min) for experiments using





















Ml = Melatonin lmg/kg
M10 = Melatonin lOmg/kg
D-ML = Dark at mid-light (ML)
L-MD = Light at mid-dark (MD)
£D-ML = 30 mins dark treatment at ML




















Fig. 6.10. Effect of melatonin on lever choice for experiments using a conflict of visual





























































This series of experiments were prompted by the thought 
that although melatonin might alter the cognitive state of a rat to 
that more appropriate to the dark phase of the LD cycle, this was 
not a sufficient aberration of normality to be recognized in the 
form of a discriminative cue by the animal. Since melatonin failed 
to increase the proportion of subjects pressing the night- 
appropriate lever in any of the experiments it can be concluded from 
this work that melatonin does not act as a darkness-related 
stimulus, at least using this model in the nocturnally active rat. 
However, certain properties of discriminative behaviour have been 
revealed. The animals were trained essentially to discriminate a 
temporal/visual complex cue in a manner analogous to that of the 
tactile/visual complex cue of Koek and Slangen (1984). When the two 
components of the discriminative stimulus are presented in conflict 
with one another to individual animals it is clear that one 
component takes precedence over the other. If the two stimuli are of 
equivalent discriminative strength then during conflict experimental 
sessions one might expect an even split between the two components 
according to which was perceived as dominant at the time. This would 
appear to be the case in the experiments described above (see Fig.
6.10) moreover, most animals shifted their responding between the 
visual and the temporal stimuli as the study progressed. Neither 
stimulus assumed complete dominance in an animal such that it 
responded purely according to the prevailing temporal or 
environmental conditions in every experiment. An alternative 
explanation for this dichotomous responding is that the cues given 
in conflict with one another may simply disrupt normal behaviour 
such that random responding ensues (Koek and Slangen, 1984; Jarbe
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and Swedberg, 1982).
The problem in this instance is whether or not the 
subjects have been trained to discriminate the night/activity-time 
of the 24 h cycle from the day/rest-time of the cycle. That a 
significant proportion of the group responded according to the 
time-of-day rather than the environmental cue when the two component 
stimuli were given in conflict indicates that temporal parameters 
were being distinguished from the visual stimulus and that the 
subjects were not simply reacting to the presence or absence of 
light. Additionally, the temporal cue proved remarkably resilient in 
certain individual animals when the group were subjected to 30 min 
of the visual stimuli before the experimental session. (In future 
experiments it would be worthwhile to see whether a dose-response 
curve to this factor could be constructed). It seems likely, 
therefore, that the animals were trained to a temporal component of 
the compound stimuli. Less clear is whether that cue corresponded to 
the nocturnal state of the animal rather than some internal 
cognitive time-keeper analogous to that responsible for measuring 
time-dependent schedules in more complex operant conditioning 
procedures and, ultimately, whether or not this aspect of the cue is 
actually separate from the nocturnal state of the subject. Within 
the framework of time measurement might lie the route for an animal 
to be trained to discriminate between melatonin and saline.
Circadian rhythms and photoperiodism can be viewed as 
forms of vegetative time-measurement (see Herbert, 1989), that is 
the internal analysis of time lies beneath the consciousness of the 
animal which under the influence of external environmental stimuli 
can be very accurate. The other means of measuring time in the brain 
is termed cognitive time-measurement which is concerned with the
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internal perception of the passage of time and has an accuracy more 
vulnurable to variability between individual subjects. It would seem 
probable that cognitive time measurement has the ability to exploit 
information derived from the vegetative clock (Herbert, 1989). 
Melatonin is concerned with vegetative time measurement - as 
demonstrated by its effects on photoperiodism and circadian rhythms. 
It is not yet clear whether the duration of the night-time melatonin 
signal or its presence in the plasma at a critical concentration 
coincident with a sensitive period of target organs is responsible
for its action (see Reiter, 1987). (It might well turn out to be a
combination of both hypotheses). As mentioned above, a 
discriminative cue to melatonin might not actually be derived from 
the direct effect of melatonin on cognition but rather its effect on 
vegetative time-measurement in communication with cognitive
time-measurement. Melatonin was given in all experiments as a
pulse, rather than a sustained infusion. This was because melatonin 
entrained free-running locomotor activity rhythms when the time of 
injection coincided with the onset of activity (Redman et al., 1983; 
chapter 5, this thesis). It has been presumed that the melatonin
pulse acting on some sensitive region of the brain, probably the
SCN, is responsible for eliciting entrainment (Cassone et al., 
1986b). The fact that endogenous melatonin subsequently reaches high 
plasma levels (in comparison to day-time levels) may have been 
ignored as a factor in this entrainment. This question has been 
indirectly addressed by Chesworth et al. (1987) who subjected
rodents to LL which subsequently demonstrated free-running or 
disrupted wheel-running and drinking circadian rhythms. Daily
melatonin injections led to partial synchronization but not 
entrainment of free-running rhythms. Chesworth et al. used light
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250 and 300 lux which should be sufficient to suppress partially the 
subjective night-time levels of melatonin in nocturnally-active 
rats, although no biochemical details were given in the paper. The 
question raised, therefore is whether sustained release of 
melatonin into the plasma over 8-12 h would elicit a greater degree 
of synchronization and perhaps entrainment? This, in turn, leads to 
the questions concerning the ability of melatonin to act as a 
discriminative cue. Would animals subjected to LL, sufficient to 
suppress melatonin secretion, be able to differentiate injections of 
melatonin from saline? Would animals maintained in DD be able to 
differentiate melatonin from saline? The complication that regular 
training sessions might elicit entrainment could be overcome if 
training times and food availability were randomized over the 
activity and rest periods of the subjects (if a shock escape 
discrimination paradigm was used food could be made available ad 
libitum). This could be more easily achieved if locomotor activity 
was monitored. An alternative strategy, which is more dependent on 
the vegetative time-measurement mechanism, might be to administer 
either melatonin or saline as a 12 h s.c. infusion and subject the 
animals, maintained in LL, to randomized training sessions.
A further consideration is that exteroceptive and 
interoceptive cues might elicit discrimination via different 
mechanisms. A psychoactive drug acts upon a particular 
neurotransmitter system, at least initially, ultimately to elicit a 
perceptual change in the animal's internal awareness. This may take 
the form of drowsiness which can make hypnotic drugs like the 
barbiturates and the benzodiazepines difficult for the animal to 
differentiate. Alternatively, the cue can be specific for a 
particular neurotransmitter system, or even a receptor. Thus, an
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agent specific for the serotonergic system, that acts as a 
discriminative stimulus, generates an internal state perceptually 
different to that generated by an agent specific for, say, the 
cholinergic system. This can be shown by training animals to 
discriminate between two drugs (i.e. a drug vs. drug study, rather 
than drug vs. saline) or using a cholinergic drug as a test compound 
having first trained a group of rats to discriminate between a 
serotonergic compound and saline. Distinguishing between cues 
generated by the activation (or inhibition) of a particular receptor
requires the use of antagonism studies and agents with a high
specificity of action but such studies can enable the drug 
discrimination technique to make a significant contribution to 
receptor subtype classification (see Stolerman et al., 1987). Unless 
a compound actually disrupts the process of responding, Overton
(1966) suggests that an animal trained using a compound specific for 
one neurotransmitter system or receptor is most likely to reply with 
saline-appropriate responding if tested with a drug specific for 
another system or receptor. The same author also propounds that 
totally random responding during test sessions might reflect a test 
state that resembles neither training state (Overton, 1966).
Disrupted behaviour is usually reflected by non-responding or 
occasionally by intermediate results (Jarbe and Swedberg, 1982). The 
discrimination of non-aversive exteroceptive stimuli does not depend 
upon the generation of any disruptive internal signal. In this 
instance it can be quite specific; e.g. different types of tactile, 
visual and sound cues can be distinguished (Jarbe and Johansson, 
1984; Koek and Slangen, 1984). In order for discrimination to take 
place there must be some kind of internal process of interpretation 
to select the correct response. This process must be based on two
244
guiding aspects of behaviour - perception and memory - a cue must be 
perceived and recognized. It may be that distinction between 
exteroceptive stimuli depends on the activation of highly specific 
systems of the brain whereas drugs, unless deliberately targeted, 
elicit generalized effects that disrupt lower levels of brain 
function. The work of Koek and Slangen (1984) does not suggest 
that either memory or perception are vulnerable to certain 
psychoactive drugs, but rather the capacity to respond is affected. 
Disruption occurred only at the higher doses used and was reflected 
in a reduced number of animals responding and a reduced degree of 
responding. It has not been reported that the presence of 
non-aversive exteroceptive discriminative stimuli disrupt drug- 
generated cues. Thus, from this argument, since melatonin has no 
behaviourally-disruptive actions, it would seem unlikely to be 
capable of affecting the temporal/visual stimulus unless it acted 
upon the higher centres of the brain responsible for perception and 
information retrieval. Such activity has not been reliably 
attributed to melatonin.
The final aspect of this work that should be discussed is 
the reduction in the number of correct responses, according to time 
and visual cues, at the EOL phase (see Fig. 6.7). This might reflect 
a property of anticipatory behaviour. It might also indicate that 
the onset of the dark period exerts greater influence to overt 
behaviour than the onset of the light period with respect to 
nocturnally-active animals since no such disruption of behaviour 
occurred at the end of the dark phase. Regulated access to food acts 
as a potent zeitgeber for activity which is resistent to SCN 
lesioning (Stephan, 1984, 1989). Anticipatory activity is often
measured in experiments analysing the effects of feeding and
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periodic feeding tiroes on circadian rhythms (e.g. Stephan and 
Becker, 1989). The nature of the experiments described above meant 
that access to food was randomized over the light-dark period, and 
would therefore not act as a zeitgeber. Additionally, animals were 
maintained on a 12:12 LD cycle. Ideally, simultaneous recording of 
locomotor activity throughout the course of this experiment would 
have provided information about the nature of the circadian rhythm 
of locomotor activity of animals maintained under these 
circumstances. During the course of the light-dark training 
programme animals were subjected to several training episodes that 
took place within 2 h from lights-out, this approximates to one 
every two weeks. Any erroneous responding during training would, 
therefore, be incorporated in the results of 5 successive sessions 
and not show up. Examination of the raw data does not reveal any 
discrepancy in the accuracy of training sessions conducted within 2 
h of lights-out in comparison to those conducted at any other 
time-point. Another consideration is that experimental sessions took 
slightly less time to complete than training sessions since animals 
occupied the operant conditioning chamber for 5 rather than 15 rain 
during experiments. This allowed end-of-light phase experiments to 
be conducted slightly later than a comparative training episode and 
hence the last animals subjected to experimentation would be closer 
to the time of lights-out than those that preceded them. The 
expected implication, however, namely that the last animals would be 
more likely to respond erroneously than the others is once again not 
supported by the raw data. The experiments were repeated at the four 
time points and the initial results verified.
In conclusion, these time-of-day results suggest that the 
influence of the pacemaker responsible for anticipatory behaviour
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can overcome the' discrimination of visual and temporal cues 
generated by successive training sessions and is not vulnerable to 
modification by melatonin. It would be of interest to conduct an 






The results presented in this thesis have already been 
extensively discussed in each of the relevant chapters. It is the 
purpose of this final chapter to focus attention upon general
aspects of the methods used and to suggest areas where further
investigation might be particularly beneficial.
7.1. 5-Hydroxytryptamine
The serotonergic system has been shown to be intimately 
involved in the expression of a range of unconditioned behaviours. A
selection of these, namely locomotor activity, feeding, headtwitches 
and temperature (though this is not, strictly speaking, a 
"behaviour"), were used to investigate a possible interaction
between the serotonergic system and melatonin as described in
chapter 3. Much of this work is based on the argument that the
modifications effected by the serotonergic system on these
behaviours are mediated by the activation of specific 5-HT receptor 
subtypes. Evidence to support (and refute) this contention is 
presented in chapter 3. To be considered here is the fact that these 
behaviours result from an abnormally active serotonergic system. 
Thus any melatonin-5-HT interaction would be apparent on a 
pharmacological basis only and not necessarily have any 
physiological relevance. The use of non-selective serotonergic
antagonists (methysergide and cyproheptadine) by Gaffori and Van Ree 
(1985) in their investigation of "melatonin-induced behaviour" 
warrant a repeat study using the more selective agents that have 
since become widely available before any definitive conclusions
(that would account for the origin of the behaviour) can be made.
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It would be of interest to use other models of 5-HT2 
receptor activation to test for interactions between the 
serotonergic system and melatonin. As mentioned in chapter 3, 
section 3.4, Dugovic (1988, 1989b) has demonstrated the involvement 
of the 5-HT2 receptor in melatonin-induced changes in slow-wave 
sleep. The drug discrimination technique using a 5-HT2-receptor 
mediated discriminative stimulus, e.g. that elicited upon the 
administration of the hallucinogen DOI, is an obvious model to use 
since it would also complement the work using L-5HTP as the 
generator of a 5-HTi-receptor mediated cue.
Observer bias is a necessary factor that must be taken 
into account with regard to the conclusions reached for the 
experiments described in this thesis. It was not possible to conduct 
any study "blind”, mainly because drug solutions were prepared 
immediately before use and certain injections and experiments had to 
be given during unsocial hours. This in itself introduces the 
problem of 24 h variability in observer performance. Moreover, the 
poor solubility of melatonin permits easy identification of control 
and drug preparations. The headtwitch experiments are most 
vulnerable to empirical interpretation but the results concerning 
their circadian rhythm is in agreement with earlier studies in that 
the maximum number of headtwitches occur during the light phase.
7.2. Drug Discrimination
The subject of bias in drug discrimination has received 
little formal attention since it was tackled by Rosenthal and Fode 
(1963). Their extensive study found that the expectations of the 
experimenter could affect the performance of an animal in learning a 
T-maze discrimination task. Precisely how this might be achieved is
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not known but the authors suggested that information could be 
conveyed to the animal by, for instance, differences in handling 
procedures or changes in skin temperature. This seems unlikely in 
light of the results in chapter 4 which demonstrate that melatonin 
is not capable of eliciting a discriminative cue perceptible to the 
animal using the T-maze and Skinner box drug discrimination 
paradigms, unless, of course, melatonin generated a weak stimulus 
that could be overcome by signals from the experimenter. It was 
plausible that discrimination between saline and high dose 
melatonin/tragacanth could have occurred on the basis of an animal 
being capable of perceiving the change in viscosity of the injected 
material from mild suspension (tragacanth/saline) to heavy 
suspension (melatonin 50mg/kg in tragacanth/saline), but this did 
not occur.
The method adopted for training animals to learn a 
discriminative task using the T-maze paradigm inherently minimizes 
the potential for an animal to discriminate between training and 
experimental sessions in comparison to the Skinner box paradigm. In 
training, animals are put into the T-maze one after the other, being 
returned to the home cage after each trial and then used again for 
the second series of trials until each animal has received the 
desired number of trials per training session. The experimental 
procedure follows the same pattern but each animal receives only one 
trial. Thus animals cannot perceive a difference between a training 
and a test session until the first trial has finished. The Skinner 
box discrimination paradigm requires animals to be put into the 
operant conditioning chamber for, what is in essence, a single 
training trial that usually lasts for 10-15 min They are therefore 
absent from the home cage for a significant period of time in
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comparison to an experimental session which can last for between 3-5 
min. Experimental sessions are invariably shorter than training 
sessions to reduce the risk of an animal learning an inappropriate 
response to a task during an experiment - this is analogous to the 
single trial given to animals during experiments conducted with the 
T-maze paradigm. It is possible that animals in the home cage can 
learn to discriminate between experimental and training sessions 
according to the duration of absence of one of its conspecifics. 
Hence the use of an additional "neutral" cage to house animals for 
the remaining 10 min after a 5 min test session during experiments 
involving the Skinner box.
Non-uniformity of methodology and discrimination indices 
between research groups is a problem in drug discrimination
experiments (see Colpaert et al.v 1976; Colpaert, 1977; Stolerman 
and D'Mello, 1981). Aside from the differences between equipment and 
reinforcement/punishment parameters, the schedules to which a group 
of animals are trained can vary enormously. The experiments 
conducted for this thesis used a simple FR procedure, but some 
workers prefer more elaborate schedules which combine two or more 
conditioning strategies, for example a variable interval (VI) with a 
FR schedule. This variability in technique is caused by differences 
of opinion as to which method is best for reducing the probability 
of animals being able to differentiate between training and 
experimental sessions, especially if the experimental session adopts 
an extinction procedure. The extinction procedure involves recording 
the number of responses on either lever but not providing a reward 
once the criterion of the schedule has been attained. If the session 
were allowed to proceed to its natural conclusion less responses 
would be made until responding ceased altogether. Similarly, at the
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other extreme overlong experimental sessions which provide 
reinforcement once a chioce has been made also carry the risk of 
disturbing the integrity of the learnt behaviour. Both extremes must 
be avoided and so experimental sessions of usually between 3 and 5 
min are used. Once the test session has finished one of two 
measurements of "discriminability" can be used - the quantal index 
or the quantitative index (see Colpaert, 1977; Stolerman and 
D'Mello, 1981). The former, used for the work described in this 
thesis, is usually based on the percentage of rats that respond on 
the drug-appropriate lever at the start of the test session. The 
quantitative index has most often been calculated as the mean 
percentage of the total number of responses made upon the 
drug-appropriate lever during brief test sessions in which no 
reinforcers are given. Contrary to the earlier work of Colpaert 
(e.g. Colpaert, 1977) which expresses a preference for the quantal 
index, Stolerman and D'Mello (1981) have shown that there is a very 
high correlation between these two parameters and that either can be 
used as a measure of the discriminative strength of a compound. Due 
to this range of techniques employed in drug discrimination studies, 
and most especially if the Skinner box paradigm is used, the most 
simple procedure was adopted for the purpose of the work carried out 
for this thesis. There remains, however, a range of schedules that 
can be used to investigate the general effect of melatonin on 
operant conditioning behaviour. Of particular interest is the 
differential reinforcement of low rate responding schedule (DRL). 
This schedule depends on the ability of an animal to learn an 
association between time and a pre-determined criterion of responses 
required for reinforcement. Thus a schedule of DRL-72' indicates 
that there must be at least 72 seconds between two responses for a
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reinforcement to be given, i.e. if an animal presses a lever once at 
time=0 it is rewarded 72 seconds later provided a second lever-press
is not made. Any response within that time resets the clock, and
within the time limits of the whole trial, reduces the number of 
reinforcements that a subject can achieve. This schedule has been 
used in rats by O'Donnell and Seiden, (1982, 1983) who demonstrated
that certain antidepressant drugs (tricyclic antidepressants, 
atypical antidepressants and MAOIs) increased the number of
reinforcements obtained and decreased the total number of responses 
(i.e. lever-presses). Antipsychotics decreased both the number of 
reinforcements and the number of responses, suggesting that this
heightened temporal awareness was selective for antidepressant 
treatment. The same group later reported that electroconvulsive 
therapy had a similar "antidepressant" effect (Seiden et al., 1985). 
More recent work has also implicated opposing roles for 5-HTia and 
5-HT2 receptors, in that the 5-HTia agonist 8-OHDPAT (but not the 
mixed 5-HTib and 5-HTic agonists, mCPP and TFMPP) and the 5-HT2 
antagonists, ketanserin and ritanserin, elicit a similar "anti- 
depressant-like" effect (Marek et al., 1989a, 1989b). The main
question mark over this work is how applicable it is to the clinical 
situation since it involves analysing acute effects of drugs given 
repeatedly to the same group of animals, while perhaps the most
classical feature of antidepressant therapy is that it can take
between 2-4 weeks for a clinical response to become apparent after 
treatment has begun (Oswald et al., 1972). The relationship between 
melatonin and depression has already been briefly discussed in 
chapter 3, section 3.4. The possible role of melatonin and seasonal 
depression (Seasonal Affective Disorder, or SAD) has received much
attention since its description by Lewy et al (1982) who also
253
reported its successful treatment with bright, white light. 
Subsequent research has forced a rethink on the role of melatonin in 
this condition, if it is involved at all (see Thompson, 1988 and
references cited therein) although Thompson has speculated upon the
involvement of the serotonergic system. Despite this, it would be 
interesting to investigate the acute and chronic effects of 
melatonin on rats trained to a DRL conditioning strategy and housed 
under various lighting schedules, i.e. long photoperiod, short 
photoperiod and DD and LL. It would also provide a further 
opportunity to investigate possible interactions between melatonin 
and the serotonergic system.
The work described in chapter 6 takes to a logical 
conclusion the concept that melatonin might at as a chemical "dark" 
signal (see Arendt, 1988). It also examined the effects of melatonin 
on temporal discrimination in the rat, though not to the precise 
accuracy required by a DRL schedule of operant conditioning.
Melatonin was not found to mimick the cue elicited by the
exteroceptive stimulus of darkness in rats. However, if the presence 
of melatonin generated a weak stimulus this might not have been 
potent enough for detection. An alternative training technique that 
is worth investigating would be to pair the supposed melatonin 
signal with the exteroceptive stimulus in a manner similar to the 
"overshadowing" procedure adopted by Jarbe and Johansson (1984). 
Thus melatonin would be administered in conjunction with a dark 
training session, while saline would be given as a pretreatment with 
a light training session. Once trained any contribution to the dark 
stimulus made by melatonin can be tested by substituting a melatonin 
injection for saline. This also yields further opportunities to 
study exteroceptive and interoceptive cues in conflict. Caution must
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be exercised with this technique, though, since any psychoactive 
drug capable of generating an interoceptive discriminative stimulus, 
e.g. pentobarbital, if paired with an exteroceptive stimulus, would 
form a drug-exteroceptive compound stimulus - a position that might 
well be expected if melatonin was used as one of the training 
stimuli (Jarbe and Johansson, 1984; Stolerman et al., 1987). The 
difference in this instance, however, is that melatonin, unlike the 
psychoactive drug, on its own, does not elicit a discriminative cue.
7.3. Melatonin
The work described in this thesis relies entirely on 
behavioural parameters and makes the assumption that they originate 
from a central source. The work therefore also assumes that 
melatonin can readily penetrate the brain. The use of an 
intraperitoneal route of administration for melatonin was chosen on 
the basis that this was a site where systemic absorption would be 
rapid via the mesenteric circulation, although there is a 
significant risk that much of the dose would be lost via hepatic 
first pass metabolism (Pardridge and Mietus, 1981). However, Sugden
(1980) had reported that peak plasma levels of 45ug/ml were attained 
following an ip dose of 50mg/kg 10 min after injection. Normal 
plasma melatonin levels vary in the rat between 6pg/ml (daytime 
nadir) and 75pg/ml (night-time zenith) (cited from Binkley, 1988). 
Gibbs and Vriend (1981) have reported that the half-life of 
melatonin in the rat plasma is approximately 20 min, although in 
mice it is thought to display a biphasic pharmacokinetic pattern 
with a half life of approximately 2 min, and a secondary half-life 
of 35 min (Kopin et al., 1961). Thus, although most of the 
experiments described in the preceding chapters have reported
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negative results, it is unlikely to be due to insufficient melatonin 
reaching the brain reaching the brain. Moreover, 1mg/kg (i.p.) of 
melatonin was shown to entrain free-running locomotor activity, in 
agreement with Redman et al. (1983).
Perhaps the best known property of melatonin, that of its 
effects on mammalian reproductive organs, is not thought to be the 
result of a direct action (despite putative cytoplasmic binding 
sites for (3H)-melatonin having been identified in hamster ovaries 
and rat uterus by Cohen et al. in 1978). Instead, melatonin is 
thought to regulate the release of the active principles that in 
turn regulate reproductive state. The picture is complicated 
further because melatonin is dependent upon the variability in 
sensitivity of the target organ (e.g. the SCN) in order to behave in 
this manner (Reiter, 1987; Armstrong, 1989). An extension of this 
reasoning would be that melatonin has no direct action on any 
particular neurotransmitter system, but its indirect influence might 
extend throughout the body according to the sensitivity of the SCN. 
In this sense, the pineal gland and its principal product, 
melatonin, rather than acting as a co-ordinator of rhythmic activity 
in mammals, would appear to act as a tool of the co-ordinator - the 
SCN, possibly as its "fine-tunerM. This would allow it to be very 
much more flexible in its actions. It would also make an interaction 
with a particular system more difficult to identify because, 
together with evidence to suggest that it is a highly potent 
molecule (e.g. Cassone et al., 1986a; Reiter, 1983b), a small amount 
could be sufficient to alter the function or characteristics of a 
neurotransmitter system. A behavioural approach to detect this 
change which, considering the diurnal variation in melatonin 
secretion, would not deviate from normality, may simply not be
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sensitive enough. The electrophysiological procedure adopted by 
Mason and Garrett (1990) may hold more promise although their 
results suggest that the electrophysiological effects of melatonin 
on select SCN neurones are not mediated by 5-HT. An alternative 
behavioural approach to this problem, and indeed, the relationship 
between melatonin and depression as mentioned above, would be to 
observe patterns and characteristics of social behaviour in an 
ethological context. It has recently been shown that acute and 
chronic treatment with certain antidepressants elicit opposing 
effects on endogenous patterns of social behaviour in rats. Using 
doses which had little or no effect on the total number of 
behavioural elements observed during a social interaction test 
between a resident rat and an unfamiliar intruder, Mitchell (1989, 
1990a, 1990b) found that acute antidepressant treatment decreased 
aggressive and increased flight behaviour exhibited by the resident 
animal. Acute treatment with the antipsychotic, haloperidol, or the 
anxiolytic, diazepam, had similar effects but only at doses which 
concomitantly reduced the total number of behavioural elements 
observed. Additionally, haloperidol decreased flight-submit 
behaviour and diazepam reduced environmentally-directed exploratory 
behaviour. Conversely, chronic antidepressant treatment, but not 
haloperidol or diazepam, increased the overt aggressive behaviour of 
resident rats towards the intruder. Increased aggression leading to 
an increase in rank position within a social hierarchy was also 
observed in subdominant rats treated chronically with either 
mianserin or clomipramine. This technique has the disadvantage of 
being time-consuming, in addition to its dependence on the expertise 
of the observer to identify and accurately record behavioural 
elements - making it a rather subjective method. But, together with
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the more quantitative operant conditioning procedure discussed 
above, it may provide a more sensitive means of analysing 
behavioural manifestations of acute and chronic melatonin treatment 
in rodents. The ethological technique has an added advantage of 
being more amenable to investigating the behavioural effects of 
melatonin on "jet-lagged" rats in a social context.
7.4. Conclusions
The work presented in this thesis allows several deductions 
to be made although there are a number of areas that require further 
investigation before definitive conclusions can be drawn. No 
evidence has been found to substantiate the initial hypothesis that 
the serotonergic system mediates the effects of melatonin, indeed, 
melatonin was found to have no direct behavioural effects in the 
animal models used, excepting its ability to entrain free-running 
circadian locomotor activity rhythms. Melatonin does not affect the 
rate or direction of a 180° phase-shift involving 24 h of dark. 
The question as to whether melatonin influences the phase-shifting 
ability of appropriately-timed light-pulses on free-running 
circadian rhythms remains unanswered but worthy of investigation.
The ability of melatonin to act as a discriminative 
stimulus was explored in chapters 4 and 6. At the doses employed 
melatonin did not elicit a discriminative stimulus and has no 
influence on the discriminative cue generated by L-5HTP. Moreover, 
melatonin was found to be without effect on both the visual and 
temporal components of a combined light:dark/time-of-day 
discriminative cue. Interestingly, the results suggest that in this 
circumstance of using operant conditioning, anticipatory behaviour 
can overcome visual and temporal discriminative cues.
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Finally, the most intriguing deduction that can be made 
from this work stems from the fact that melatonin can entrain 
free-running rhythms but does not elicit a discriminative stimulus. 
Thus melatonin does not appear to alter the cognitive state of the 
rat in a manner that is perceptible to the animal. This suggests 
that entrainment is not dependent on the periodic generation of an 
internal signal that the animal is "consciously” aware of. It would 
be of interest to compare the capacity of a range of psychoactive 
compounds to generate a discriminative stimulus, with their ability 
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The Skinner boxes used in chapters 4 and 6 enabled a 
certain degree of automation in the running of drug discrimination 
experiments and in the collection and analysis of the data 
generated. However, they first had to be interfaced with a BBC 
Master computer and the appropriate software written. This was 
achieved using the SPIDER INTERFACE manufactured by Paul Fray Ltd. 
which expands the computer language, BBC Basic, with additional 
keywords recognizable only by SPIDER. The following pages lists the 
programs written by the author of this thesis. The first program was 
used for training animals to press the appropriate lever and the 
second for controlling the Skinner boxes during experiments and 
recording the appropriate responses. The final program listed was 
used for analysing the data and obtaining a printout of a particular 
training or experimental session (an example of an experimental 
session printout and its corresponding cumulative response graph is 
also shown).
LISTING OF SKINNER BOX TRAINING PROGRAM
10REM ********pLOT-BOX PROGRAM*********


























280PRINT TAB(4,4)"This is the advanced rat-training program, designed to " 
290PRINT TAB(4,6)"increase the number of times a rat presses a lever for a " 
300PRINT TAB(4,8)"food 'reward'."
310PRINT TAB(4,10)"The desired FR value MUST be attained gradually. Increases" 
320PRINT TAB(4,12)"in the FR value should be made in steps of 2 or 3 each "
330PRINT TAB(4,14)"week until FR10 is achieved if a two session per day "
340PRINT TAB(4,16)"routine is used. From then on it is possible to use steps"
350PRINT TAB(4,18)"of 5. Each session is 15 mins long."
360PRINT TAB(40,20)"By D.M. Pache, 1988"
370REPEAT: PRINT TAB(10,30)"PRESS 'C' TO CONTINUE :S$=GET$:UNTIL S$="C" 
380M0DE128
390PRINT TAB(4,0)"Take care to input the information correctly"
400REM *****Prog-PROPER*****
410:
420INPUT TAB(4,2)"ENTER TODAY'S DATE "E$
430PRINT TAB(4,4)"ENTER the conditions under which the rat is being subjected, 
435INPUT TAB(4,6)"eg LIGHT/DARK OR TRAINING ";H$
440INPUT TAB(4,8)"ENTER time of start (1st injection time) ";TM$
445INPUT TAB(4,10)"ENTER time of food withdrawal ";FW$
450INPUT TAB(4,12)"ENTER details of any drug/dose used"G$
460INPUT TAB(4,14)"ENTER the length of the session (usually 15 mins)"h%
470INPUT TAB(4,16)"ENTER the filename you wish to save the data under"F$
480INPUT TAB(4,18)"ASSIGN FR VALUE____"n%
490INPUT TAB(4,20)"HOW LONG CAN THE ANIMALS FEED FOR "o%
500INPUT TAB(4,22)"First Rat No "p%
510INPUT TAB(4,24)"Second Rat No "q%
515INPUT TAB(4,26)"ENTER CHOSEN RAT (A or B)";RAT$
520:
530REM ****ASSIGN SWITCH CONSTANTS FOR 'CORRECT' AND 'WRONG' LEVERS****
540:
550REPEAT:PRINT "ASSIGN REWARD LEVER FOR BOX 1---":A$=GET$:UNTIL A$="L" OR A$
560IF A$="L" THEN A$="LEFT":c1%=1: C$="RIGHT": w1%=0 
562PRINT TAB(35,27)A$:ELSE c1%=0:A$="RIGHT":C$="LEFT":w1%=1 
564PRINT TAB(35,27)A$
570REPEAT:PRINT "ASSIGN REWARD LEVER FOR BOX 2___ "
572B$=GET$:UNTIL B$="L" OR B$="R"
574IF B$="L" THEN B$="LEFT": c2%=4: D$="RIGHT": w2%=7
300
576PRINT TAB(35,28)B$:ELSE c2%=7:B$="RIGHT":D$="LEFT":w2X=4 
578PRINT TAB(35,28)B$
580IF B$="L" THEN B$="LEFT": c2%=4: D$="RIGHT": w2%=7 
582PRINT TAB(35,28)B$:ELSE c2X=7:B$="RIGHT":D$="LEFT":w2%=4 
583PRINT TAB(35,28)B$
585REPEAT: PRINT TAB(10,30)"CHECK INFO. PRESS 'C' TO CONTINUE 
587S$=GET$: UNTIL S$="C"
590:













730REM ****INITIALIZE THE SYSTEM****
740KILL ALL
750G0VN SWITCH r% TO sX 













870PRINT TAB(30,5)"BOX No. A"
880PRINT TAB(10,7)"Rat No. ";p%
890PRINT TAB(30,7)"FR Value ";n%
900PRINT TAB(50,6)"Reward lever "A$
910PRINT TAB(50,7)"Wrong lever "C$
920PRINT TAB(30,19)"BOX No. B"
930PRINT TAB(10,21)"Rat No. ";q%
940PRINT TAB(30,21)"FR Value ”;n%
950PRINT TAB(50,20)"Reward lever "B$
960PRINT TAB(50,21)"Wrong lever "D$
970REPEAT:PRINT TAB(0,0)"Press 'C' to continue, then IMMEDIATELY 




1000REM ****HERE COMES THE WORKING PART OF THE PROGRAM****
1010:
1020!(SWITCH c1%, ON) PROCreward_1 
1030J(fc1%) PROCkey(clX)
1040!(SWITCH c2%, ON) PROCreward_2 
1050!(fc2%) PROCkey(c2%)
1060J(SWITCH w1%, ON) PROCwrong_1 
1070! (fw1%) PROCkey(wU)


































1420PRINT TAB(2,10) "REWARD-LEVER (";A$") COUNT.......";E%
1430t_one(i%)=TIME/100
1435PRINT TAB(2,11)"TIME AT LAST R LEVER PRESS = ";t_one(i%):i%=i%+1
1440IF E%=n% AND C% THEN PR0CcaI_FR_1
1450PR0Ctotalcounts_1
1460IF b%=n% THEN KILL SWITCH c1%:KILL SWITCH w U







1540PRINT TAB(2,23) "REWARD-LEVER (";B$") COUNT.......";F%
1550t_two(j%)=TIME/100
1555PRINT TAB(2,24)"TIME AT LAST R LEVER PRESS = ";t_two(j%):j%=j%+1 
1560IF F%=n% AND D% THEN PR0Ccal_FR_2 
1570PR0Ctotalcounts_2
1580IF c%=n% THEN KILL SWITCH c2%:KILL SWITCH w2%





































1950PRINT TAB(43,11) "WRONG lever (";C$") count at FRF = ";I%
1960PRINT TAB(2,12) "FRF value for REWARD lever..... ";M%
1970PRINT TAB(43,12) "FRF value for WRONG lever........";N%





2030PRINT TAB(43,24) "WRONG lever (";D$") count at FRF = ";J%
2040PRINT TAB(2,25) "FRF value for REWARD lever..... ";0%
2050PRINT TAB(43,25) "FRF value for WRONG lever........";P%




















2260PRINT TAB(55,29) "TOTAL COUNTS = ";F%+J%
2270ENDPR0C
2280:
2290REM ****HERE ARE THE PROCEDURES THAT WORK THE DIPPERS****
2300:















3085 IF RS$="Y" THEN PROCdisc ELSE 3100
31OOREPEAT:PRINT TAB(0,2)"DO YOU WISH TO PLOT THE DATA "
3105UNTIL GS$="Y" OR GS$="N":PRINT TAB(35,2)GS$














3 2 50PRINT£X,t_one(s ave_1%):save_1%= s ave_1%+1 




















3460F0R x_plotX=0 TO 5:MOVE 900*x_plotX/5+220,170:PLOT 1,0,-20:PLOT 0,0,20:NEXT
3470M0VE 220,130









3570F0R q%=0 TO 5 





























3860UNTIL t_one(t_1%)=0 OR t_one(1750)








3950UNTIL t_two(t_2%)=0 OR t_two(1750)





LISTING OF SKINNER BOX EXPERIMENTAL PROGRAM
10REM ********PLOT-BOX PROGRAM EXPERIMENT**********





















































540PRINT TAB(4,4)"This is the rat EXPERIMENT program, designed to " 
550PRINT TAB(4,6)"reward an animal if it presses either lever a " 
560PRINT TAB(4,8)"designated number of times. This becomes the CHOSEN 
570PRINT TAB(4,10)"lever, while the other assumes the REJECT identity. 
580PRINT TAB(4,12)”Each session is 5 mins long."
590PRINT TAB(40,20)"By D.M. Pache, 1988"
600REPEAT: PRINT TAB(10,30)"PRESS 'C' TO CONTINUE ";:S$=GET$:UNTIL S$= 
610MODE128




650INPUT TAB(4,6)"ENTER TODAY'S DATE "D$
660PRINT TAB(4,7)"ENTER the conditions under which the rat is being subjected,"
6701NPUT TAB(4,8)"eg LIGHT/DARK/MD/ML/EOD/EOL";C$
680INPUT TAB(4,9)"TIME OF EXPT (IN 24hr notation, eg 18-30)";TM$
685INPUT TAB(4,10)"ENTER time of food withdrawal";FW$
690INPUT TAB(4,11)"ENTER details of any drug/dose used";DD$
700INPUT TAB(4,12)"ENTER details of PRE-TREATMENT TIME";T$
710INPUT TAB(4,13)"ENTER the length of the session (usually 15 mins)";DT%
720INPUT TAB(4,14)"ENTER the filname you wish to save the data under";filename!
730INPUT TAB(4,16)"ASSIGN FR VALUE--- "FRa%
740INPUT TAB(4,18)"HOW LONG CAN THE ANIMALS FEED FOR_"feed_time%
7501NPUT TAB(4,20)"First Rat No.... "RAT_1%
760REPEAT:PRINT TAB(4,22)"Enter LIGHT lever for first rat...":L1$=GET$
765UNTIL L1$="L" OR L1$="R"
770IF L1$="L" THEN L1$="LEFT":D1$="RIGHT"
775PRINT TAB(40,22)L1$ ELSE L1$="RIGHT":D1$="LEFT":PRINT TAB(40,22)L1$
780INPUT TAB(4,24)"Second Rat No "RAT_2%
790REPEAT:PRINT TAB(4,26)"Enter LIGHT lever for SECOND rat...":L2!=GET!
795UNTIL L2$="L" OR L2$="R"
800IF L2$="L" THEN L2$="LEFT":D2$="RIGHT"
805PRINT TAB(40,26)L2$: ELSE L2$="RIGHT":D2$="LEFT":PRINT TAB(40,26)L2$
810REPEAT: PRINT TAB(10,30)"CHECK INFO. PRESS 'C' TO CONTINUE ";:S$=GET$
815UNTIL S$="C"
820:













960REM ****INITIALIZE THE SYSTEM****
970KILL ALL
980G0VN SWITCH motor_1X TO motor_2%











1100PRINT TAB(60,3)"FR Value = ";FRa%
1110PRINT TAB(60,4)"Pre-T Time = ";T!
1120PRINT TAB(30,5)"B0X No. 1"
1130PRINT TAB( 10,7)"Rat No. ";RAT_U
1140PRINT TAB(60,7)"LIGHT lever = ";L1!
1150PRINT TAB(30,7)"CHOSEN lever = ";chosen_1!
1160PRINT TAB(30,8)"REJECT lever = ";rej_lev1!
1170PRINT TAB(30,19)"BOX No. 2"
1180PRINT TAB(10,21)"Rat No. ";RAT_2%
1190PRINT TAB(60,21)"LIGHT lever = "L2!
1200PRINT TAB(30,21)"CHOSEN lever = ";chosen_2!
1210PRINT TAB(30,22)"REJECT lever = ";rej_lev2!
1220REPEAT





1250REM ****HERE COMES THE WORKING PART OF THE PROGRAM****
1260:
1270!(SWITCH left_1%, ON) PR0C1_1 
1280!(fieft_1%) PROCkey(left_1%)
1290J(SWITCH left_2%, ON) PR0C1_2 
1300!(fieft_2%) PROCkey(left_2%)
1310!(SWITCH right_1X, ON) PROCr_1 
1320!(fright_1%) PROCkey(right_1%)

































1660PRINT TAB(1,10) "LEFT-LEVER COUNT.......";c_left_1%
1670IF chosen_1$=”LEFT" THEN t_one(dim_aX)=TIME/100
1675PRINT TAB(1,11)”TIME AT LAST R LEVER PRESS = ";t_one(dim_aX):dim_aX=dim_aX+1 
1680IF c_left_1%=FRa% AND c_right_1X<FRaX AND nd_l1% THEN PROCass_L1 
1690PR0Ctotalcounts_1
1700IF lc1%=FRa% AND 11X=1 THEN KILL SWITCH left_1%:KILL SWITCH right_1%








1790PRINT TAB(30,7)"CHOSEN LEVER = ";chosen_1$
1800PRINT TAB(30,8)"REJECT LEVER = ";rej_lev1$
1810IF chosen_1$=L1$ THEN PRINT TAB(60,8)”LIGHT lever chosen"








1880PRINT TAB(1,24) "LEFT LEVER COUNT.......";c_left_2%
1890IF chosen_2$="LEFT" THEN t_two(dira_b%)=TIME/100
1895PRINT TAB(1,25)"TIME AT LAST R LEVER PRESS = ";t_two(dim_b%):dim_b%=dira_b%+1 
1900IF c_left_2%=FRa% AND c_right_2%<FRa% AND nd_12% THEN PROCass_L2 
1910PR0Ctotalcounts_2
1920IF lc2%=FRa% AND 12%=1 THEN KILL SWITCH left_2%:KILL SWITCH right_2%








2010PRINT TAB(30,21)"CHOSEN LEVER = ";chosen_2$
2020IF chosen_2$=L2$ THEN PRINT TAB(60,22)"LIGHT lever chosen"
2025ELSE PRINT TAB(60,22)"DARK lever chosen"







2100PRINT TAB(40,10) "RIGHT-LEVER COUNT.........";c_right_1%
211 OIF chosen_1$="RIGHT" THEN t_one(diiu_a%)=TIME/100
2115PRINT TAB(1,11)"TIME AT LAST R LEVER PRESS = ";t_one(dim_a%):dim_a%=dim_a%+1 
2120IF c_right_1X=FRa% AND c_left_1%<FRa% AND nd_r1% THEN PROCass_R1 
2130PR0Ctotalcounts_1
2140IF rc1%=FRa% AND r1X=1 THEN KILL SWITCH left_1%:KILL SWITCH right_1%








2230PRINT TAB(30,7)"CHOSEN LEVER = ";chosen_1$
2240IF chosen_1$=L1$ THEN PRINT TAB(60,8)"LIGHT lever chosen"
2245ELSE PRINT TAB(60,8)"DARK lever chosen"







2320PRINT TAB(40,24) "RIGHT-LEVER COUNT.........";c_right_2%
2330IF chosen_2$="RIGHT" THEN t_two(dim_bX)=TIME/100
2335PRINT TAB(1,25)"TIME AT LAST R LEVER PRESS = t_two(dim_b%):dim_b%=dim_b%+1 
2340IF c_right_2%=FRa% AND c_left_2%<FRa% AND nd_r2% THEN PROCass_R2 
2350PR0Ctotalcounts_2
2360IF rc2%=FRa% AND r2%=1 THEN KILL SWITCH left_2%:KILL SWITCH right_2%









2450PRINT TAB(30,21)"CHOSEN LEVER = ";chosen_2$
2460IF chosen_2$=L2$ THEN PRINT TAB(60,22)"LIGHT lever chosen"
2465ELSE PRINT TAB(60,22)"DARK lever chosen"




























2750PRINT TAB(40,11) "REJECTED lever (";rej_lev1$") count at FRF = ";FRrej_1% 
2760PRINT TAB(1,12) "FRF value for CHOSEN l everFRFa_1%
2770PRINT TAB(40,12) "FRF value for REJECT l everFRFb.1%







2840PRINT TAB(40,25) "REJECTED lever (";rej_lev2$") count at FRF = ";FRrej_2% 
2850PRINT TAB(1,26) "FRF value for REWARD l e v e rFRFa_2%
2860PRINT TAB(40,26) "FRF value for REJECT l everFRFb_2%















3010PRINT TAB(55,30) "TOTAL COUNTS = ";c_left_2%+c_right_2%
3020ENDPROC
3030:
3040REM ****HERE ARE THE PROCEDURES THAT WORK THE DIPPERS****
3050:

























3300!(SWITCH left_1%, ON) PR0C1_1 

















3480,' (TIMER 1, feed_time%*100) PR0Cdip_down_2
3490ENDPR0C
3500:
3 510DEFPROCd ip_down_2 
3520SWITCH ON motor_2%





3580', (SWITCH left_2%, ON) PR0C1_2 




3630IF chosen_1$="LEFT" AND c_left_1%>FRa%-1 THEN c_cho_1%=c_lef t_1%: c_rej_1%=c_right_1% 
3640IF chosen_1$="RIGHT" AND c_right_1%>FRa%-1 THEN c_cho_1%=c_right_1%:c_rej_1%=c_left_1% 
3650IF c_left_1%<1 AND c_right_1%<1 THEN 3680
3660IF c_left_1%<1 AND c_right_1X>0 THEN FRF_t_cr_1%=c_right_1%/(c_left_1%+c_right_1%)*100 
3665FRF_t_cl_1%=100-FRF_t_cr_1%
3670IF c_left_1%>0 THEN FRF_t_cl_1%=c_lef t_1%/(c_lef t_U+c_right_1%)*100 
367 5FRF_t_cr_1%=100-FRF_t_cl_1%
3680PRINT TAB(1,15) "End FRF Value for LEFT lever = ";FRF_t_cl_1%





3740IF chosen_2$="LEFT" AND c_left_2X>FRaX-1 THEN c_cho_2X=c_left_2X:c_rej_2X=c_right_2X 
3750IF chosen_2$="RIGHT" AND c_right_2%>FRa%-1 THEN c_cho_2X=c_right_2X:c_rej_2X=c_left_2X 
3760IF c_left_2X<1 AND c_right_2X<1 THEN 3790
3770IF c_left_2X<1 AND c_right_2X>0 THEN FRF_t_cr_2X=c_right_2X/(c_left_2X+c_right_2X)*100 
3775FRF_t_cl_2X=100-FRF_t_cr_2X
3780IF c_left_2X>0 THEN FRF_t_cl_2X=c_left_2X/(c_left_2X+c_right_2X)*100 
3785FRF_t_cr_2X=100-FRF_t_cl_2X
3790PRINT TAB(1,29) "End FRF Value for LEFT lever = ";FRF_t_cl_2X






3860SWITCH OFF 8 TO 9
3870INPUT "DO YOU WISH TO SAVE THE DATA... (enter Y/N) "RESPONSES
3880IF RESPONSE$="Y" THEN PROCdisc
38901NPUT "DO YOU WISH TO PLOT THE DATA"GRAPH$







3970PRINT£X,D$,C$,DD$,f ilename$,DTX,TM$,FW$,T$,L1$, L2$ 
3980PRINT£X,RAT_1X,RAT_2X,FRaX,chosen_1$,chosen_2$ ,rej_lev1$, rej_lev2$































4280FOR x_plotX=0 TO 5:MOVE 900*x_plotX/5+220,170:PLOT 1,0,-20:PLOT 0,0,20:NEXT
4290M0VE 220,130





































4660DRAW 220+t_one(t_1X)*(900/(DT%*60)) ,t_1%*800/1200+170 
4670t_U=t_1X+1
4680UNTIL t_one(t_1%)=0 OR t_one(1200)






4750DRAW 220+t_two(t_2%)*(900/(DT%*60) ) , t_2%*800/1200+170 
4760t_2%=t_2X+1
4770UNTIL t_two(t_2%)=0 OR t_two(1200)






LISTING OF SKINNER BOX ANALYTICAL PROGRAM





50INPUT ’’Filename to be analysed..."F$
60MODE131
70:












270PRINT TAB(2,1)"Date  "E$
280PRINT TAB(40,1)"Filename "F$
290PRINT TAB(40,2)"Training Conditions  "H$
300PRINT TAB(2,2)"Drug  "G$
310PRINT TAB(30,3)"B0X No. 1"
320PRINT TAB(10,5)"Rat No. ";p%
330PRINT TAB(30,5)"FR Value ";n%
340PRINT TAB(50,5)"Reward lever "A$
350PRINT TAB(30,14)"BOX No. 2"
360PRINT TAB(10,16)"Rat No. ";q%
370PRINT TAB(30,16)’’FR Value ";n%
380PRINT TAB(50,16)"Reward lever "B$
390PRINT TAB(2,7) "REWARD LEVER COUNT = ";E%
400PRINT TAB(2,18) "REWARD LEVER COUNT = ";F%
410PRINT TAB(43,7) "WRONG LEVER COUNT = ";I%
420PRINT TAB(43,18) "WRONG LEVER COUNT = ";J%
430IF t_one(0)>0 THEN PRINT TAB(2,8) "TIME AT LAST REWARD LEVER PRESS= 
435PRINT TAB(2,8)t_one(E%-1) ELSE
437PRINT TAB(2,8)"TIME AT LAST REWARD LEVER PRESS= 0"
440PRINT TAB(43,8) "WRONG lever count at FRF ";K%
450PRINT TAB(2,9) "FRF value for REWARD lever.
460PRINT TAB(43,9) "FRF value for WRONG lever.
470PRINT TAB(2,10) "Time at FRF value.......
480PRINT TAB(43,10) "FRF value response time..
490IF t_two(0)>0 THEN PRINT TAB(2,19) "TIME AT LAST REWARD LEVER PRESS= " 
495PRINT TAB(2,19)t_two(FX-1) ELSE
497PRINT TAB(2,19) "TIME AT LAST REWARD LEVER PRESS= 0"
500PRINT TAB(43,19) "WRONG lever count at FRF ";L%
510PRINT TAB(2,20) "FRF value for REWARD lever.
520PRINT TAB(43,20) "FRF value for WRONG lever
530PRINT TAB(2,21) "Time at FRF value......
540PRINT TAB(43,21) "FRF value response time.
550PRINT TAB(55,12) "TOTAL COUNTS = ";E%+I%
560PRINT TAB(55,23) "TOTAL COUNTS = ";F%+J%
570PRINT TAB(2,11) "FRF value at end of expt for
580PRINT TAB(2,12) "FRF value at end of expt
590PRINT TAB(2,22) "FRF value at end of expt
600PRINT TAB(2,23) "FRF value at end of expt
610:
620REM ****PRINT0UT****
630INPUT "DO YOU REQUIRE A PRINTOUT "P$
640IF P$="Y" THEN PROCprintout ELSE 650 









REWARD lever = " ;S%
for WRONG lever = ";T%
for REWARD lever = ";U%
for WRONG lever = ";V%
315














790PRINT TAB(2)"Drug...";G$ TAB(40)"CHOSEN RAT = "RAT$
800PRINT TAB(2)"Conditions---";H$ TAB(40)"Start Time..."TM$






860REM ****PRINT-OUT FOR FIRST BOX****
870VDU2,1,27,1,ASC"E"
880VDU2,1,27,1,ASC"W",1,ASC"1"




930PRINT TAB(2)"Rat No. ";p% TAB(25)"FR value = ";n%
935PRINT TAB(48)"REINFORCEMENT lever = ";A$
940PRINT TAB(56)"WRONG lever = ";C$
950PRINT
960PRINT
970PRINT TAB(2) "REWARD-LEVER COUNT = ";E%, TAB(43) "WRONG-LEVER COUNT = ";I% 
980PRINT
990PRINT TAB(2) "REWARD lever count at FRF.... ";G%
995PRINT TAB(43) "WRONG lever count at FRF.... ";K%
1000PRINT
1010PRINT TAB(2) "FRF value for REWARD lever... ";M%
1015PRINT TAB(43) "FRF value for WRONG lever... ";N%
1020PRINT
1030PRINT TAB(2) "Time at FRF value....... ";d%
1035PRINT TAB(43)"Rate of lever press..."E%/h%
1040PRINT
1050PRINT TAB( 14) "FRF value at end of expt for REWARD lever = ";S%
1060PRINT
1070PRINT TAB( 14) "FRF value at end of expt for WRONG lever = ";T%
1080PRINT
1090PRINT
1100PRINT TAB(2) "TOTAL COUNTS = ";E%+I%












1230PRINT TAB(2)"Rat No. ";q% TAB(25)"FR value = ";n%
1235PRINT TAB(48)"REINFORCEMENT lever = ";B$
316
1240PRINT TAB(56)"WRONG lever = ";D$
1250PRINT
1260PRINT
1270PRINT TAB(2) "REWARD-LEVER COUNT = ";F% TAB(43) "WRONG-LEVER COUNT = ";JX 
1280PRINT
1290PRINT TAB(2) "REWARD lever count at FRF.... ";H%
1295PRINT TAB(43) "WRONG lever count at FRF.... ";L%
1300PRINT
1310PRINT TAB(2) "FRF value for REWARD lever... ";0%
1315PRINT TAB(43) "FRF value for WRONG lever... ";P%
1320PRINT
1330PRINT TAB(2) "Time at FRF value.......";e%
1335PRINT TAB(43)"Rate of lever press..."F%/h%
1340PRINT
1350PRINT TAB( 14) "FRF value at end of expt for REWARD lever = ";U%
1360PRINT
1370PRINT TAB(14) "FRF value at end of expt for WRONG lever = ";V%
1380PRINT 
1390PRINT
1400PRINT TAB(2) "TOTAL COUNTS = ";F%+J%
1410PRINT
1420PRINT
1430PRINT TAB(2) "COMMENTS "

















10130F0R x_plot%=0 TO 5:M0VE 900*x_plot%/5+220,170: PLOT 1,0,-20:PLOT 0,0,20:NEXT 
10140MOVE 220,130 







































10530UNTIL t_one(t_1%)=0 OR t_one(1750)








10620UNTIL t_two(t_2%)=0 OR t_two(1750)
10630PRINT; " RAT 1B"
10640MOVE 0,0 
10650END




Training Conditions....MD Time of expt —  2215
Length of session 5mins Food withdrawal__1400
BOX No.
Rat No. 1 FR value = 20 CHOSEN lever = RIGHT 
REJECT lever = LEFT
CHOSEN lever count = 460 
Last CHOSEN lever press = 281.9
FRF value for CHOSEN lever 95
Time at FRF value.......49.97
REJECT lever count = 1 
REJECT lever count at FRF.. 
FRF value for REJECT lever 
Rate of lever press...92
FRF value at end of expt for LEFT lever = 0 
FRF value at end of expt for RIGHT lever = 100
TOTAL COUNTS = 461
BOX No-
Rat No. 1 FR value = 20 CHOSEN lever = RIGHT 
REJECT lever = LEFT
CHOSEN lever count = 366
Last CHOSEN lever press = 299.97
FRF value for CHOSEN lever 100
Time at FRF value...... 36.86
REJECT lever count = 0 
REJECT lever count at FRF.. 
FRF value for REJECT lever. 
Rate of lever press 73.2
FRF value at end of expt for LEFT lever = 0 










6 66 128 188 246 388secs
8 1 2 3 4 5 wins
























































































Adapted from: TIPS (1990), 11(1) (Suppl); Dumius et al., (1988); Leonhardt et al., (1989).
Abbreviations: Pind = Pindolol; Prop = Propranolol; Post-S = Post-synaptic; Auto-R = Autoreceptor; cAMP( ) = stimulation of 
adenylate cyclse; cAMP( ) = inhibition of adenylate cyclase; G-prot = coupled to G-protein; IP3/DG = stimulation of phospho- 
metabolism.
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